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I. SUMMARY
Posttranslational modifications (PTMs) of proteins by covalent attachment of
functional groups (like phosphorylation, acetylation, methylation, glycosylation, etc.)
are of key importance for the cell as they regulate various aspects of protein behavior
after its synthesis, e.g., dictate protein interaction properties, change catalytic activity
of enzymes, induce conformational changes, guide subcellular localization and
determine protein stability. A special class of protein PTMs is the conjugation of small
proteins of the ubiquitin family to typically acceptor lysine residues of the substrates.
The reversible nature of this PTM and the presence of dedicated domains that
specifically recognize modified substrates make this type of protein modification
instrumental for the regulation of numerous biological pathways. For ubiquitylation,
strong substrate selectivity due to the presence of highly diversified conjugation
machinery is characteristic and well studied, especially in case of ubiquitin’s
proteolytic role. On the contrary, much less is known about the principles of substrate
specificity and mechanisms of PTM action in the ubiquitin-like protein SUMO
modification system.
Despite the fact that SUMOylation specifically targets hundreds of substrates and
major conjugation steps are identical with ubiquitin system, strikingly only a handful of
enzymes operate in the SUMO pathway, suggesting that other principles of substrate
selectivity must apply and perhaps distinct mechanisms of PTM action exist in the
SUMO pathway. Moreover, the recognition of SUMO modification is surprisingly
simple and relies mainly on a short hydrophobic sequence known as SUMO-
interacting motif (SIM), in striking contrast to the ubiquitin system, where numerous
ubiquitin-binding domains exist with different interaction specificities. All these,
together with the observations that SUMO conjugation machinery seems rather
promiscuous in vitro, that typically only a small fraction of a protein is being
SUMOylated at a given time, and that specific SUMOylation-defective mutants often
exhibit no obvious phenotypes, whereas SUMO pathway mutants do, emphasize the
question of substrate specificity in the SUMO system and suggest other principles of
SUMO action on its substrates.
Here, we address the question of SUMOylation specificity and function using
DNA double-strand break (DSB) repair pathway via homologous recombination (HR)
as a case study because of its strong ties to the SUMO system. First, using SILAC-
based proteomic approach we show that proteins acting in the same DNA repair
pathway become collectively SUMOylated upon a specific stimulus (HR factors –
upon DSB induction; nucleotide excision repair factors – upon exposure to UV light),
suggesting that SUMO machinery often targets protein groups within the same
pathway. Then, focusing on the DSB repair we find that DNA-bound SUMO ligase
Siz2 catalyzes collective multisite SUMOylation of a whole set of HR factors. Repair
proteins are loaded onto resected single-stranded DNA (ssDNA) in the vicinity of the
ligase, thus making exposure of ssDNA a precise trigger for modification. Protein
group SUMOylation fosters physical interactions between the HR proteins engaged in
DNA repair, because not only that they become collectively modified at multiple
SUMO-acceptor sites, but they also possess multiple SIMs, which promote
SUMO-SIM mediated complex formation. Only wholesale elimination of SUMOylation
of the core HR proteins significantly affects the HR pathway by slowing down DNA
repair, suggesting that SUMO acts synergistically on several proteins. Thus, we show
that SUMOylation collectively targets functionally engaged protein group rather than
individual proteins, whereas localization of modification enzymes and specific triggers
ensure substrate specificity.
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II. INTRODUCTION
II.1 Ubiquitin and Ubiquitin-like Protein Modifiers
Regulation of protein behavior by various posttranslational modifications (PTMs) is
vital for the cell. Numerous functional groups (e.g., phosphate, acetyl, alkyl, glycosyl)
can be conjugated to proteins, rapidly affecting their physical properties and thus
greatly expanding functional assortment and dynamics of the proteome. The covalent
attachment of small proteins of the ubiquitin family to substrates is a special PTM
class widely used in the cell to direct diverse physiological processes (Kerscher et al.,
2006). The first characterized and most well studied member of this protein modifier
family is a small globular 76-amino acid (aa)-long protein called ubiquitin, highly
conserved among the eukaryotes (Jentsch, 1992). The characteristic feature of
ubiquitin is its -grasp fold – globular three-dimensional core structure, which is being
shared by other known ubiquitin-like (Ubl) protein modifiers including Rub1/NEDD8,
Atg8, Atg12, Urm1, UFM1, ISG15, FAT10, FUB1/FAU, and Smt3/SUMO (Kerscher et
al., 2006; Welchman et al., 2005).
Ubiquitin and SUMO (small  ubiquitin-like modifier) both are known to reversibly
modify hundreds of substrates affecting numerous cellular processes. For
ubiquitylation, the principles of substrate selectivity and mechanistic consequences of
the modification are extensively studied and relatively well understood. Highly
diversified ubiquitin pathway components and existence of multiple ubiquitin-binding
domains (UBDs) that can recognize various ubiquitylation events ensure high
substrate specificity (Dikic et al., 2009; Husnjak and Dikic, 2012). For SUMOylation,
on the contrary, much less is known regarding how relatively simple organized
conjugation machinery recognizes its multiple targets (Gareau and Lima, 2010) and
what are the functional outcomes of SUMO modification, especially that in many
cases specific SUMOylation-defective mutants barely exhibit any abnormalities, while
SUMO pathway mutants do show strong phenotypes.
II.1.1 Comparison of the Ubiquitin and SUMO Modification Pathways
The ubiquitin and SUMO modification pathways might seem very similar at the first
sight  (Fig. 1), however several striking differences exist that will be emphasized
below.
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Both protein modifiers are being synthesized as inactive precursors, which need
to be further processed by dedicated proteases in order to expose carboxyl
(C)-terminal double-glycine motifs required for conjugation (Geiss-Friedlander and
Melchior, 2007; Johnson, 2004; Kerscher et al., 2006). Covalent conjugation of
modifiers to protein substrates involves an elaborate enzymatic cascade that via
isopeptide bond formation attaches the modifier typically to the -amino group of an
acceptor lysine (K) residue. This cascade is ATP-dependent and consists of several
kinetically distinct steps mediated by the sequential action of specialized enzymes
(Capili and Lima, 2007).
Figure 1. Comparison of the Ubiquitin and SUMO Modification Pathways
Ubiquitin (Ub, top, red) and SUMO (S, bottom, blue) conjugation machinery selectively
targets hundreds of substrates (middle, green), despite striking difference in the number of
ubiquitin E2 and E3 enzymes compared to the SUMO pathway. Processed modifiers are
covalently attached to lysine (K) residues of substrates via their C-terminal glycine (G)
residues. Modifiers can target single or multiple acceptor lysines of the substrate, or can form
chains mediated by various K-linkages. Modification of the substrate changes its protein-
interaction properties and can be recognized by protein receptors containing dedicated
binding motifs (e.g., SIMs in the SUMO-targeted ubiquitin ligases). Modifications are
reversible due to the presence of a large number of UBPs and relatively small number of
ULPs, which mediate deconjugation of ubiquitin and SUMO from substrates, respectively.
The major steps (processing, activation, conjugation, ligation and deconjugation) of ubiquitin
and SUMO cycles are depicted and the number of involved enzymes in budding yeast and
humans, respectively, are shown in parentheses.
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The ubiquitin/SUMO conjugation starts with the ATP hydrolysis required for the
initial adenylation of the C-terminal glycine residue of the modifiers that has been
exposed during processing of the precursors. This first step (termed activation) is
catalyzed by modifier-specific activating enzymes (also called E1s). A single protein
(Uba1) operates in budding yeast S. cerevisiae for the ubiquitin pathway, and a
heterodimer (Aos1/Uba2) is utilized for the SUMO pathway (Johnson, 2004).
Subsequently, ubiquitin/SUMO-AMP adducts become attached via high-energy
thioester bonds to internal catalytic cysteine residues of the dedicated E1 enzymes
(Johnson et al., 1997; Lois and Lima, 2005). This reaction requires large
conformational changes in E1 and is needed to position the “activated” modifiers in
the favorable orientation for their consecutive transfer to the catalytic cysteine
residues of the respective conjugating enzymes (termed E2s). Whereas for the
ubiquitin pathway 11 E2s exist in S. cerevisiae and more than 30 operate in humans,
a single enzyme (Ubc9) mediates all SUMOylation events in budding yeast as well as
in mammals (Johnson and Blobel, 1997; Tong et al., 1997). As a result of this second
catalytic step (termed conjugation) thioester-linked complexes between the modifiers
and the E2s are being formed. In case of the SUMO pathway, modifier-charged Ubc9
is capable of direct substrate recognition and modification of correct acceptor lysine
residues in vitro (Bernier-Villamor et al., 2002; Gareau and Lima, 2010; Ulrich, 2009).
Moreover, direct Ubc9 fusion to substrates mediates specific SUMOylation of these
targets also in vivo (Jakobs et al., 2007). However, for most proteins and especially
for ubiquitin targets the substrate modification reaction requires the presence of so-
called ligases or E3s. It is important to note that the term “ligase” is operationally
defined, as it refers collectively to proteins that stimulate the final transfer of the
modifier from the E2 to the substrate (final conjugation step termed ligation),
disregarding differences in mechanisms. For instance, in the case of the HECT
(Homologous to E6-AP C-terminus) family of ubiquitin ligases the modifier is further
transferred from E2s to catalytic cysteines of E3s forming high-energy intermediates
prior to substrate modification (Rotin and Kumar, 2009). However, in most other
cases, the ligases play non-enzymatic role as adaptors recruiting modifier-charged
E2s in close vicinity of their substrates and enhancing the activity of the conjugating
enzymes. In the ubiquitin system hundreds of E3s (due to combinatorial complexity)
operate and determine high substrate selectivity of ubiquitylation (Woodsmith et al.,
2012). However, it is not the case for the SUMO modification pathway, where a
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handful of E3s (only 4 in budding yeast) mediate specific SUMOylation of the
substrates (Geiss-Friedlander and Melchior, 2007; Ulrich, 2009).
The ubiquitin and SUMO modifications are reversible. Dedicated enzymes
mediate their cleavage from substrates. Again, multiple ubiquitin-specific proteases
(UBPs) function in the ubiquitin pathway, while just a few ubiquitin-like protein
(SUMO)-specific proteases (ULPs) operate in the SUMO system (Hickey et al.,
2012). In the budding yeast only 2 SUMO deconjugating enzymes (Ulp1 and Ulp2)
exist and are differentially localized in the cell, which seems to determine their
substrate specificity. The maturation of the modifiers from their inactive precursors is
another duty of the deconjugating enzymes.
The ubiquitin/SUMO conjugation machinery can target substrates for modification
not only at individual or multiple acceptor lysine residues (termed
mono/multi-ubiquitiylation/SUMOylation), but can also generate chains consisting of
multiple modifier moieties attached to each other via their internal lysines
(poly-ubiquitylation/SUMOylation). For the ubiquitin system, chain formation plays
important roles and tremendously increases the versatility of the pathway (Komander
and Rape, 2012). In fact, not only all seven internal lysine residues of ubiquitin (K6,
K11, K27, K29, K33, K48 and K63) can be used for chain formation, but also the -
amino group of its N-terminal methionine, resulting in poly-ubiquitin chains of different
topologies (Kulathu and Komander, 2012). These chains of various lengths and
linkages attached to substrates define unique signals that can be recognized by
specialized ubiquitin receptors or interaction partners that harbor specific UBDs,
many of which were identified in the ubiquitin pathway (Dikic et al., 2009; Finley,
2009; Husnjak and Dikic, 2012; Richly et al., 2005). On the contrary, in the SUMO
system much less is known about the function of poly-SUMO chains (Ulrich, 2008). In
S. cerevisiae mainly first three lysines (K11, K15, K19) located in the N-terminus of
SUMO are being used for chain formation most likely due to the fact that they lie
within so-called SUMO “consensus” motifs (see below), however all other internal
lysines (K27, K38, K40, K41, K54, K58) are also found by mass spectrometry to be
SUMOylated in vitro and in vivo (I. Psakhye & S. Jentsch, unpublished data). The
biological functions of these various poly-SUMO chains and their recognition mode
remain poorly characterized, especially that in striking difference to the ubiquitin
pathway, which utilizes multiple UBDs, SUMOylated substrates are being recognized
mainly by the single short hydrophobic SUMO-interacting motif (SIM, see below).
Only recently, global analysis of SUMO chain function in budding yeast using SUMO
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variant with all nine lysines replaced by arginine was performed, implicating the
poly-SUMO chain synthesis in the maintenance of transcriptional repression and
higher-order chromatin structure (Srikumar et al., 2013).
High substrate selectivity is characteristic for the ubiquitin system, which can be
largely explained by the complexity of its enzymatic repertoire. Ubiquitin E3 ligases
specifically recognize and interact with particular protein motifs of individual
substrates. These elements are termed degradation signals (degrons) in case of the
ubiquitin-proteasome system (UPS), e.g., D-box and KEN-box motifs found in all
targets of the APC/CCdc20 and APC/CCdh1 E3 complexes (Pfleger and Kirschner,
2000; Visintin et al., 1997; Wasch and Cross, 2002). In contrast, in the SUMO system
the only E2 available (Ubc9) is often on its own able to recognize and correctly
SUMOylate appropriate acceptor lysine residues both in vitro and in vivo, as was
mentioned earlier. The validated SUMO-targeted lysines are most frequently found in
extended loops or disordered regions of the substrates outside of conserved globular
domains. In many cases an acceptor lysine lies within a KX(D/E) motif, where  is a
large hydrophobic residue (Rodriguez et al., 2001; Sampson et al., 2001). These
residues can directly interact with Ubc9; the motif (termed consensus) adopts an
extended conformation allowing the acceptor lysine to reach into the catalytic site of
E2, while flanking residues within the motif facilitate interaction with Ubc9 (Bernier-
Villamor et al., 2002; Gareau and Lima, 2010). In addition, several variants of the
SUMO consensus motif were described, e.g., phosphorylation-dependent SUMO
motif (PDSM), negatively charged amino acid-dependent SUMO motif (NDSM), N-
terminal hydrophobic cluster SUMO motif (HCSM), all of which have additional
elements extending interactions with Ubc9, or inverted consensus motif (Matic et al.,
2010; Mohideen et al., 2009; Yang et al., 2006). Despite different motif names, it
rather seems that SUMO-acceptor lysine simply has to be accessible and flexible
enough within its surrounding context in order to fit into catalytic groove of Ubc9 for
its modification.
Whereas recognition of different ubiquitin signals is mediated by a large variety of
dedicated UBDs (at least 20 known), non-covalent interaction between SUMOylated
substrate and its binding partners seems to be mediated by a SIM alone. The SIMs
can be largely defined as short stretches of hydrophobic amino acids (typically V/I-X-
V/I-V/I or inverted), which are in many, but not all, cases flanked by acidic residues
that further support the interaction with basic residues on the surface of SUMO
(Kerscher, 2007; Minty et al., 2000; Song et al., 2004). When bound to SUMO, the
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hydrophobic residues of the SIM fit into the hydrophobic groove on the SUMO
surface extending its -sheet structure. Many variants of SIMs exist (e.g., SIMa,
SIMb, phosphor-SIM), but the hydrophobic core, consisting of just 3-4 aliphatic
residues, is their essential component (Kerscher, 2007). In fact, short synthetic
SIM-containing peptides carrying the hydrophobic core are fully capable of binding
SUMO in vitro (Namanja et al., 2012). In essence, the SUMO modification is
recognized by proteins harboring simple short “adhesive surfaces” known as SIMs.
Not surprisingly, these motifs are found often at multiple copies in a wide range of
proteins, including SUMO substrates and especially enzymes of the SUMO pathway,
for instance ligases and SUMO-specific proteases (Gareau and Lima, 2010; Hickey
et al., 2012).
In summary, despite seeming similarity between the ubiquitin and SUMO
pathways, the two modification systems have several major differences. First, while
the components of the ubiquitin system are highly diversified in order to ensure
immense substrate selectivity, the enzymatic apparatus of the SUMO system is
surprisingly simple, yet both pathways target hundreds of substrates with high
precision. Second, the SUMO conjugation machinery seems rather promiscuous, as
in vitro Ubc9 (E2) alone is fully capable of substrate modification at correct SUMO-
acceptor sites without the need for any ligase. Similarly, in vivo Ubc9 fusions to
substrates mediate their correct modification in the absence of the ligases. Moreover,
if accessible acceptor lysines are introduced (in context of a protein tag, e.g.,
Myc-tag) into SUMO substrates, they will in most cases also become readily modified
in vivo. Third, while multiple dedicated UBDs specifically distinguish various types of
ubiquitin modifications, the recognition of numerous SUMOylated targets largely
depends on the single simple module – SIM. These striking differences suggest that
other principles of substrate selectivity must apply and perhaps distinct mechanisms
of PTM action exist in the SUMO pathway.
II.1.2 Molecular Mechanisms of SUMO Modification
To better understand the unusual behavior of the SUMO pathway, it is necessary to
have a closer look at how SUMOylation affects principal biochemical properties of the
modified substrates. There are three basic molecular consequences currently known
for SUMO modification (Fig. 2).
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First, SUMO conjugation machinery can compete for the acceptor lysine residue
of a substrate with other possible PTMs, such as methylation, acetylation and
ubiquitylation, thus preventing their possible effects on the target. The competition
between SUMO modification and acetylation can be exemplified in the cases of
MEF2A and HIC1 transcription factors, where SUMOylation inhibits their activity, for
which acetylation is required (Shalizi et al., 2006; Stankovic-Valentin et al., 2007).
Similarly, SUMO antagonizes poly-ubiquitylation of I B  and its subsequent
degradation via the UPS by blocking the target lysine residue (Desterro et al., 1998).
Second, SUMO modification may alter protein surface of the substrate required
for interaction with its binding partners and thus interfere with protein-protein
interactions. In such a way, SUMOylation of transcription repressor ZNF76 blocks its
binding site for the TATA-box binding protein (Zheng and Yang, 2004). Similarly,
SUMO-modified corepressor CtBP cannot longer interact with the PDZ domain of the
neuronal nitric-oxide synthase, while the SUMOylated ubiquitin-conjugating enzyme
E2-25K loses its ability to bind the ubiquitin E1 (Lin et al., 2003; Pichler et al., 2005).
Figure 2. Basic Consequences of SUMO Modification
In principal, SUMO modification affects its substrate properties in three different ways:
SUMO can compete for acceptor lysine (K) with other PTMs (e.g., ubiquitylation, acetylation,
methylation), preventing their action on the substrate; SUMO is a bulky moiety that can
interfere with protein-protein interactions, allowing binding only in the absence of
modification; SUMO can bind SUMO to SIMs either inter- or intra-molecularly, thereby
fostering physical associations or conformational changes, respectively.
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Another example of SUMO modification inhibiting protein binding is the SUMOylation
of the budding yeast proliferating cell nuclear antigen (PCNA) at K127 during S-
phase, which was shown to interfere with Eco1 interaction and thus repress Eco1-
dependent sister chromatid cohesion establishment (Moldovan et al., 2006, 2007).
The third consequence of the SUMO modification, which seems to be by far the
most abundant, is the fostering of protein-protein interactions mediated by
SUMO-SIM binding (Geiss-Friedlander and Melchior, 2007). Multiple studies provide
evidence that SUMOylation further strengthens weak affinities that exist between the
interacting proteins, acting like a molecular glue. One of the most well studied cases
of SUMO modification promoting physical interaction between two proteins is the
SUMOylation of PCNA at K164, which is crucial for the recruitment of the budding
yeast PCNA-interacting anti-recombinogenic enzyme Srs2 (Hoege et al., 2002;
Moldovan et al., 2007; Papouli et al., 2005; Pfander et al., 2005). PCNA becomes
SUMOylated during the S-phase of the cell cycle once it is loaded onto chromatin in
the vicinity of the dedicated DNA-bound SUMO ligase Siz1. This in turn recruits DNA
helicase Srs2 specifically to sites of ongoing replication, where it prevents unwanted
aberrant recombination events by removing the recombinase Rad51 from chromatin.
For its binding to PCNA Srs2 harbors a so-called PIP (PCNA-interacting protein) box,
but the crucial additional affinity for the SUMOylated PCNA engaged in DNA
replication comes from the SIM located next to the PIP box in the C-terminal tail of
Srs2 (Armstrong et al., 2012; Pfander et al., 2005). Thus, SUMOylation of PCNA at
K164 ensures efficient recruitment of the right binding partner (Srs2) at the right time
(during replication) and within the right context (replicating chromatin). Interestingly,
SUMO modification not only fosters intermolecular protein binding, but was also
shown to induce protein conformational changes by stimulating intramolecular
SUMO-SIM mediated physical interactions, as in the case of the base excision repair
(BER) enzyme thymine DNA glycosylase (TDG). The SUMOylation of TDG results in
the binding of the modifier to the SIM located within TDG itself, which changes the
conformation of the enzyme allowing DNA release and thereby driving the enzymatic
cycle (Steinacher and Schär, 2005).
II.1.3 SUMO Pathway Enzymes and Substrate Specificity
As discussed earlier, the basic mechanisms defining the acceptor lysine selection by
the SUMO conjugating enzyme Ubc9 are relatively well understood, however the
SUMOylation substrate specificity in general remains largely unresolved, especially
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because only a handful of ligases contribute to global SUMO levels and in many
cases share overlapping substrate selectivity. This in part can be explained by the
fact that the SUMO ligases largely play the role of adaptors that bring SUMO-charged
E2 in the vicinity of its targets, which harbor accessible acceptor lysines. Therefore,
the localization and local concentration of the SUMO pathway enzymes in the cell
seem to be the crucial determinants that guide substrate specificity and define protein
pools to be targeted by the SUMO pathway components (Gareau and Lima, 2010;
Heun, 2007; Hickey et al., 2012; Takahashi et al., 2008).
The largest group of SUMO ligases identified belongs to the Siz/PIAS family and
can be characterized by the presence of the Siz/PIAS-RING (SP-RING) domain that
specifically recruits Ubc9 (Hochstrasser, 2001; Johnson and Gupta, 2001; Palvimo,
2007). In fact, in the budding yeast all four known E3s (Siz1, Siz2, Mms21; and the
meiosis-specific Zip3) are a part of this SUMO ligase family (Fig. 3). The SP-RING is
a conserved zinc finger type domain related to the RING (Really Interesting New
Gene) domain found in a respective class of ubiquitin ligases (Freemont, 2000;
Hershko and Ciechanover, 1998; Weissman, 2001). The RING contains a C3HC4
amino acid motif that coordinates two zinc cations and binds charged ubiquitin E2s,
whereas the SP-RING domain lacks two key cysteine residues (C2HC3), coordinates
single zinc ion and binds SUMO-charged Ubc9. A subgroup of SP-RING ligases
(yeast Siz1-2, human PIAS1-4), in addition to the described SP-RING domain,
harbors a SAP (after SAF-A/B, Acinus and PIAS) domain for sequence nonspecific
DNA targeting (Aravind and Koonin, 2000) and a PINIT domain, involved in substrate
interaction (Yunus and Lima, 2009). The domain architecture of these canonical
Siz/PIAS ligases is largely similar (Fig. 3), with the main differences allocated to their
C-terminal tails, which additionally guide the subcellular localization of the E3s and
thus contribute to their substrate selectivity (Reindle et al., 2006). In contrast, yeast
Mms21 (or NSE2 in humans) and Zip3 are different as they lack both PINIT and SAP
domains. However, these ligases are also specifically localized in the cell, as Mms21
is the component of the structural maintenance of chromosomes Smc5/6 complex
involved in DNA repair and genomic stability (Andrews et al., 2005; Branzei et al.,
2006; Potts and Yu, 2005; Zhao and Blobel, 2005), while Zip3 is exclusively recruited
to the synaptonemal complexes (SCs) during meiosis (Cheng et al., 2006; de
Carvalho and Colaiacovo, 2006). Not surprisingly, the cellular localization largely
determines their SUMO substrate specificity, as Zip3 targets specifically proteins
involved in SC formation (Eichinger and Jentsch, 2010), whereas Mms21 mediates
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Figure 3. Scheme of SP-RING SUMO Ligases, SUMO-specific Proteases and SUMO-
targeted Ubiquitin ligases
Shown are enzymes from S. cerevisiae (Sc), S. pombe (Sp) and humans (Hs) with their
sizes and functional domains. The indicated domains are: sequence non-specific
DNA-binding domain (SAP); substrate-binding PINIT domain; Ubc9-binding Siz/PIAS-RING
finger (SP-RING); predicted SUMO-interaction motifs, SIMs (blue); protease domain
(maroon) with catalytic His and Cys residues (yellow); RING and RING-like domains of
STUbLs; ubiquitin-binding UBZ domain. The presence of multiple SIMs ensures efficient
recognition of SUMOylated substrates. The insert depicts schematically Mms21 (NSE2)
ligase integrated into the yeast Smc5/6 complex.
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SUMO modification of certain DNA repair proteins as well as components of the
Smc5/6 complex itself (Potts, 2009).
The importance of subcellular localization for the function and substrate
selectivity of the canonical Siz/PIAS SUMO ligases can be exemplified in the case of
the yeast Siz1. As was mentioned earlier, Siz1 is normally localized to chromatin via
its sequence nonspecific DNA-binding SAP domain and mediates SUMOylation of
the chromatin-bound substrates, for instance, replication processivity clamp PCNA at
K164 specifically during the S-phase (Hoege et al., 2002; Papouli et al., 2005;
Pfander et al., 2005). However, later during mitosis, a fraction of Siz1 relocalizes from
the nucleus to the filamentous ring structure formed at the bud neck of dividing yeast
cells (Takahashi et al., 2008). This scaffolding ring, composed of proteins called
septins, provides a structural support for cell division and recruits other proteins
involved in bud site selection, cell polarity, cytokinesis and spore formation. As a
consequence of Siz1 recruitment, three out of five septins (Cdc3, Cdc11, Shs1)
become collectively SUMOylated (Johnson and Blobel, 1999; Johnson and Gupta,
2001; Takahashi et al., 2001). Truncation analysis revealed that the C-terminus of
Siz1 is required for its bud neck localization and septin SUMOylation, but not for its
ligase activity in vitro. Notably, another SP-RING family member Siz2 is also capable
of modifying septins in vitro, however in vivo it localizes to the nucleus and is
therefore not involved in the modification of septin network (Takahashi and Kikuchi,
2005; Takahashi et al., 2003).
In addition to the SP-RING SUMO ligases several other proteins including Pc2,
MUL1, TOPORS, HDAC4, HDAC7, TRAF7, FUS, RSUME were characterized as
SUMO E3s in humans, as they can stimulate SUMO modification of certain
substrates, yet, they do not harbor SP-RING domain for Ubc9 recruitment and their
mode of action is largely not clear (Ulrich, 2009). However, humans additionally
utilize a composite multisubunit SUMO ligase RanBP2/RanGAP1-SUMO1/Ubc9
complex (Werner et al., 2012), in which RanBP2/Nup358 is a component of the
nuclear pore complex (NPC). During the interphase it serves essential functions in
the nucleocytoplasmic transport, while the E3 ligase activity was shown to be
important for chromosome segregation in mitosis. There, the ligase complex
relocalizes to the mitotic spindle and mediates the SUMO modification of Borealin, a
component of the chromosomal passenger complex that acts as a key regulator of
mitosis (Klein et al., 2009).
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Subcellular localization is not only important for the substrate specificity of SUMO
conjugation machinery, but also strongly influences substrate choice of the
SUMO-specific proteases – yeast ULPs and mammalian SENPs (Hickey et al.,
2012). In S. cerevisiae the two deconjugating enzymes Ulp1 and Ulp2 have restricted
cellular localization; Ulp2 resides in the nucleoplasm, while Ulp1 is mainly associated
with the inner surface of the NPC (Li and Hochstrasser, 2000, 2003). However, a
fraction of Ulp1 relocalizes to the nucleolus under stress conditions, while during the
last stages of cell division a portion is also exported to the cytoplasm and targets
SUMOylated septin network mentioned earlier (Makhnevych et al., 2007; Sydorskyy
et al., 2010). Similarly, mammalian SENPs are mainly concentrated in the nucleus
and additionally have distinct subnuclear localization pattern (Kolli et al., 2010). For
example, SENP3 and SENP5 are found in the nucleolus, while SENP1 is associated
with the NPC and also concentrates in nuclear foci. The localization of ULPs/SENPs
is governed by their variable N-terminal tails, which typically harbor multiple SIMs
(Fig. 3). Indeed, the deletion of the N-terminus of Ulp1 results in its localization
throughout the cell.
SUMOylated substrates may not only be recognized and processed by
differentially localized dedicated SUMO proteases, but can also be handled by
so-called STUbLs (SUMO-Targeted Ubiquitin Ligases, Fig. 3). These are RING-type
ubiquitin ligases that harbor multiple SIMs, which mediate the recognition of
SUMO-conjugates (Perry et al., 2008; Praefcke et al., 2012). Initially two STUbLs
have been characterized in budding yeast, both of which seem to be specifically
localized in the nucleus. Ris1 is a member of the SWI/SNF family of DNA-dependent
ATPases that plays a role in antagonizing silencing during mating-type switching
(Zhang and Buchman, 1997). It was shown to bind Ubc4 and SUMO-conjugates,
determining their half-lives (Uzunova et al., 2007). The second S. cerevisiae STUbL
is a heterodimer consisting of Slx5 and Slx8, both of which are SIM-containing
RING-finger proteins, that localizes to nuclear DNA repair foci and was also shown to
be associated with the NPC (Nagai et al., 2008; Prudden et al., 2007). Interestingly,
in fission yeast S. pombe, the known STUbL is related to Slx5/Slx8 and is also
involved in genome stability and DNA damage repair. This composite ligase consists
of the Slx8 protein (homologous to the one of budding yeast) and either of two
related proteins Rfp1 or Rfp2. In mammals, the nuclear RING-finger ubiquitin ligase
RNF4 binds SUMO-conjugates via four putative SIMs in its N-terminus, displays
homology to Rfp1/Rfp2 and can complement deletions of STUbL genes in yeast (Sun
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et al., 2007). A proteomic analysis with the SIM-containing N-terminal domain of
RNF4 identified multiple SUMOylated proteins as potential substrates of this
homodimeric vertebrate STUbL (Bruderer et al., 2011). Notably, many other
RING-type ubiquitin ligases harbor predicted SIMs, suggesting that they may also act
as STUbLs (e.g., yeast Rad18, human RNF111/Arkadia). Moreover, depending on
the ubiquitin E2 enzyme associated with the STUbL and the ubiquitin signal
generated by their concerted action, different outcomes for the SUMO substrates are
possible. They can either be targeted for selective proteasomal degradation via the
UPS, or become endowed with novel functions. For example, RNF4 binds to and
polyubiquitylates the SUMOylated PML protein, targeting it for degradation, which in
turn results in the disassembly of PML nuclear bodies (Lallemand-Breitenbach et al.,
2008; Tatham et al., 2008). However, upon DNA damage, RNF4 gets recruited to the
SUMO-modified repair factors in so-called repair foci and induces the assembly of
nonproteolytic K63-linked polyubiquitin chains (Yin et al., 2012). Similarly, in budding
yeast, SUMOylated PCNA stimulates the recruitment of the Rad18 ubiquitin ligase
via its SIM, thereby enhancing mono- or K63-linked poly-ubiquitylation at K164 of a
different subunit within PCNA homotrimeric complex and thus promoting DNA
damage tolerance (Parker and Ulrich, 2012).
II.2 DNA Damage Repair
The integrity of the genetic information is essential for all biological processes in
cells, however it is constantly being threatened by numerous endogenous as well as
exogenous DNA-damaging assaults. To counter these threats and protect the
genome is therefore of critical importance, and life has evolved several lines of
defense against DNA damage – collectively termed the DNA damage response
(DDR) – in order to detect various DNA lesions, signal and tolerate their presence,
and finally mediate their repair (Jackson and Bartek, 2009; Zhou and Elledge, 2000).
Cells constantly receive thousands of DNA lesions that can affect DNA
transcription or block genome replication. Moreover, if the lesions are not correctly
repaired, they may result in mutations or gross chromosomal rearrangements
(GCRs) that can eventually lead to the development of diverse genetic diseases,
including cancer syndromes (Hoeijmakers, 2001). Depending on the type of DNA
damage inflicted, different dedicated repair pathways step into play, e.g., base-
excision repair (BER), nucleotide-excision repair (NER), mismatch repair (MMR).
Many DNA lesions arise during normal physiological processes, like DNA
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mismatches erroneously introduced during replication, or DNA strand breaks
occurring as a consequence of faulty topoisomerase activity. Reactive oxygen
species, hydrolytic and alkylating reactions produce numerous DNA-base lesions
continuously. Chemical adducts, UV-light and ionizing radiation generate various
forms of DNA damage leading to base loss, DNA single-strand breaks (SSBs) or
stalling of progressing replication forks, that can eventually lead to fork collapse and
formation of the DNA double-strand breaks (DSBs) (Pfeiffer et al., 2000). Despite
being relatively rare compared to other types of DNA lesions, DSBs are difficult to
repair and are extremely toxic to the cell (Haber, 1999; van Gent et al., 2001). Even a
single DSB, if left unrepaired, may result in the cell death or lead to the formation of
GCRs and ultimately in vertebrates to cancerogenesis. However, in certain cases the
generation of the DSBs is programmed by cells. Meiotic recombination relies on
error-free DSB repair and is required for correct chromosome segregation during the
first meiotic division (Keeney et al., 1997). The V(D)J recombination of
immunoglobulin genes in lymphocytes (Gellert, 1992) as well as the process of
mating-type switching in budding yeast (Schiestl and Wintersberger, 1992) also
depend on the controlled induction and repair of the DSBs. Not surprisingly, cells
have evolved efficient mechanisms to sense, signal and repair this DNA lesion.
Two major pathways exist in cells to deal with the DSBs that are called
non-homologous end-joining (NHEJ) and homologous recombination (HR). As can be
judged from the pathway names, the NHEJ involves, in principal, the ligation of
broken DNA ends, while HR uses homologous DNA sequences to guide DSB repair.
The main differences as well as the pathway choice between the NHEJ and HR are
dictated by the events that take place at broken DSB ends (Symington and Gautier,
2011). In NHEJ, the double-stranded DNA (dsDNA) ends become bound and are
held together by the heterodimeric Ku70/Ku80 protein complex, which prevents the
5’ DNA-end resection and promotes their direct ligation. This is a fast and effective
way to re-join broken ends, but NHEJ often results in small deletions, insertions,
mismatches at the DSB site, as well as GCRs, when different breaks are incorrectly
ligated, and is therefore considered error-prone (Daley et al., 2005). In contrast to the
NHEJ, the HR pathway relies on the resection of the DSB ends by nucleases
together with helicases and exposure of 3’ ssDNA overhangs, which are being
eventually covered by the Rad51 recombinase forming a so-called nucleoprotein
filament. In the process of genome-wide homology search, this filament is capable of
finding and invading the homologous dsDNA sequence, one of the strands of which
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is then used as a template for DNA synthesis (Filippo et al., 2008). Therefore, HR is
considered largely error-free. Moreover, the joint DNA molecule intermediates
produced after stand invasion are differentially handled to generate noncrossover
and crossover products, depending on the favored outcome appropriate in different
contexts. Whereas NHEJ is favored in G1-phase but is also active throughout the cell
cycle, the HR is preferentially utilized after DNA replication, when sister chromatid
becomes available as a template for error-free repair.
II.2.1 Homologous Recombination-mediated DNA Double-strand Break Repair
The key reaction in HR is the pairing and exchange of strands between two
homologous DNA sequences. This step is mediated by the action of the conserved
RecA/Rad51 protein family of recombinases (Chen et al., 2008). To initiate
homologous pairing Rad51 has to first bind to ssDNA, for which the complementary
sequence is then being found during the genome-wide homology search (Renkawitz
et al., 2013). Therefore, the HR-mediated DSB repair requires the resection of the
broken DNA ends, which is achieved through coordinated action of multiple repair
factors (Fig. 4). It is important to note that all DNA transactions take place in the
context of chromatin and are tightly regulated by the cell cycle control as well as DNA
damage checkpoint signaling (Branzei and Foiani, 2008; Chapman et al., 2012;
Lukas et al., 2011; Symington and Gautier, 2011).
The first step in HR is the recognition of the DSB and initiation of resection by the
conserved heterotrimeric MRX complex (Stracker and Petrini, 2011), which in
S. cerevisiae, is composed of Mre11, Rad50 and Xrs2 (Nbs1 in humans). This DSB
sensor binds to the broken chromosome ends and using extended coiled-coils of
Rad50 that are crowned with the Zn-hook for dimerization (Hopfner et al., 2002)
physically tethers the ends together (Fig. 4). The Mre11 subunit of the MRX complex
is the bifunctional endo/exonulcease, which together with Sae2 (CtIP) endonuclease
initiates short-range 5’ strand degradation proximal to the DSB, resulting in limited
end processing. Endonuclease activity is crucial when the DSB-ends are not clean,
e.g., blocked by bound proteins, such as trapped topoisomerases or meiosis-specific
endonuclease Spo11. However, resection of free DNA ends can also occur in the
absence of Mre11 and Sae2 activity (Symington and Gautier, 2011). The Xrs2
subunit of MRX serves as a scaffold to recruit other proteins like checkpoint kinase
Tel1 (ATM), which phosphorylates substrates in the vicinity of the break. In general,
the MRX complex not only senses the DSBs and initiates short-track resection, but
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also recruits downstream repair factors and stimulates their activity (Stracker and
Petrini, 2011).
Short-range resection mediated by MRX-Sae2 alone can only generate 3’ ssDNA
overhangs of around 100-700 nt that can be used for Rad51-dependent
recombination, however the presence of heterology adjacent to the DSB greatly
Figure 4. The Homologous Recombination in DNA Double-strand Break Repair
The DSB is sensed and broken ends are tethered by the heterotrimeric MRX complex, which
together with Sae2 endonuclease initiates 5’-3’ DNA resection and recruits downstream
repair and checkpoint factors. Long track resection is mediated by the Exo1 exonuclease and
in parallel by Sgs1-Top3-Rmi1 helicase working together with Dna2 endonuclease. Exposed
ssDNA overhangs are immediately coated by RPA, which is then replaced by the Rad51
recombinase with the help of mediators (Rad52-Rad59 in yeast, BRCA2 in mammals).
Rad51 forms nucleoprotein filaments stabilized by its paralogs (Rad55-Rad57 heterodimer)
that counteract the action of the anti-recombinogenic helicase Srs2. These filaments search
for homology genome-wide and catalyze the invasion of the homologous dsDNA resulting in
the formation of D-loop. Homologous pairing is stimulated by the chromatin remodeling
protein Rad54. DNA Pol  then extends the 3’ end of broken chromosome using the donor
strand as a template. In the SDSA scenario (left), the extended strand is displaced from the
D-loop with the help of Srs2 and anneals to complementary sequences exposed by resection
allowing the gaps to be filled by DNA synthesis, thus forming noncrossover products. If the
other DSB-end is captured (right), annealed to the displaced strand of the D-loop and
extended, the repair proceeds via double Holliday junctions (center), resulting in
noncrossover or crossover formation depending on the dis- or resolution of the junctions.
Alternatively, early D-loop can be cleaved by resolvases (right), promoting the formation of
crossovers (adapted from (Mazon et al., 2010)).
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reduces the efficiency of repair (Mimitou and Symington, 2008). Moreover, long-
range resection is required to activate the DNA damage checkpoint and also needed
to prevent incorrect repair between short repeats. To achieve long-range resection,
two parallel independent pathways operate in the cell (Mimitou and Symington, 2008;
Zhu et al., 2008). One relies on the action of the Exo1 exonuclease, while the second
utilizes the STR complex composed of RecQ-family helicase Sgs1 (BLM), the type I
topoisomerase Top3 and OB-fold containing protein Rmi1. Sgs1 helicase in STR
complex unwinds dsDNA from broken ends, while the formed ssDNA is degraded by
the endonuclease activity of bifunctional helicase/endonuclease Dna2 (Mimitou and
Symington, 2011). Importantly, the MRX-Sae2 complex stimulates the recruitment
and activation of both branches of long-track resection at the DSB (Nicolette et al.,
2010; Symington and Gautier, 2011).
Exposed in the process of DSB resection ssDNA becomes rapidly coated by the
ssDNA-binding heterotrimeric replication protein A (RPA), composed of Rfa1, Rfa2,
and Rfa3 subunits in yeast. Coating of ssDNA by RPA dissolves secondary DNA
structures, protects broken ends from cleavage (Chen et al., 2013) and serves as a
platform for recruitment of the downstream repair and DNA damage checkpoint
factors. Importantly, crucial checkpoint kinase Mec1 (ATR) via its recruiting factor
Ddc2 (ATRIP) binds to RPA-covered ssDNA and initiates DNA damage checkpoint
signaling (Zou and Elledge, 2003). Subsequently, in order for HR to proceed, RPA
has to be displaced from resected ssDNA and exchanged by the Rad51
recombinase. This crucial step in S. cerevisiae is mediated by the action of the
conserved homo-oligomeric ring-shaped protein Rad52 with the help of its paralog
Rad59, while in humans BRCA2 promotes the RPA-Rad51 exchange (Filippo et al.,
2008). Rad51 then forms a dynamic nucleoprotein filament on ssDNA stabilized by
the heterodimer of its paralogs Rad55-Rad57, which balance the anti-recombinase
activity of Srs2 helicase (Liu et al., 2011). Once formed, the Rad51 filament in the
process of intricate genome-wide homology search scans the chromatin, invades the
homologous dsDNA displacing one strand and subsequently forming a joint
heteroduplex structure known as the displacement D-loop (Fig. 4). Homology search
and homologous pairing by Rad51 are additionally stimulated by the member of the
Swi2/Snf2 family of chromatin remodeling proteins Rad54 (Bugreev et al., 2006;
Mazin et al., 2010; Petukhova et al., 1998). After invasion of ssDNA into donor
dsDNA and base pairing the DNA polymerase  gets access to and extends the
INTRODUCTION
19
3’ ssDNA end of the broken chromosome using the donor strand as a template (Li et
al., 2009).
The subsequent steps and the outcomes of HR depend on the events that take
place at the D-loop following DNA repair synthesis. In the simplest case, the joint
DNA molecule intermediate is resolved by displacing the extended strand via action
of the Srs2 and Mph1 DNA helicases that can disrupt D-loops (Ira et al., 2003;
Prakash et al., 2009; Veaute et al., 2003). The displaced strand then anneals to
complementary sequences formed by the resection of the other side of the DSB. This
in turn initiates another round of gap filling DNA synthesis followed by ligation and
results in noncrossovers exclusively (Fig. 4, left). Notably, this mechanism of HR,
known as synthesis-dependent strand annealing (SDSA), leads to gene conversion;
the duplicate copy of the donor allele is transferred to the recipient locus, while the
recipient allele is lost. In the canonical DSB repair model (Szostak et al., 1983),
initially proposed in meiosis, the other end of the break is annealed with the help of
Rad52 to the displaced strand in D-loop (second end capture). This event primes
DNA synthesis and extension of the second broken end, forming a stable double
Holliday junction (dHJ) intermediate (Fig. 4, center). The dHJ can be subsequently
either dissolved by the STR complex forming noncrossovers (Cejka et al., 2010; Wu
and Hickson, 2003) or resolved by a number of resolvases (Svendsen and Harper,
2010) giving rise to both crossovers and noncrossovers. Alternatively, the extended
D-loop could be cleaved prematurely prior to dHJ formation (Fig. 4, right), promoting
crossovers. After cleavage of HJs, the ends are ligated to complete the reaction.
II.2.2 DNA Damage Checkpoint
The DNA damage checkpoints are multifaceted signal transduction pathways that
coordinate sensing of different DNA lesions with the signaling of their presence,
repair and cell cycle progression (Bartek and Lukas, 2007; Harper and Elledge,
2007). Ultimately, checkpoint signaling stalls cell division providing sufficient time for
efficient repair to take place. The signaling cascade is mediated by the DNA damage
checkpoint kinases that phosphorylate numerous effectors involved in the regulation
of diverse physiological functions (Matsuoka et al., 2007). The key factors implicated
in sensing and transducing the checkpoint signals are highly conserved in eukaryotes
and can be grouped according to their function into the DNA damage sensors, apical
kinases, signal transducers and effector kinases.
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At the heart of the DNA damage checkpoint signaling are the apical
phosphoinositide 3-kinase (PI3K)-like Mec1 (ATR) and Tel1 (ATM) kinases,
mentioned earlier. Whereas, Tel1 is activated by direct binding to the MRX DSB
sensor (Lee and Paull, 2005), the Mec1 activation involves its recruitment to the
ssDNA-bound RPA complexes via the interacting protein Ddc2 (ATRIP) (Rouse and
Jackson, 2002; Zou and Elledge, 2003). Therefore, the activation of these DNA
damage checkpoint kinases is directly coupled to the sensing and resection of DSBs.
Moreover, the apical kinases can regulate the DNA resection itself by targeting the
key players of the resection machinery. For instance, in budding yeast the long-range
resection factor Exo1 is phosphorylated at several sites following extensive formation
of ssDNA, and these modifications are suggested to inhibit its activity in order to
prevent aberrant hyper-resection (Morin et al., 2008). Another important early factor
involved in full activation of the checkpoint signaling at resected DSB-ends and
stalled replication forks is the 9-1-1 checkpoint clamp (Rad9/Rad1/Hus1 complex in
mammals; Rad17/Mec3/Ddc1 in S. cerevisiae), which is structurally highly similar to
PCNA, forming a heterotrimeric ring around DNA. After DNA resection and coating of
ssDNA by RPA, the 9-1-1 complex is loaded to 5’ ssDNA/dsDNA junctions (in
contrast to PCNA, which localizes at 3’ junctions) by an alternative form of the
replication factor C (RFC) complex, in which Rad24 replaces the Rfc1 subunit (Majka
et al., 2006; Sancar et al., 2004). The 9-1-1 loading is independent of Mec1
recruitment and is highly stimulated by RPA. The checkpoint clamp is subsequently
phosphorylated by Mec1 and serves as a platform for the recruitment of downstream
checkpoint factors thus strengthening the checkpoint signaling (Parrilla-Castellar et
al., 2004).
After the activation of the apical checkpoint kinases at the sites of DNA damage,
the next step of the signaling cascade involves the recruitment of the mediator
proteins that transduce the checkpoint signal further to the effector kinases Chk1,
Rad53 (Chk2) and Dun1. One of such signal transducers in budding yeast is the
checkpoint adaptor protein Rad9 (53BP1 in mammals). Upon DNA damage it
becomes hyperphosphorylated by Mec1 at multiple sites in a 9-1-1
complex-dependent manner, which in turn stimulates its oligomerization and
strengthens localization to DNA lesions (Emili, 1998; Naiki et al., 2004). Following its
hyperphosphorylation, Rad9 serves as a binding platform for the recruitment and
activation of the downstream effector kinase Rad53. Multiple Rad53 molecules bind
to patches of Rad9, which triggers rapid activation of the kinase through trans-
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autophosphorylation (Gilbert et al., 2001). The activated Rad53 kinase is
subsequently released from Rad9 and targets multiple factors leading to cellular
arrest, upregulation of dNTP levels, stabilization of stalled replication forks, and
transcriptional repression of cyclins along with upregulation of DNA damage repair
genes.
In general, the extent of resection and consequently the local concentration of
early DNA damage checkpoint factors seem to be important for efficient checkpoint
activation. A single RPA complex stably binds 30 nt of ssDNA, while at least 2 RPA
complexes are required to recruit ATRIP-ATR heterodimer in vitro (Zou and Elledge,
2003). However, activation of ATR requires at least 200 nt of ssDNA and is greatly
induced with ssDNA length above 1000 nt (Choi et al., 2010), suggesting that Mec1
(ATR) activation should be proportional to the length of DNA resection. Supporting
this model, mutants lacking both branches of long-track resection ( exo1 sgs1) in
budding yeast are defective in Mec1/Ddc2 recruitment to DNA lesions and therefore
fail to efficiently activate Rad53 kinase (Gravel et al., 2008; Zhu et al., 2008).
Moreover, since the resected ssDNA in principle serves as a recruiting platform for
checkpoint and other DDR factors, the artificial colocalization of Mec1/Ddc2 with the
checkpoint 9-1-1 complex on DNA by fusing these factors to the LacI repressor and
expressing in cells harboring Lac operator arrays is in fact sufficient to trigger DNA
damage checkpoint signaling in the absence of any ssDNA (Bonilla et al., 2008).
II.2.3 SUMO Modification in DNA Repair
SUMO pathway is strongly implicated in the DDR (Bergink and Jentsch, 2009;
Jackson and Durocher, 2013; Lukas et al., 2011) and several DNA repair factors
were shown to be SUMO-modified in the last decade. One of the first potential SUMO
substrates involved in HR-mediated DSB repair identified was the fission yeast
protein Rad22 (Ho et al., 2001), homolog of the recombination protein Rad52, which
was subsequently shown to be SUMOylated in response to DNA damage in budding
yeast and human cells (Sacher et al., 2006). Despite the fact that SUMO pathway
mutants are very sensitive to various DNA damaging agents (MMS, UV, ionizing
radiation) and exhibit strong defects in damage-induced HR (Maeda et al., 2004), a
SUMOylation-defective Rad52 mutant is largely recombination proficient and
demonstrated only partial defect in MMS-induced interchromosomal HR (Ohuchi et
al., 2008; Sacher et al., 2006). In addition, Rad52 SUMOylation was shown to sustain
Rad52 activity and shelter the molecules engaged in repair from accelerated
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proteasomal degradation. Following studies in budding yeast revealed that Rad52
SUMOylation-defective mutant does not support nucleolar exclusion of Rad52
recombination foci (Torres-Rosell et al., 2007), while in general the duration of these
repair foci is reduced (Altmannova et al., 2010).
In human cells, SUMO isoforms and SUMOylation machinery were also shown to
rapidly co-localize with sites of DNA damage in repair foci and several DDR proteins
were shown to be SUMO modified, including BRCA1, 53BP1 and MDC1 (Galanty et
al., 2009; Luo et al., 2012; Morris et al., 2009). Moreover, responsible SUMO ligases
PIAS1 and PIAS4 were shown to be required for complete accumulation and
prolonged residence time of the DDR proteins downstream of RNF8 at DNA damage
sites, for effective formation of ubiquitin conjugates mediated by RNF8, RNF168 and
BRCA1, and for efficient DSB repair via both NHEJ and HR.
The next SUMOylation target involved in efficient DNA repair via HR to be
identified was the ssDNA-binding protein RPA. Dou and coworkers found that upon
camptothecin (CPT)-induced replication stress and after ionizing radiation SENP6
deSUMOylating enzyme dissociates from RPA allowing its modification by SUMO,
which in turn facilitates the recruitment of Rad51 recombinase to the DNA damage
foci and promotes repair via HR (Dou et al., 2010; Dou et al., 2011).
SUMOylation-defective RPA mutant fails to efficiently recruit Rad51 to repair foci and
shows partially reduced sister chromatid exchange (SCE) rates in response to CPT
as well as reduced repair of SceI-induced DSBs.
Another piece of evidence demonstrating importance of SUMOylation machinery
this time targeting multiple NER proteins for efficient repair of UV-induced lesions
came from the study of Silver and coworkers in budding yeast. They demonstrated
that cells lacking both canonical Siz/PIAS SUMO ligases Siz1 and Siz2 are sensitive
to UV-light and show delayed cyclobutane pyrimidine dimer (CPD) repair. Moreover,
many NER factors (Rad4, Rad16, Rad7, Rad1, Rad10, Ssl2, Rad3, and Rpb4) are
SUMO targets, modification of which is increased by DNA damage (Silver et al.,
2011). Importantly, blocking downstream steps of the repair pathway results in the
accumulation of SUMOylated species of repair proteins acting upstream, analogous
to increase of Rad52 SUMOylation in the absence of Rad51 (Ohuchi et al., 2009;
Sacher et al., 2006), which indicates that modified molecules are engaged in repair
process. However, despite strong modification of Rad16 after UV-treatment,
SUMOylation-defective Rad16 mutant alone had no detectable abnormalities in NER,
which suggested the possibility that Siz1/Siz2-dependent SUMO modification of
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multiple repair proteins collectively promotes efficient NER. Similarly, recent study
showed that SUMOylation machinery mutants are sensitive to MMS, and by using a
directed biochemical screen, confirmed SUMOylation of multiple proteins involved in
replication, HR, NHEJ, BER, NER and MMR in response to genotoxic stress
(Cremona et al., 2012).
These observations strongly implicate SUMO modification in the regulation of
DNA damage repair and DDR in general. However, mechanistic details and basic
principles clarifying how simply organized SUMO machinery precisely recognizes its
substrates upon DNA damage and what are the consequences of multiple
SUMOylation events at numerous DDR factors frequently organized into repair foci
are largely missing.
II.3 Aim of This Study
The principles of substrate specificity and the mechanistic consequences of the
ubiquitin modification are extensively studied and well understood. The highly
diversified and elaborate ubiquitin conjugation machinery ensures precise recognition
of individual substrates, whereas numerous ubiquitin-binding domains specifically
recognize various types of ubiquitin signals. On the contrary, much less is known
about the principles of substrate selectivity and mechanisms of action of the ubiquitin-
related modifier SUMO.
The SUMO pathway targets hundreds of substrates with high specificity, yet
surprisingly only a handful of enzymes mediate the entire modification spectrum.
Moreover, the recognition of the SUMOylated substrates is extremely simple, as it in
principle relies on a single short hydrophobic SUMO-interacting motif (SIM). SUMO
modification is essential for viability, and therefore, SUMO pathway mutants have
strong pleiotropic phenotypes. However, for the most substrates the biological
significance of the modification is not known, and in many cases the respective
specific SUMOylation-defective mutants barely exhibit any phenotypes.
Here, instead of studying the phenotypes of SUMO pathway mutants, we aimed
to address the principles of substrate specificity and mechanistic consequences of
SUMO modification at the substrate level, using the DNA double-strand break repair
pathway via homologous recombination as a case study. This pathway has strong
ties to the SUMO system, and several repair factors are known to be SUMOylated.
We show that DNA damage triggers a SUMOylation wave collectively targeting
multiple repair proteins of the same pathway. This suggests that perhaps
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SUMOylated proteins act in concert. Indeed, we find that SUMO machinery targets
functionally engaged protein group rather than individual repair factors, and show
that multiple modifications act synergistically by fostering SUMO-SIM mediated
interactions between proteins. We propose and provide evidence for the model, in
which regulated and highly spatially confined protein group SUMOylation provides
glue-like properties to the substrates at reach of localized conjugation machinery in
order to promote physical interactions, stabilize protein complexes and concentrate
enzymatic activities.
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III. RESULTS
III.1 Protein Group SUMOylation upon DNA Damage
III.1.1 Identification of SUMO Substrates Induced by Specific DNA Damage Types
To address the question of substrate specificity in the SUMO system we focused on
the HR-mediated DNA DSB repair pathway as a model for our study. This pathway is
well characterized, and many of the HR proteins are modified by SUMO after DNA
damage, while SUMO pathway mutants show strong sensitivities towards DSB-
inducing agents (Cremona et al., 2012; Dou et al., 2010; Sacher et al., 2006).
To screen for novel SUMO substrates and confirm previously identified targets
that accumulate after specific DNA damage, we used a SILAC-based mass
spectrometry approach (Mann, 2006; Ong et al., 2002). It allows the quantitative
comparison of the protein abundance in differentially treated cell cultures on a
proteome-wide level. For our purpose, we treated yeast cycling cells with a high dose
of methyl methanesulfonate (MMS), the DNA-alkylating agent that induces replication
fork stalling with subsequent fork collapse and DSB formation, and compared the
isolated SUMO-conjugates from MMS-treated and untreated cells (Fig. 5). The mass
spectrometry screen identified 844 potential SUMO substrates, the abundance of the
majority of which did not change after MMS-induced damage. However, among those
few SUMO-conjugates that were strongly enriched in response to DSB induction
were specifically proteins involved in the HR and the DNA damage checkpoint
response to replication stress (Fig. 5, right). This suggests that proteins acting in the
same DNA damage repair pathway become collectively SUMOylated upon a specific
stimulus, and that perhaps the modifications may serve a common purpose. The
observed behavior of the SUMO machinery to simultaneously modify a number of
repair factors that act together functionally and also form protein complexes is
unusual, since most canonical PTMs typically target individual substrates with high
selectivity to affect their properties. However, in case of the SUMO system this mode
of action might be rather typical, as in a number of previous studies multiple factors
involved in the ribosome biogenesis (Finkbeiner et al., 2011a; Panse et al., 2006),
proteins of the septin network (Johnson and Blobel, 1999; Johnson and Gupta, 2001;
Takahashi et al., 2001), and many nucleotide excision repair (NER) factors (Silver et
al., 2011) were identified as SUMO substrates.
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To further confirm the observed behavior of the SUMO system to collectively
target a whole set of proteins acting in the same DNA repair pathway following
specific DNA damage stimulus, we repeated the mass spectrometry screen
described earlier with the only difference that this time cells were treated with UV-
light instead of MMS. Exposure to UV-light creates crosslinking between adjacent
cytosine and thymine bases resulting in pyrimidine dimers, bulky DNA lesions that
require NER factors for recognition, excision and repair. The NER pathway can be
further divided into global genomic NER and transcription-coupled NER
subpathways, which differ in the mechanisms of DNA lesion recognition but share the
same steps needed for the repair of bulky adducts (de Laat et al., 1999). In our
quantitative proteomic screen for SUMO-conjugates that increasingly accumulate
after UV-irradiation we specifically identified repair proteins playing roles in both
branches of the NER (Fig. 6), whereas SUMOylation of the HR factors was not
induced significantly. Thus, this strongly suggests that multiple proteins functionally
Figure 5. Proteins Acting in the HR-mediated DSB Repair Pathway are Collectively
SUMOylated after MMS Treatment
Outline of SILAC experiment performed to detect SUMOylated substrates enriched after
MMS-induced DNA damage (Left). SILAC ratios (MMS-treated versus untreated) for 844
quantified proteins plotted against the sum of the relevant peptide intensities (Right). Proteins
are colored according to values of MaxQuant Significance(B): gray, Significance(B) > 10 2;
black, SUMOylated proteins enriched after DNA damage with Significance(B)  10 2; red,
proteins with Significance(B) < 10 4 that are involved in HR and checkpoint activation.
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engaged in specific repair pathway in response to certain type of DNA damage
become collectively modified by SUMO conjugation machinery.
III.1.2 Synchronous Collective SUMOylation of a Whole Set of HR Proteins
After establishing that the SUMO system collectively modifies multiple HR and
checkpoint factors following MMS-treatment, we then studied these proteins
individually in order to estimate the extent of SUMOylation, to evaluate the timing of
its induction, and characterize the requirements for the modification in greater detail.
To this end, we C-terminally tagged yeast repair factors of interest with HA (human
influenza hemagglutinin) or Myc (human c-Myc) epitopes at their endogenous
genomic loci, treated the cells with MMS and isolated SUMO-conjugates using
denaturing HisSUMO Ni-NTA pull-down assays (Ni PD; as described in (Sacher et al.,
2005)), subsequently probing with HA/Myc and substrate-specific antibodies. The
SUMOylation of the 3-phosphoglycerate kinase Pgk1 is largely not affected by DNA
Figure 6. Proteins Acting in the Nucleotide Excision Repair Pathway are Collectively
SUMOylated after UV-light Treatment
Following UV-light treatment specifically factors implicated in nucleotide excision repair
(NER) become increasingly SUMOylated. Cells grown in heavy media were UV-irradiated
(80 J/m2) instead of MMS-treatment. SILAC ratios (UV-treated versus untreated) for 717
quantified proteins plotted against the sum of the relevant peptide intensities. Proteins are
colored according to values of MaxQuant Significance(B): gray, Significance(B) > 10 7; black,
SUMOylated proteins enriched after UV-irradiation with Significance(B)  10 7; red, proteins
with Significance(B)  10 8 that are involved in NER (both transcription-coupled and global
genomic repair) and base-excision repair.
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damage and was therefore used to control the pull-down efficiency, whereas
hyperphosphorylation of the Rad53 checkpoint kinase served as a read-out for the
DNA damage checkpoint activation.
First, we analyzed SUMOylation of the HR factors involved in the DSB repair
directly and found that basically all early repair proteins (Lisby et al., 2004)
participating in break sensing, DNA resection initiation and Rad51 recombinase
loading onto resected ssDNA (Fig. 7) become massively SUMOylated specifically
after MMS treatment.
Figure 7. SUMOylation of Proteins Involved in HR-mediated DSB Repair
(A) SUMOylation of all three subunits of yeast RPA is triggered after exposure to MMS
(indicated by dots). Ni-NTA pull-down (Ni PD) under denaturing conditions was performed
from untreated or MMS-treated WT cells, or cells overexpressing His-tagged SUMO
(HisSUMO), in which RPA subunits (Rfa1, Rfa2, Rfa3) were C-terminally tagged with an HA
epitope. Slower migrating bands corresponding to RPA subunits modified by several SUMO
moieties are indicated. SUMOylation of the RPA complex and of Rad52 is synchronously
triggered by DNA damage. Pgk1 SUMOylation was followed to control pull-down efficiency.
(B) Rad59 is SUMOylated upon DNA damage. Experiment was conducted similar to (A); the
asterisk denotes a cross-reactive band. (C) Two subunits of the DSB-sensing MRX complex,
Mre11 and Rad50, as well as Sae2 are SUMOylated upon DNA damage. Experiment was
conducted similar to (A).
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Moreover, in all cases, several slower-migrating SUMO-modified species of repair
proteins were detected, indicating that modification targets multiple acceptor lysines
or SUMO-chain formation takes place on the substrates. SUMOylation synchronously
targeted repair factors acting upstream of the Rad51 nucleoprotein filament
formation, however without affecting Rad51 itself, which suggested that perhaps
modifications play a role earlier in the HR pathway.
Next, we focused on SUMOylation of the DNA damage checkpoint mediator
proteins found in our SILAC screen (Rad9 and Mrc1) as well as apical checkpoint
kinases (Mec1 and Tel1) that become recruited to the DSB sites (Fig. 8). We could to
some extent detect MMS-induced SUMOylation of these factors by Western blot
despite their hyperphosphorylation and broad distribution of the signal in gel.
However, their SUMOylation was already significant in the absence of MMS,
indicating that probably endogenous DNA lesions are sufficient to induce the
modification.
Figure 8. SUMOylation of the DNA Damage Checkpoint Proteins after MMS Treatment
(A-D) To confirm enrichment of SUMOylated proteins involved in checkpoint activation
following exposure to MMS, DNA damage checkpoint mediator protein Rad9 (A), S-phase
checkpoint protein Mrc1 (B) (identified by the SILAC approach), and the apical checkpoint
kinases Mec1 (C) and Tel1 (D) were C-terminally tagged with either HA or Myc epitopes in
WT cells, or cells overexpressing HisSUMO. SUMOylated species of the checkpoint proteins
were detected by Ni PD already in untreated cells. Upon DNA damage, checkpoint proteins
become hyperphosphorylated, causing mobility shifts (smears) and a weakening of Western
blot signals; nevertheless SUMOylation of Rad9 and Mrc1 is detected by Ni PD from
HisSUMO cells after exposure to MMS. Pgk1 SUMOylation was followed to control pull-down
efficiency.
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We next aimed to characterize the kinetics of HR protein SUMOylation following
DNA damage and found that not only the MMS dose-dependent induction of SUMO
modification was very similar for all analyzed core repair proteins (Fig. 9A), but also
the timing of their SUMOylation after exposure to MMS was almost identical. In
addition, SUMOylation perfectly coincided with the activation of the DNA damage
checkpoint as can be judged from the Rad53 hyperphosphorylation profile (Fig. 9B).
This suggests that the synchronous SUMOylation wave is rapidly triggered after DNA
damage, in parallel to the checkpoint-signaling cascade, and collectively targets
multiple repair proteins. Supporting the latter, in mutant yeast strains lacking
individual HR factors ( rad51 or rad52),  the  SUMO  modification  of  other  repair
proteins still took place (Fig. 9C). Moreover, the SUMOylation levels of the early-
acting ssDNA-binding protein RPA were even higher in the absence of Rad51 or
Rad52, which mediate the removal of RPA from resected DNA. This further indicates
that SUMOylation targets proteins functionally engaged in repair reaction, because
preventing the pathway completion most likely traps early SUMO-modified factors at
the sites of DNA damage and causes their accumulation.
Figure 9. Synchronous SUMOylation Wave Collectively Targets HR Proteins
(A) SUMOylation of the HR proteins in response to DNA damage is triggered in a dose-
dependent manner. Hyperphosphorylated Rad53 was followed to assay for checkpoint
activation. (B) SUMOylation of repair proteins is triggered upon DNA damage and can be
detected by Western blot already 15-20 min after induction with 0.2% MMS. The
SUMOylation wave occurs parallel to checkpoint activation as judged from the Rad53
hyperphosphorylation profile. (C) Absence of the downstream-acting HR proteins Rad51 and
Rad52 results in increased SUMOylation of RPA (Rfa1). HisSUMO Ni PD from WT or mutant
cells ( rad51, rad52) after treatment with MMS.
RESULTS
31
III.2 Resection and Exposure of ssDNA Triggers SUMOylation Wave in HR
III.2.1 Long-range DNA Resection is Required for SUMOylation of HR Proteins
We next addressed what the requirements for the DNA-damage induced protein
group SUMO modification in the HR pathway are. As expected, HR protein
SUMOylation was heavily induced not only by MMS, but also by a member of the
bleomycin family Zeocin that causes DSBs by cleaving DNA. By contrast, exposure
to UV-light (assayed by SILAC approach earlier) or 4-nitroquinoline 1-oxide (4NQO),
which act similarly by creating bulky DNA lesions that are repaired by NER, induced
SUMOylation only to some extent (Fig. 10). The same was also true when cells were
treated with hydroxyurea (HU), a ribonucleotide reductase (RNR) inhibitor that
depletes dNTP pools and causes replication arrest (Bianchi et al., 1986). The HU-
induced replication fork stalling in S. cerevisiae is, however, reversible, and the fork
collapse and DSB formation occur only in strains defective in the DNA replication
checkpoint response, e.g., mec1 or rad53 mutants (Lopes et al., 2001), in which the
HR pathway is activated for repair (Meister et al., 2005). Together, these
observations suggest that in wild-type (WT) yeast cells primarily the DSBs are robust
inducers of the HR protein group SUMOylation.
The finding that protein group SUMOylation of the HR factors is rapidly triggered
primarily after DSB induction (Fig. 9B and Fig. 10) suggested that perhaps the
Figure 10. DSB Induction Leads to Massive SUMOylation of HR Proteins
In cycling yeast cells, SUMOylation of HR proteins is strongly induced following treatment
with MMS (0.2%) or the DSB-inducing agent Zeocin (0.2 mg/ml), but to a much lesser extent
following DNA damage either with replication inhibitor HU (100 mM), or UV-light (80 J/m2)
and exposure to 4NQO (1 g/ml), both of which generate bulky DNA lesions repaired by
NER.
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DSB-sensing MRX complex recruits the SUMO conjugation machinery to the break
sites. In fact, previous work (Sacher et al., 2006) already established that the
presence of the MRX complex is required for efficient DNA damage-induced
SUMOylation of Rad52. Consistent with this finding, yeast mutants lacking individual
MRX complex subunits ( mre11, rad50, xrs2) exhibited strongly reduced
SUMOylation levels of other HR factors upon DNA damage as well (Fig. 11A).
However, the SUMO modification was not completely absent, indicating that the MRX
complex facilitates the induction, but is not absolutely required to trigger the
SUMOylation wave in HR.
The MRX complex is not only involved in sensing the DSBs and tethering the
broken ends together, but is also strongly implicated in initiating DNA-end resection
and, importantly, recruiting long-range resection factors to the DSB (Mimitou and
Symington, 2011; Symington and Gautier, 2011). These factors then generate
extensive ssDNA tracts at the break sites, which in turn serve as a recruiting platform
for repair proteins. We therefore investigated whether DNA resection is the crucial
trigger for protein group SUMOylation in HR.
Resection starts with short-range trimming of DSB-ends mediated by the
nucleolytic activities of the Mre11 subunit of MRX complex and its associated
endonuclease Sae2. This step is in many cases not required, but may stimulate the
long-range resection executed by the 5  exonuclease Exo1 and also in parallel by
another pathway involving Sgs1 helicase operating together with the endonuclease
Dna2 (Symington and Gautier, 2011). When we hindered the initial short-range
resection by deleting Sae2 endonuclease alone ( sae2), or in a mutant strain
additionally defective in the nuclease activity of Mre11 (mre11-H125N), the
SUMOylation of HR proteins was hardly affected (Fig. 11B and 11C). However,
interfering with long-range resection by deleting Exo1 ( exo1), or by abolishing its
nuclease activity (exo1-D173A, ND), resulted in strong reduction of HR protein
SUMOylation (Fig. 11B and 11D). The same was true when we abrogated the other
branch of the long-range resection by deleting Sgs1 helicase ( sgs1; Fig. 11B).
Finally, elimination of both long-range resection pathways ( exo1 sgs1) resulted in
barely detectable SUMOylation of HR proteins (Fig. 11B) following MMS treatment.
Therefore, we conclude that the long-range DSB-end resection is required for the
efficient induction of the SUMOylation wave in HR.
RESULTS
33
III.2.2 Exposure of ssDNA is the Trigger for HR Protein Group SUMOylation
As mentioned earlier, the DSB-end resection generates long ssDNA tracts that are
needed to recruit a large number of HR and checkpoint factors to the sites of DNA
damage in order to efficiently signal and repair the DNA breaks. We therefore asked
Figure 11. Long-range DNA-end Resection is Required for Efficient SUMOylation in HR
(A) Disruption of MRX complex by deleting individual subunits results in pronounced
decrease of SUMOylation of HR proteins following DNA damage. Denaturing Ni-NTA pull-
down (Ni PD) was performed to isolate HisSUMO-conjugates from MMS (0.2%)-treated cells
lacking Rad50, Mre11 or Xrs2. (B) Long-range resection by the action of Exo1 and
Sgs1/Dna2, but not short-range processing of DNA ends by Sae2 endonuclease, triggers
SUMOylation of DNA repair proteins. Similar to (A), but with MMS-treated cells lacking Sae2,
Exo1, Sgs1, or both Exo1 and Sgs1. Both branches of long-range resection contribute to
induction of SUMOylation wave in DNA repair pathway. (C) Short-range processing of DNA
DSB-ends by Sae2 and Mre11 is not required for the induction of SUMOylation wave
following DNA damage. Similar to (A), but with MMS-treated mre11 sae2 cells expressing
either WT or nuclease-dead (mre11-H125N) Mre11. (D) Nuclease activity of Exo1 is required
for SUMOylation induction in response to DNA damage. Similar to (A), but with MMS-treated
cells expressing either WT or nuclease-dead (exo1-D173A, ND) Exo1.
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whether it is the exposure of ssDNA, rather than the process of resection during DSB
processing, that is the primary trigger for SUMOylation of HR proteins. To address
this issue, we induced the accumulation of ssDNA in cells independently of DSB
formation by three different means. First, we used the property of noncycling G1-
arrested cells that were treated with UV-light to convert NER intermediates into long
ssDNA gaps through the action of Exo1 (Fig. 12A) and thereby promote checkpoint
activation (Giannattasio et al., 2010). Second, we induced the accumulation of
ssDNA gaps behind replication forks by shifting the mutant strain lacking the
nonessential DNA polymerase  subunit Pol32 to low temperature (Fig. 12B), at
which it undergoes faulty replication (Karras and Jentsch, 2010). Third, we took
advantage of the telomere-capping protein Cdc13 mutant (cdc13ts) that releases
telomeric ssDNA when shifted to higher temperatures (Garvik et al., 1995)
(Fig. 12C). Under all tested conditions we detected SUMOylation of HR proteins
coinciding with checkpoint activation. Thus, the exposure of ssDNA stretches of
sufficient length, and not DSB processing as such, is the crucial trigger for protein
group SUMOylation in HR.
Figure 12. Exposure of ssDNA Triggers SUMOylation of HR Proteins
(A) ssDNA gaps generated after UV-light treatment by Exo1 in G1-arrested cells are
sufficient to trigger SUMOylation of repair proteins. Denaturing Ni-NTA pull-down (Ni PD)
was performed to isolate HisSUMO-conjugates from cycling or G1-arrested WT or Exo1-
deficient ( exo1) cells, which were treated either with MMS (0.2%) or UV-light (80 J/m2).
Hyperphosphorylated Rad53 indicates checkpoint activation triggered by resection following
DNA damage. (B) ssDNA gaps that accumulate due to faulty replication in cells lacking the
polymerase  subunit Pol32 ( pol32) grown at 14°C are sufficient to trigger Rad53
phosphorylation and HR protein SUMOylation, detectable by Ni PD of HisSUMO conjugates.
(C) Uncapping of telomeres and exposure of ssDNA in temperature-sensitive cdc13ts
mutants triggers HR protein SUMOylation. HisSUMO Ni PD from WT and cdc13ts cells, grown
to an OD600 of 0.7 at 24°C and then shifted to 37°C.
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III.2.3 Crosstalk between SUMOylation in HR and DNA Damage Checkpoint
The HR pathway is largely limited to the S and G2 phases of the cell cycle when
following DNA replication sister chromatid becomes available as a template for
repair. In part, this can also be explained by the reduced DSB resection efficiency in
G1 phase, which is negatively regulated by DSB binding of the NHEJ Ku70/Ku80
complex that competes with MRX and Exo1. However, DSB resection in G1 is not
abolished (Barlow et al., 2008) and is in fact sufficient to trigger SUMOylation of HR
proteins (Fig. 13A), which is largely dependent on Exo1. In parallel, generation of
ssDNA tracts activates checkpoint kinases that target numerous substrates including
resection machinery. Multisite phosphorylation of Exo1 was shown to inhibit its
activity, preventing excessive ssDNA formation and thus limiting the checkpoint
activation (Morin et al., 2008). We therefore analyzed how phosphorylation-defective
exo1-SA mutant, which is no longer negatively regulated by checkpoint control, would
affect HR protein SUMOylation, and found that it was indeed significantly increased
compared to WT cells (Fig. 13B).
The increased levels of Rad52 SUMOylation were observed previously in DNA
damage checkpoint mutants, e.g., in rad53 cells, and were proposed to correlate with
Figure 13. Exo1 Resection-induced SUMOylation in HR Is under Checkpoint Control
(A) SUMOylation of repair proteins can be efficiently triggered by Exo1-resected DNA DSB-
ends in cells arrested in G1. Denaturing Ni-NTA pull-down (Ni PD) was performed to isolate
HisSUMO-conjugates from G1-arrested and Zeocin-treated WT cells, cells lacking
nonhomologous end-joining factor Yku70 ( ku70), or both Yku70 and Exo1 ( ku70 exo1).
(B) Exonuclease activity of Exo1 is required for efficient DNA resection and SUMOylation of
HR proteins following MMS treatment in G1-arrested cells. -factor arrested cells expressing
nuclease-dead Exo1 ( exo1 cells expressing exo1-D173A; ND) do not show efficient
SUMOylation of RPA and Rad52 compared to cells expressing WT Exo1. In contrast, cells
expressing Exo1 mutant (exo1-S372A,S567A,S586A,S692A; SA) that is not negatively
regulated by DNA damage checkpoint kinases, show elevated levels of SUMOylated repair
proteins due to uncontrolled resection.
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elevated levels of ssDNA formation during replication (Ohuchi et al., 2009). Our
findings provide explanation for these observations and suggest that inactivation of
the checkpoint signaling leads to the accumulation of HR protein SUMOylation not
only because DNA damage levels are elevated, but also because excessive DNA
resection is no longer repressed.
When we analyzed SUMOylation of HR proteins in mutant cells lacking apical
checkpoint kinase Mec1, or its adaptor protein Ddc2, which recruits the kinase to the
ssDNA-RPA bound complexes (Rouse and Jackson, 2002; Zou and Elledge, 2003),
strong enrichment of SUMOylated HR proteins was observed even in the absence of
exogenous DNA damage (Fig. 14A). Deletion of Mec1/Ddc2 is lethal to the cells, but
can be suppressed by removal of Sml1, an inhibitor of ribonucleotide reductase that
catalyzes the rate-limiting step in dNTP synthesis (Zhao et al., 1998). Sml1 deletion
increases the dNTP levels otherwise downregulated in checkpoint kinase mutants.
Similar to the absence of Mec1/Ddc2, deletion of the checkpoint mediator Rad9,
which is crucial for the DNA damage checkpoint but is not required for normal growth,
resulted in strong accumulation of SUMOylated HR factors (Fig. 14B). Mutants
lacking the components of the 9-1-1 checkpoint clamp ( rad17, mec3) or its loader
( rad24) also showed elevated SUMOlyation levels of HR proteins (Fig. 14C)
following MMS treatment.
Elimination of the DNA damage checkpoint signaling resulted in pronounced
enrichment of HR protein SUMOylation in cycling cells even when both long-range
resection pathways were absent ( exo1 sgs1; Fig. 14D), in contrast to the scenario
when the checkpoint is intact. This is indicative of a high DNA damage load leading
to accumulation of ssDNA in checkpoint mutants most probably arising from the
stalling and subsequent collapse of multiple replication forks. Interestingly, disruption
of the DSB-sensing MRX complex ( rad50; Fig. 14D) did not reduce SUMOylation of
HR proteins to the same level as in resection-defective mutants, further suggesting
that ssDNA in checkpoint mutants arises largely in the form of extensive single-
stranded gaps and faulty replication intermediates. Moreover, exposure of checkpoint
mutants to HU or 4NQO, which in WT cells barely induce SUMOylation in HR,
resulted in strong accumulation of SUMO-modified repair factors (Fig. 14E). Thus,
the HR protein SUMOylation wave and checkpoint signaling are initiated in parallel;
however, checkpoint kinases restrict excessive ssDNA formation and therefore
regulate the extent of SUMOylation in HR.
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Figure 14. HR Protein SUMOylation Accumulates Heavily in the Absence of
Checkpoint
(A) Inactivation of the DNA damage checkpoint in mutants lacking the apical checkpoint
kinase Mec1 ( mec1 sml1), or its adaptor protein Ddc2 ( ddc2 sml1), results in strong
SUMOylation of HR proteins, even in the absence of exogenous DNA damage. (B) Absence
of the checkpoint mediator Rad9 ( rad9) results in increased SUMOylation of HR proteins,
similar to mec1 sml1 cells. (C) Absence of subunits of the 9-1-1 checkpoint clamp
( rad17, mec3), or of its loader ( rad24), results in a partial increase of SUMOylation of HR
proteins upon MMS treatment. (D) Strong accumulation of SUMOylated HR proteins in DNA-
damage checkpoint mutants can be attributed to increased DNA resection by Exo1- and
Sgs1/Dna2-dependent resection pathways. HisSUMO Ni PD from checkpoint-deficient
( mec1 sml1) cells lacking additionally DNA resection pathways, following MMS treatment.
HR protein SUMOylation is reduced in mutants lacking resection pathways ( exo1, sgs1,
exo1 sgs1). SUMOylation is still substantial even in resection-defective cells because
DNA damage is significant in the absence of checkpoint signaling. Disruption of the MRX
complex ( rad50) does not reduce SUMOylation of repair proteins to the same extent as in
mutants defective in long-range resection ( exo1 sgs1). (E) In the absence of normal
checkpoint activation ( mec1 sml1), SUMOylation of HR proteins can be efficiently
triggered even by DNA-damaging agents (HU, 4NQO) that do not normally trigger the
SUMOylation wave in unperturbed cycling cells. HisSUMO Ni PD from WT and checkpoint
deficient mec1 sml1 cells following treatment with indicated DNA-damaging agents.
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III.3 DNA-bound SUMO Ligase Siz2 Induces a SUMOylation Wave in HR
III.3.1 SUMOylation in HR is Mediated by Sequence-nonspecific DNA-bound Siz2
After establishing that exposure of ssDNA triggers protein group SUMOylation in HR,
we next asked how this is being achieved mechanistically. Substrate selectivity in the
SUMO pathway is mediated largely by the localization of conjugation machinery,
therefore we initially hypothesized that the responsible SUMO ligase is specifically
recruited by ssDNA. There are currently three SUMO ligases known to operate in the
mitotic cells of S. cerevisiae (Geiss-Friedlander and Melchior, 2007). Consequently,
we individually analyzed DNA-damage induced SUMOylation of HR proteins in
mutants lacking canonical Siz/PIAS SUMO ligases Siz1 or Siz2, as well as in mutant
mms21-11 cells, harboring Mms21 defective in its ligase activity (Fig. 15). The
SUMOylation of HR proteins was virtually absent in cells lacking Siz2, whereas it was
largely not affected in other SUMO E3 mutants. Therefore, Siz2 is the key SUMO
ligase that mediates protein group SUMO modification in HR.
We next determined whether Siz2 binds to DNA in vitro. To this end, we purified
N-terminally His-tagged recombinant Siz2 protein expressed in E. coli and analyzed
Figure 15. SUMO Ligase Siz2 Mediates Protein Group SUMOylation in HR
(A) SUMO ligase Siz2 stimulates SUMOylation of RPA and Rad52 after DNA damage.
Denaturing Ni-NTA pull-down (Ni PD) was performed to isolate HisSUMO conjugates from
MMS-treated WT cells, mutants lacking SUMO ligases Siz1 ( siz1)  or  Siz2  ( siz2), or
mutant mms21-11 cells, lacking ligase activity of Mms21. (B) SUMO ligase Siz2 stimulates
modification of the HR protein Rad59 in response to DNA damage. HisSUMO Ni PD from WT
cells or cells lacking Siz2 ( siz2) before and after MMS treatment. SUMO modified species
of C-terminally Myc-epitope-tagged Rad59 are almost absent in cells lacking Siz2.
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its ability to bind DNA using chemiluminescent-based electrophoretic mobility shift
assay (EMSA). Indeed, Siz2 could bind to both random dsDNA and ssDNA, however,
very weakly to the latter (Fig. 16A). Moreover, we did not detect any binding
preference of Siz2 toward preassembled DNA structures that represent resected
DSB-ends or replication forks (Fig. 16B). Thus, in the absence of accessory proteins,
recombinant Siz2 in vitro preferentially binds to dsDNA in a sequence-nonspecific
manner.
The canonical Siz/PIAS SUMO ligase Siz2 contains an unstructured C-terminal
tail harboring s SIM close to an SP-RING domain that is required for binding to
SUMO-charged Ubc9, a PINIT domain associated with substrate binding, and an N-
terminal SAP domain, which mediates DNA binding in many other proteins
(Fig. 17A). We next verified whether sequence-nonspecific interaction of Siz2 with
DNA is achieved through this short conserved module. Indeed, Siz2 binds to DNA via
the SAP domain, because purified recombinant Siz2 variants with either deleted SAP
( SAP) or carrying substitutions of the three conserved residues to alanines within
this domain (G64A, K66A and L69A; SAP*) are no longer able to bind DNA in vitro
(Fig. 17B).
Figure 16. Recombinant SUMO Ligase Siz2 Preferentially Binds to dsDNA in vitro
(A) Recombinant HisSiz2 protein binds dsDNA and weaker ssDNA. Increasing amounts of
HisSiz2 were added to 5’-end biotin-labeled 77-nucleotide long dsDNA and ssDNA (20 fmol),
and the binding was detected using chemiluminescent-based electrophoretic mobility shift
assay (EMSA). (B) Recombinant, purified HisSiz2 protein has no binding preference in vitro to
assembled DNA structures, representing replication forks or 3’-end ssDNA overhangs.
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We then examined the role of SAP-mediated DNA binding of Siz2 in the
SUMOylation of HR proteins after DNA damage in vivo. Interestingly, expression of
the DNA-binding-deficient Siz2-SAP* from its endogenous promoter resulted in the
loss of HR protein group SUMOylation, however, the ligase mutant variant was barely
detectable in the cell lysates compared to WT Siz2 (Fig. 18A). Expression of the
mutant protein via a strong copper-inducible promoter (pCUP-SAP*) restored its
intracellular levels (Fig. 18B) and to some extent rescued the DNA-damage-induced
SUMOylation of HR proteins (Fig. 18C). This suggests that the mutant is not
enzymatically inactive, but that the SUMO ligase has to properly localize to DNA in
order to efficiently mediate the modification of its substrates.
The SAP domain with a consensus sequence of just 35 residues is a putative
DNA-binding domain found in diverse nuclear proteins implicated in chromosomal
organization (Aravind and Koonin, 2000), which was previously shown to
nonspecifically bind to A/T-rich DNA sequences. In our in vitro DNA-binding
experiments (EMSA) we also used random DNA oligos and observed strong
sequence-nonspecific SAP-mediated interaction of Siz2 preferentially with dsDNA,
suggesting that the SAP domain localizes the SUMO ligase to chromatin broadly and
not specifically to certain DNA sequences or ssDNA. To further test if Siz2 has to
Figure 17. DNA Binding of Siz2 is Mediated via the Conserved SAP Domain
(A) Schematic representation of the domain architecture of Siz2 and its mutant variants
constructed to study the role of the SAP domain in the DNA binding and SUMOylation of HR
proteins. SAP denotes a Siz2 variant, in which conserved residues (aa 43-77) of the DNA-
binding domain (DBD) were deleted. SAP* denotes a ligase variant, in which three
conserved residues (G64, K66 and L69) of the SAP domain were changed to alanines.
(B) Recombinant HisSiz2 variants either lacking the DNA-binding SAP domain ( SAP) or
having three highly conserved residues replaced by alanine residues (SAP*) are unable to
bind DNA. EMSA with random 5’-end biotin-labeled 77-nucleotide long dsDNA (20 fmol).
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bind DNA in a sequence-nonspecific manner in order to support DNA-damage-
induced SUMOylation of HR proteins, we decided to exchange the SAP domain of
Siz2 with the short sequence-specific DBD of the well-known transcription factor Gal4
(Fig. 19A).
Remarkably, localization of Siz2 to specific DNA sequences by the DBD of Gal4
(siz2-Gal4DBD) restored the protein level of the SUMO ligase compared to its DNA-
binding-deficient variant, however, without supporting HR protein group SUMOylation
(Fig. 19B). By contrast, when we replaced the N-terminus of Siz2 harboring SAP
domain with the N-terminus of related canonical Siz/PIAS ligase Siz1 carrying its
SAP domain (Siz1 SAP; Fig. 19A), not only the protein levels of chimeric protein
were identical to WT Siz2, but also the SUMOylation wave in HR was fully supported
(Fig. 19C). Thus, together these findings strongly suggest that SAP-mediated
Figure 18. SAP-mediated DNA Binding Stabilizes Siz2 and Ensures SUMOylation in HR
(A) DNA-binding-deficient Siz2 is destabilized in vivo and does not stimulate SUMOylation of
HR proteins after DNA damage. HisSUMO  Ni  PD  from siz2 cells expressing either Myc-
tagged WT Siz2 or DNA-binding-deficient Siz2 (SAP*) following MMS treatment.
(B) Intracellular protein level of Siz2 SAP* expressed under CUP1-promoter control (100 M
CuSO4) is similar to the protein level of WT Siz2. (C) Expression of DNA-binding-deficient
Siz2 via the strong CUP1 promoter (CUP1-SAP*) partially restores its protein level and HR
protein SUMOylation after MMS treatment.
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localization of Siz2 to DNA is required for efficient DNA damage-induced protein
group SUMOylation in HR. Moreover, and importantly, Siz2 binds DNA widely in a
sequence-nonspecific manner and is not explicitly recruited by ssDNA, which
nevertheless serves as a key trigger for HR protein SUMOylation.
III.3.2 Features of Siz2 Required for Efficient Protein Group SUMOylation in HR
After establishing an important role of the conserved SAP domain in broad sequence-
nonspecific localization of Siz2 to DNA and efficient SUMOylation of HR proteins
upon DNA damage, we next addressed what other features of Siz2 are required for
full-scale SUMOylation response in HR.
Figure 19. Sequence-nonspecific DNA Binding of Siz2 via the Conserved SAP Domain
is Required for Efficient SUMOylation in HR
(A) Schematic representation of mutant variants constructed to study the role of the DNA-
binding SAP domain of Siz2 in the modification of HR proteins. Gal4DBD denotes a Siz2
variant in which its SAP domain (aa 43-77) was replaced by the sequence-specific DBD of
the Gal4 transcription factor (aa 5-49). Siz1 SAP denotes a chimeric Siz2 variant, in which
the N-terminal region (aa 1-77) of Siz2 (harboring its SAP domain) was replaced by the N-
terminal region (residues 1-68) of Siz1 (harboring its SAP domain). (B) A Siz2 variant
harboring the sequence-specific DNA-binding domain of Gal4 (siz2-Gal4DBD) instead of
Siz2’s SAP domain does not support efficient SUMOylation of HR proteins after DNA
damage even though its intracellular protein level is similar to WT Siz2. (C) Chimeric Siz2
carrying the N-terminus of Siz1 harboring Siz1’s SAP domain (Siz1 SAP) is expressed to a
similar level as WT Siz2 and is fully functional in stimulating HR protein SUMOylation.
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The conserved PINIT domain of the related canonical Siz/PIAS SUMO ligase
Siz1 was previously shown to be important for correct positioning of the ligase
substrate (PCNA) and its efficient SUMO modification at the non-consensus SUMO-
acceptor site (K164) (Yunus and Lima, 2009). To test whether also the PINIT domain
of Siz2 contributes to the SUMOylation of HR proteins, we again constructed a
chimeric protein this time carrying the PINIT domain of Siz1 in place of the Siz2’s
PINIT (Siz1 PINIT; Fig. 20A).
Figure 20. C-terminal Tail of Siz2 is Required for Full-scale SUMOylation Wave in HR
(A) Schematic representation of Siz2 mutant variants constructed to study the role of its
PINIT domain and the C-terminal tail in the modification of HR proteins. Siz1 PINIT denotes a
Siz2 variant, in which its conserved PINIT domain (aa 141-291) was replaced by the PINIT
domain of Siz1 (aa 172-314). Siz2 Cterm denotes a C-terminal truncation (aa 416-726) of
Siz2. (B) A Siz2 variant Siz2-Siz1PINIT harboring the PINIT domain of Siz1 fully supports
SUMOylation of HR proteins. (C) A Siz2 variant Siz2 Cterm with a deleted C-terminal tail (aa
416-726) supports SUMOylation of HR proteins, however, with reduced activity.
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The chimeric Siz2 protein harboring Siz1’s PINIT was stably expressed in vivo
and fully supported HR protein group SUMOylation after DNA damage (Fig. 20B).
This indicates that the features of Siz2 required for efficient SUMOylation in HR are
located elsewhere in the ligase, most likely in its C-terminal tail, which differs
significantly from the C-terminal domain of the related canonical Siz/PIAS SUMO
ligase Siz1. Indeed, a Siz2 variant lacking its C-terminal tail (Siz2 Cterm, Fig. 20A)
failed to induce a full-scale SUMOylation wave in HR (Fig. 20C) compared to the full-
length ligase, even though it was expressed at similar levels. Importantly, however,
truncated Siz2 was still able to weakly catalyze SUMO modification of HR proteins,
suggesting that C-terminal elements of the ligase further facilitate, but are not
absolutely necessary for protein group SUMOylation in HR.
We next investigated how C-terminal tail of Siz2 contributes to the full-scale
SUMOylation wave induction in HR, hypothesizing that specific motifs located in this
domain target or restrict the ligase, which is sequence-nonspecifically distributed on
DNA, to the DSB repair sites. Interestingly, using yeast two-hybrid assays, we found
that the C-terminal domain of Siz2 interacts specifically with the Mre11 subunit of the
DSB-sensing MRX complex (Fig. 21A). Mapping of the Mre11 interaction site in the
tail of Siz2 revealed that deletion of the last 25 residues readily abolishes ligase
binding to Mre11 (Fig. 21B). Interestingly, this C-terminal stretch of Siz2 contains a
potential SIM (aa 720-723). Destroying this motif by the replacement of two
hydrophobic residues to alanines (V720A, V721A; Fig. 21C) resulted not only in the
loss of interaction with Mre11 (Fig. 21B), but also strongly reduced SUMOylation of
HR proteins after DNA damage (Fig. 21D). Since Mre11 can directly bind to Ubc9 in
two-hybrid assays (Fig. 21A), Ubc9-mediated SUMOylation of Mre11 likely further
stimulates Siz2 binding to the MRX complexes loaded at DSB sites. This is
reminiscent of Srs2 binding to SUMOylated PCNA via tandem SIM and PIP-box
(Armstrong et al., 2012; Pfander et al., 2005). Therefore, the C-terminal tail of Siz2
most likely contains additionally a specific motif necessary for interaction with Mre11,
which alone without its C-terminal SIM is not sufficient to bind Mre11. We next asked
whether replacement of the C-terminal domain of the related Siz/PIAS ligase Siz1
with the C-terminal tail of Siz2 (Fig. 21C) would be sufficient to stimulate
SUMOylation in HR. However, the chimeric protein failed to support SUMOylation of
HR proteins (Fig. 21E), but was expressed at very low levels, suggesting that either
two proteins additionally differ in other aspects, or the expression levels of the ligases
play an important role.
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Taken together, these findings indicate that Siz2 is localized to DNA broadly in a
sequence-nonspecific manner via its SAP domain, where it can potentially encounter
and mediate collective modification of HR proteins loaded onto resected ssDNA in its
Figure 21. Binding to the Mre11 Subunit of MRX via SIM-containing Tail of Siz2 is
Required for Efficient SUMOylation in HR
(A) SUMO-conjugating enzyme Ubc9 and SUMO ligase Siz2, but not Siz1 interact with
Mre11 in the two-hybrid system. C-terminal tail of Siz2 (aa 348-726) is sufficient for Mre11
interaction. (B) The C-terminal SUMO-interacting motif of Siz2 (SIM2, aa 720-723) mediates
its binding to the Mre11 subunit of MRX in a two-hybrid assay. (C) Schematic representation
of mutant variants constructed to study the role of Siz2’s C-terminal tail in the modification of
HR proteins. Siz2-V720A,V721A denotes a Siz2 variant with mutated C-terminal SUMO-
interacting motif. Siz1-siz2Cterm denotes a Siz1 variant, in which its C-terminal tail (aa 424-
904) was replaced by the C-terminal tail of Siz2 (aa 416-726). (D) Siz2 with mutated C-
terminal SUMO-interacting motif (Siz2-V720A,V721A), which no longer binds to Mre11 in the
two-hybrid system, does not fully support HR protein SUMOylation. (E) A Siz1 chimeric
protein harboring the C-terminal domain of Siz2 (Siz1-siz2Cterm) does not support
SUMOylation of HR proteins after DNA damage.
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vicinity. At the same time, the C-terminal tail unique to Siz2 harbors a dedicated SIM
and probably additional motifs that restrict the ligase on DNA to SUMO-modified
Mre11 at DSB sites recognized by the MRX complexes in order to stimulate full-scale
SUMOylation in HR.
III.3.3 Artificial Targeting of HR Proteins to DNA Triggers Their SUMOylation
After we verified that the dedicated SUMO ligase Siz2 responsible for DNA-damage
induced SUMOylation in HR is not specifically recruited to exposed ssDNA, which
serves as a key trigger for protein group modification, we then scrutinized another
plausible model briefly outlined earlier. Specifically, since ssDNA acts as a recruiting
platform for HR proteins engaged in DSB repair, we speculated that perhaps simple
localization of repair factors to chromatin in the vicinity of the broadly DNA-bound
SUMO ligase Siz2 is sufficient for their modification.
To test this hypothesis, we decided to artificially target the HR proteins to DNA by
directly fusing them to the sequence-specific DBD of the Gal4 transcription factor
(residues 1-147, termed BD). As anticipated, the ectopically expressed BD-Rad52
fusion protein became efficiently SUMOylated in the absence of any exogenous DNA
damage in a Siz2-dependent manner (Fig. 22A), bypassing the requirement of
ssDNA as a crucial trigger. Notably, artificial DNA targeting of Rad52 did not induce
the SUMOylation of its interacting partner RPA, which acts earlier in the HR pathway
and is recruited to ssDNA prior to Rad52. By contrast, expression of the BD-Rfa1
fusion protein resulted not only in its robust SUMO modification in the absence of
DNA damage, but also induced the SUMOylation of Rad52, which apparently was
recruited to chromatin by the chromatin-bound RPA (Fig. 22B). Thus, these findings
strongly suggest that the localization of HR proteins to DNA in the vicinity of DNA-
bound SUMO ligase Siz2 is essential for their modification and that only DNA-bound
HR factors engaged in DSB repair become collectively SUMOylated upon DNA
damage. We therefore conclude that DNA resection and exposure of ssDNA serves
as a trigger of protein group SUMOylation in HR by recruiting and assembling the
substrates at reach of the dedicated chromatin-bound SUMO ligase.
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Importantly, Siz2-dependent SUMO modification of the DNA-targeted BD-Rad52
fusion took place at the correct SUMO-acceptor lysine residues of Rad52 mapped
previously, because no SUMOylation was observed when SUMOylation-defective
Rad52 BD-fusion with in vivo targeted lysines replaced by arginines (BD-rad52-KR,
Fig. 23A) was expressed. Notably, SUMOylation of BD-Rad52 was not further
stimulated by additional expression of Siz2 variant Siz2-Gal4DBD (Fig. 23A), which
should be specifically targeted to Gal4-binding sites where BD-fusions reside.
Moreover, in the absence of endogenous Siz2 ligase the Siz2-Gal4DBD variant failed
to support SUMOylation of BD-Rad52 fusion (Fig. 23B), emphasizing that intact SAP
domain is required for proper localization of the ligase to DNA to fulfill its functions.
Figure 22. Artificial Tethering of HR Proteins to DNA Triggers Their SUMOylation
(A) N-terminal Gal4 DNA-binding domain (aa 1-147, BD) fusion protein BD-Rad52 ectopically
expressed from high-copy pGBD vector becomes strongly SUMOylated in a Siz2-dependent
manner in the absence of DNA damage. (B) Expression of BD-Rfa1 with its subsequent
SUMOylation stimulates SUMO modification of both endogenous RPA (Rfa1) and Rad52 in
the absence of DNA damage.
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Figure 23. Siz2-dependent SUMOylation of Artificially DNA-bound HR Proteins Occurs
at Correct SUMO-Acceptor Lysine Residues and Requires Intact SAP-domain
(A) Siz2-dependent SUMOylation of BD-Rad52 takes place specifically at previously
confirmed SUMO-acceptor lysines on Rad52 and cannot be further stimulated by additionally
targeting Siz2 variant Siz2-Gal4DBD to Gal4-binding sites where BD-Rad52 resides.
(B) SUMOylation of BD-Rad52 cannot be supported by Siz2-Gal4DBD in the absence of
endogenous Siz2 ligase.
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III.4 SUMOylation Promotes Physical Interactions between HR Proteins
III.4.1 SUMOylation of HR Proteins on Chromatin Promotes Complex Formation
After concluding that ssDNA serves as a key trigger for SUMOylation in HR by
recruiting substrates to chromatin in close vicinity to the dedicated DNA-bound
SUMO ligase Siz2, which catalyzes HR protein group modification, we then verified
whether SUMOylated HR proteins are indeed located on chromatin. To this end, we
performed subcellular fractionation of MMS-treated cells followed by denaturing Ni-
NTA pull-down of HisSUMO conjugates. As expected, we observed that the SUMO-
modified HR proteins are enriched in the chromatin fraction (Fig. 24), further
strengthening that specifically DNA-bound pools of HR proteins engaged in DSB
repair after DNA damage become collectively targeted by SUMO modification.
Since the SUMOylation wave specifically targets the whole set of HR proteins
that not only act together in one DSB repair pathway, but also physically interact and
form functional protein complexes at sites of DNA damage, we therefore asked how
protein group SUMOylation might affect physical interactions between HR factors.
For that purpose, we co-immunoprecipitated (co-IP) DSB repair protein complexes
after DNA damage by pulling down the individual HR factors and quantified the ratios
Figure 24. SUMOylated HR Proteins are Enriched in Chromatin after DNA Damage
Following subcellular fractionation of MMS-treated WT cells, or cells overexpressing
HisSUMO into soluble (SOL) and chromatin-enriched (CHR) fractions, the denaturing Ni-NTA
pull-down (Ni PD) of HisSUMO conjugates was performed. SUMOylated forms of Rfa1 and
Rad52 were specifically enriched in the chromatin fraction. To control chromatin fractionation
efficiency, the levels of histone H3 lysine-4 tri-methylation (H3 K4me3) and the ER-
membrane protein Dpm1 were detected in fractions prior to Ni PD.
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of SUMO-modified/unmodified HR protein fractions in co-IPs versus inputs.
Importantly, interacting repair proteins formed complexes precisely after DNA
damage with marked preference towards SUMO-modified species. Specifically,
immunoprecipitation of Rad59, which forms a complex with RPA and Rad52 (Davis
and Symington, 2003) that is required for efficient exchange of RPA to Rad51
recombinase on ssDNA, brought down proportionally higher amounts of SUMO-
modified RPA (Rfa1) and Rad52 compared to their unmodified pools (Fig. 25).
Likewise, pulling down RPA (Rfa19Myc) from yeast cell extracts following DNA
damage preferentially co-immunoprecipitated the SUMOylated Rad52 species
compared to the unmodified Rad52 (Fig. 26A). Moreover, absence of Rad51
( rad51), HR protein that acts downstream in the pathway and is exchanged for RPA
Figure 25. SUMOylation of HR Proteins after DNA Damage Fosters Physical
Interactions
The RPA-Rad52-Rad59 repair complexes, which assemble following MMS-induced DNA
damage, were co-immunoprecipitated (co-IP) from yeast cell extracts by immunoprecipitation
of C-terminally HA-tagged Rad59. The preference for SUMOylated species is reflected by
the ratios of SUMO-modified/unmodified HR protein fractions in co-IPs versus inputs
(quantified by ImageJ software).
RESULTS
51
on ssDNA by Rad52, further increased the binding preference of RPA towards
SUMOylated partner protein (Fig. 26A). Notably, in the absence of checkpoint
signaling ( mec1 sml1), which leads to increased DNA damage and hyper-
resection, the preferential binding of RPA to SUMOylated Rad52 was observed
already without any exogenous DNA damage, but was further increased by MMS-
induced DNA lesions (Fig. 26B). Strikingly, the binding of RPA to Rad52 in our
experimental co-IP setup was dramatically reduced in the absence of the SUMO
ligase Siz2 (Fig. 26B).
Figure 26. SUMOylation of HR Proteins Promotes DSB Repair Complex Formation
(A and B) RPA-Rad52 protein complexes, which assemble on resected ssDNA following
treatment with DSB-inducing agent Zeocin, were co-immunoprecipitated (co-IP) from yeast
extracts by immonoprecipitation of either Myc-tagged RPA subunit Rfa1 (A) or Rfa2 (B). RPA
(Rfa1, Rfa2) interacts with unmodified Rad52, but with preference towards the SUMOylated
Rad52 species. This preference is indicated by the difference in the ratios of SUMO-
modified/unmodified Rad52 fractions in co-IPs compared to inputs. In the absence of Rad51
( rad51), RPA-Rad52 association is enhanced, especially with the SUMOylated form of
Rad52. In the absence of the checkpoint kinase Mec1 ( mec1 sml1), RPA-Rad52
association is strong even in the absence of exogenous DNA damage and binding exhibits
preference towards the SUMOylated form of Rad52 (B). Notably, in cells lacking the SUMO
ligase Siz2 ( siz2), RPA-Rad52 complex formation is strongly affected (B).
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After determining that SUMOylation of HR factors strengthens physical
interactions between them and promotes protein complex formation, we next asked
what mediates the stronger binding of SUMOylated repair proteins to each other.
Because SUMO modification is typically recognized by a short hydrophobic linear
SUMO-interacting motif (SIM), we first performed a bioinformatic prediction and found
that in principle all DNA DSB repair proteins potentially harbor multiple SIMs (Tab. 1).
Table 1. SUMO-interacting Motif Prediction in DNA DSB Repair Proteins
Protein Description Predicted SIMs Position
Mre11 Subunit of a complex with Rad50 and
Xrs2 (MRX DSB sensing complex),
exhibits nuclease activity
IESDK IKVV PLLFQ
AQPKY VFIL DIKYG
EISNE VGIL STNEE
IDEND IIMV STDEE
158 – 161
280 – 283
495 – 498
633 – 636
Rad50 Subunit of a complex with Mre11 and
Xrs2 (MRX DSB sensing complex)
SNSID ILDL SKPDL
KSKEK VIQL LSENL
LLEKH IITL NSINE
294 – 297
629 – 632
740 – 743
Xrs2 Subunit of a complex with Mre11 and
Rad50 (MRX DSB sensing complex)
VLKST IIEL GTTPI
LNRRR VLPL DSLDF
RVKST IVEL KDEEL
ENNRN LFVV KEMNL
102 – 105
363 – 366
578 – 581
795 – 798
Sae2 Endonuclease that processes hairpin
DNA structures with the MRX complex
at DSBs
LSLDE LLNV QYDVT
NKTRK LLGI ELENP
HRSLS VVIE SQNSD
25 – 28
167 – 170
245 – 248
Rfa1 Largest subunit of heterotrimeric
Replication Protein A
SNRKN LIMI SDGIY
ERKKY VLLV DDFEL
NSNVD VLGI IQTIN
FDRRD ITIV DDSGF
DQAKQ LLGV DANTL
47 – 50
  97 – 100
319 – 322
345 – 348
544 – 547
Rfa2 Subunit of heterotrimeric Replication
Protein A
VLTHH LEVI KCHSI 168 – 171
Rfa3 Smallest subunit of heterotrimeric
Replication Protein A
PTESQ LILQ SPTIS
LSLNG VVAL QRLCK
36 – 39
108 – 111
Rad52 Protein that stimulates strand exchange
by facilitating Rad51 binding to ssDNA
IEGWR VINL ANQIF
DSTKN LVKI ENTVS
53 – 56
218 – 221
Rad59 Protein involved in the repair of DSBs
via recombination and single-strand
annealing
WSVQR IGLL QSKIE
GWRMD VIDV EAREC
LSFEK IILD YETKI
48 – 51
  99 – 102
183 – 186
Rad51 Strand exchange protein, forms a
helical filament with DNA that searches
for homology
APRKD LLEI KGISE
MRRSE LICL TTGSK
NADHQ LRLL DAAAQ
ESRFS LIVV DSVMA
118 – 121
157 – 160
259 – 262
276 – 279
Mec1 Genome integrity checkpoint protein
required for cell cycle arrest prompted
by damaged or unreplicated DNA
YLDEL ILAI KDLNS
YSSKT ILDI FQRYI
EMVPN VVTL RSILS
IQTGK VLHV DFDCL
12 – 15
720 – 723
2135 – 2138
2239 – 2242
Tel1 Protein kinase that together with Mec1
contributes to cell cycle checkpoint
control in response to DNA damage
ISERL VAIL EFSDC
LDSSN IINI MNSIS
QIHDE VITI FSSLL
CGVDD VVLV SLLFS
839 – 842
993 – 996
1348 – 1351
1442 – 1445
Rad9 DNA damage-dependent checkpoint
protein; transmits checkpoint signal by
activating Rad53 and Chk1
ELETQ IIVS SLSQG
ATRDD IIIA GSSDF
TSPKK LVVE EETLM
AKRAK IILE DNEKN
429 – 432
545 – 548
622 – 625
906 – 909
RESULTS
53
We then wanted to check if the predicted SIMs could indeed interact with SUMO.
To validate the SUMO-binding properties of these multiple linear motifs, we
synthesized peptides of a length of 12 aa containing previously verified SIMs, as well
as potential SIMs in repair proteins flanked by their native sequences on a single
membrane, and probed the resulting peptide array for binding to poly-SUMO chains
in vitro. Indeed, a large number of the predicted SIMs in DSB repair proteins as well
as previously known SIMs could efficiently interact with SUMO, but lost this ability
when two core hydrophobic residues of a SIM were replaced with alanines (Fig. 27).
This suggests that the HR proteins engaged in DNA repair are not only collectively
SUMOylated, but are also covered with multiple SIMs that mediate stronger physical
interactions between modified proteins and foster complex formation.
Figure 27. HR Proteins are Decorated with Multiple SUMO-interacting Motifs
In vitro binding of poly-SUMO chains to membrane-bound peptides harboring known and
verified SIMs (top panel) and predicted SIMs (bottom panel) of HR pathway proteins and
their mutant versions (two core hydrophobic residues replaced by alanine residues).
Detection by anti-SUMO antibodies.
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III.4.2 Identification of SUMO-Acceptor Lysine Residues in the Core HR Proteins
Protein group SUMOylation in HR fosters physical interactions between modified
factors engaged in DNA repair and promotes SUMO-SIM-mediated protein complex
formation, indicating that multiple SUMO modifications might act in concert and have
synergistic effect on the efficiency of DSB repair. To address the functional
importance of the SUMOylation wave in HR, we aimed to map and specifically
eliminate the SUMO-acceptor sites in the core DSB repair proteins. Because HR
proteins contain multiple lysine residues that could be targeted by SUMO conjugation
machinery, we decided to apply a mass spectrometry based approach to directly map
the SUMOylation sites used in vivo.
The identification of the SUMO-targeted lysines relied on the proteomic analysis
of peptide pools generated after digestion of purified SUMO conjugates by trypsin or
thermolysin. The proteinases cleave SUMO (yeast Smt3) close to its C-terminal tail,
generating “branched” peptides in the cases when the modifier was conjugated to the
substrate. These peptides correspond to the substrate-derived sequences carrying
additional mass of the SUMO-derived fragment at acceptor lysine (EQIGG in case of
trypsin and IGG in case of thermolysin digestion), which can be detected by LC-
MS/MS analysis.
Using this approach we successfully mapped two SUMOylation sites in the
largest subunit of RPA (Rfa1) and detected individual modifications in its other
subunits (Rfa2, Rfa3), as well as in Rad59 and Rad52 (Fig. 28A), confirming
previously verified SUMO-acceptor lysine of Rad52 (K220) (Sacher et al., 2006). To
validate the mapped SUMOylation sites, we constructed mutant strains carrying
substitutions of the acceptor lysine residues to arginines that were introduced at the
endogenous genomic loci of HR proteins using pop-in/pop-out allele replacement
method (Scherer and Davis, 1979). Elimination of the mapped SUMO-acceptor sites
resulted either in the almost complete loss (for Rfa2 and Rfa3), or strong reduction
(for Rfa1 and Rad59) of SUMOylation after DNA damage (Fig. 28B-28E). This
suggests that the mass spectrometry based approach indeed identified the major in
vivo SUMOylation sites of the core HR proteins. However, Rfa1 and Rad59 carry
additional acceptor lysines targeted to a lower extent by the SUMO conjugation
machinery, because additional removal of predicted SUMOylation consensus sites
further reduced the DNA damage-induced modification of these HR proteins
(Fig. 28D and 28E).
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Figure 28. Mapping and Verification of SUMO-Acceptor Lysine Residues in HR
Proteins
(A) Identification of SUMO-attachment sites in HR proteins using proteomic mass
spectrometry. Following Ni-NTA pull-down (Ni PD) after MMS-induced DNA damage,
HisSUMO-conjugates were digested either with trypsin or thermolysin, and branched peptides
with characteristic SUMO remnants attached to target lysines were detected by LC-MS/MS.
(B-E) HR proteins are SUMOylated independently at multiple sites following DNA damage.
HisSUMO Ni PD from MMS-treated cells expressing either WT Rfa2 (B), C-terminally HA-
tagged Rfa3 (C), Rfa1 (D), C-terminally HA-tagged Rad59 (E) or their various KR mutant
variants. In addition, cells expressing a HisSUMO variant in which all lysine residues were
replaced by arginines (HisSUMO-KRall) as the only source of SUMO were used for pull-down
to distinguish poly-SUMOylation from multisite SUMOylation (B and C).
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Interestingly, when we analyzed SUMOylation of HR proteins in a mutant strain
expressing a SUMO variant with all lysine residues replaced by arginines (SUMO-
KRall) as the only source of the modifier, the disappearance of the slower-migrating
di- and tri-SUMOylated species of Rfa2 and Rfa3 was observed (Fig. 28B and 28C).
This suggests that the HR proteins are also partially modified by poly-SUMO chains,
because the lysine-less SUMO variant does not support polySUMOylation. Taken
together, these findings indicate that protein group SUMO modification in HR is
robust and excessive by not only targeting a whole set of HR proteins at multiple
sites, but also by generating poly-SUMO chains at acceptor lysine residues.
Importantly, elimination of individual SUMOylation sites did not impair the
modifications at other acceptor lysines or HR factors, strengthening that
SUMOylation targets members of the protein group independently and
simultaneously.
III.5 HR Protein SUMOylation Accelerates DNA Repair
III.5.1 Protein Group SUMOylation Facilitates HR
After we mapped and validated the in vivo SUMOylation sites of the core HR
proteins, we then addressed the functional significance of the SUMO modifications in
DNA repair. Because HR protein group SUMOylation fosters physical interactions
between modified repair factors promoting complex formation, we previously
speculated that multiple modifications might act synergistically or have redundant
roles. Indeed, SUMOylation-defective mutants of individual HR proteins did not
exhibit reduced resistance to DNA-damaging treatment ((Sacher et al., 2006) and
data not shown). We thus wondered whether elimination of the complete set of
SUMOylation sites in the core HR proteins would affect the efficiency of
recombination-mediated DNA repair.
For that purpose, we constructed a mutant strain in which we combined
SUMOylation-defective variants of the core repair proteins RPA, Rad52 and Rad59
(rfa1-K133R,K170R,K427R rfa2-K199R rfa3-K46R rad52-K10R,K11R,K220R rad59-
K207R,K228R,K238R) that were generated by pop-in/pop-out allele replacement
method. The resulting strain (termed KR mutant) carried 11 substitutions of the
SUMO-acceptor lysines to arginines in the HR proteins that form SUMO-SIM-
assisted repair complexes after DNA damage required for efficient loading of the
Rad51 recombinase onto resected DSB ends.
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The generated KR strain  grew  at  WT  rates  in  the  absence  of  DNA  damage,
however a substantial growth delay of roughly 4 hours was observed upon chronic
exposure to MMS (Fig. 29A). Furthermore, both spontaneous and MMS-induced
interchromosomal recombination rates measured between his1 heteroalleles in KR
mutant diploid cells were significantly reduced, similar to cells lacking SUMO ligase
Siz2 (Fig. 29B). In general, the KR mutant and Siz2 deficient ( siz2) strains exhibit
largely similar phenotypes and are epistatic (Fig. 29) under tested conditions,
suggesting that in the recombination-mediated DNA repair Siz2 acts mainly through
SUMO modification of HR factors. Thus, Siz2-dependent protein group SUMOylation
facilitates HR and supports efficient repair of DNA lesions that rely on recombination.
Figure 29. Protein Group SUMOylation is Required for Efficient HR
(A) Cells deficient in HR protein SUMOylation either due to the absence of Siz2 ( siz2) or
the lack of 11 SUMO-acceptor sites in the core HR proteins RPA, Rad52 and Rad59 (KR)
show delayed growth upon chronic exposure to DNA damage. Growth curves for WT cells,
cells deficient in Rad52 ( rad52) or Siz2 ( siz2), and cells deficient in SUMOylation sites of
HR proteins (KR) and also in combination with siz2 (KR siz2), were measured in YPD
medium or YPD containing 0.02% MMS. (B) Deficiency in HR protein SUMOylation results in
reduction of spontaneous and MMS-induced recombination. The interchromosomal
recombination rates between chromosomal his1 heteroalleles were measured by fluctuation
analysis in WT cells, cells lacking Siz2 ( siz2) and mutant cells deficient in SUMOylation
sites of HR proteins (KR). The results are the average of at least three independent studies
and error bars represent SD.
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III.5.2 SUMOylation in HR Accelerates DSB Repair by Promoting Rad51 Loading
After determining that protein group SUMOylation facilitates HR, we next addressed
how it might be mechanistically achieved using yeast mating-type switching
mechanism as a case study (Connolly et al., 1988; Weiffenbach and Haber, 1981;
White and Haber, 1990). During mating-type switching in S. cerevisiae, a single DSB
is generated by the HO endonuclease specifically at the mating type (MAT) locus,
which is subsequently repaired by HR using either of two homologous donor
sequences (HML  or HMRa, located on the same chromosome III with MAT). We
first confirmed that a single DSB is sufficient to trigger protein group SUMOylation in
HR using donor deficient ( hml hmr) strain defective in repair (Fig. 30). Indeed,
SUMOylation wave was induced, however to a much lesser extent compared with
MMS-treatment that generates many DNA lesions with long tracts of ssDNA.
Figure 30. A Single DSB is Sufficient to Trigger SUMOylation of HR Proteins
A single DSB is generated by HO endonuclease at the MAT locus of the yeast mating-type
switching system (top; map of chromosome III) to follow the induction of SUMOylation of HR
proteins. HO is expressed from a galactose-inducible GAL-promoter, and repair is prevented
by deletion of HML and HMR homologous donor sequences (donor deficient strain). Two
hours after HO induction, mono- and di-SUMOylated species of RPA (Rfa1) and Rad52
appear. Detection by Western blotting following Ni-NTA pull-down of HisSUMO conjugates.
MMS-induced SUMOylation is shown for comparison.
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Because Siz2-mediated protein group SUMOylation of the core HR factors
fosters physical interactions within the RPA-Rad52-Rad59 complexes that are
required for efficient loading of the Rad51 recombinase onto resected DSB ends, we
next asked whether Rad51 nucleofilament formation in mating-type switching system
is affected in the absence of Siz2. The DSB formation was rapidly induced at the
MAT locus of donor deficient WT and siz2 cells by constant expression of HO
endonuclease under the control of GAL-promoter (Fig. 31A). When we then
monitored the recruitment of the HR factors at sites 0.2 kb and 5.7 kb distal to the
persistent DSB by chromatin immunoprecipitation (ChIP), we observed that RPA
(Rfa19Myc) was efficiently loaded to the resected ssDNA with similar kinetics in both
WT and siz2 cells (Fig. 31B, top). However, recruitment of the Rad51 recombinase
was substantially delayed when HR protein group SUMOylation was abolished
(Fig. 31B, bottom).
Inefficient Rad51 nucleofilament formation in the absence of HR protein
SUMOylation should result in a delay of DSB repair, similar to the delay observed
when DSB-end resection is compromised in cells lacking MRX complex ( rad50)
(Ivanov et al., 1994). We therefore transiently induced the DSB and directly
Figure 31. Rad51 Loading at the DSB is Affected in the Absence of SUMOylation in HR
(A) A single unrepairable DSB was induced by HO-endonuclease at MAT of cells lacking
HML and HMR (donor-deficient strain). DSB-induction was monitored in WT and Siz2-
deficient cells ( siz2) by real-time quantitative PCR with primers (PMAT) spanning the HO-cut
site. (B) ChIP directed against C-terminally Myc-tagged Rfa1 and Rad51 at 0.2 and 5.7 kb
distal from DSB was performed 1, 2, and 3 hrs after HO-induction to compare loading of RPA
(top) and Rad51 (bottom) in the absence of HR protein SUMOylation. The results are the
average of at least three independent studies and error bars represent SEM.
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monitored the speed of its repair (mating type switching) in donor proficient cells that
harbor homologous sequence (HML ) as well as efficiently induce SUMOylation
wave in HR (Fig. 32A). Indeed, we found that the DSB repair was significantly
delayed in the KR mutant strain (Fig. 32B) compared to WT. Thus, HR protein group
SUMOylation accelerates DSB repair by fostering SUMO-SIM-assisted repair protein
complex formation that is required for efficient Rad51 nucleofilament assembly at
resected DSB ends.
Figure 32. The Speed of DSB Repair is Reduced in the Absence of SUMOylation in HR
(A) A single DSB can trigger SUMOylation of HR proteins independent of the absence (top
panel) or presence (bottom panel) of homology required for repair. Experiment was
conducted similar to (Fig. 30). (B) A single repairable DSB (arrow indicates repair reaction)
was transiently induced by HO at MATa in WT cells, cells lacking the MRX subunit Rad50
( rad50) defective in DSB-resection initiation, or the Rad52 protein ( rad52), and the KR
mutant. Repair kinetics was measured by real-time quantitative PCR (with primers PA and PB)
following the appearance of repaired product Y  at MAT, 1, 2, and 3 hrs after inactivation of
HO (shift from galactose to glucose-containing media). The results are the average of at
least three independent studies and error bars represent SEM.
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IV. DISCUSSION
Despite extensive studies of the SUMO modification pathway during the last decade
and identification of hundreds of proteins targeted by SUMOylation, little has been
known about the principles that guide substrate specificity of this PTM (Gareau and
Lima, 2010; Geiss-Friedlander and Melchior, 2007; Ulrich, 2009). Especially puzzling
was how precise recognition of multiple SUMO targets upon specific stimuli is
achieved by a modifier-conjugation apparatus comprised of just a handful of
enzymes, in striking contrast to the elaborate ubiquitin system. Interestingly, the
SUMOylation enzymes are additionally rather promiscuous in vitro, while SUMO
substrates lack distinctive modification signals analogous to motifs that specifically
recruit ubiquitin ligases. Moreover, the recognition of the SUMO modification is also
surprisingly simple as it basically relies on a single SUMO-interacting motif, whereas
multiple ubiquitin-binding domains operate in the ubiquitin pathway. These enigmatic
features of the SUMO system together with the observations that SUMO modification
typically affects only a small fraction of a given substrate, while specific
SUMOylation-defective mutants often barely exhibit any phenotypes, suggested that
other principles of substrate selectivity must apply and perhaps distinct mechanisms
of PTM action exist in the SUMO pathway.
IV.1 Protein Group SUMOylation
By focusing on SUMOylation of HR proteins upon cell treatment with DSB-inducing
agents, we discovered that the SUMO pathway functions remarkably distinct from
typical PTM systems. In contrast to most protein modifications that are highly specific
for individual substrates in order to selectively affect their properties, SUMOylation
often collectively targets an entire physically and functionally engaged protein group
rather than an individual protein. In case of the DSB repair, multiple HR and
checkpoint proteins recruited to DNA lesions become synchronously modified at
multiple sites by a SUMOylation wave. The modifications are catalyzed by the
chromatin-associated conjugation machinery that independently and in parallel
targets accessible SUMO-acceptor sites on a whole set of HR proteins engaged in
DNA repair. Interestingly, these sites are not conserved in homologs of other species,
SUMOylation of which still takes place (Dou et al., 2010; Sacher et al., 2006), but at
other sites typically located outside of conserved globular domains. In fact, this might
not be so surprising, because SUMOylation usually targets lysines located in context
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of flexible loops or unstructured regions that could adopt an extended conformation
and fit into catalytic site of Ubc9. Therefore, modified sites in most cases lie outside
of conserved functional regions and are themselves less conserved.
The observed SUMOylation wave in HR is not a unique phenomenon, as a
similar scenario is found for several other protein groups, like proteins involved in
nucleotide excision repair (Fig. 6 and (Silver et al., 2011)), yeast septins (Johnson
and Blobel, 1999; Johnson and Gupta, 2001; Takahashi et al., 2001), ribosomal
proteins (Finkbeiner et al., 2011a; Finkbeiner et al., 2011b; Panse et al., 2006), and
proteins of snoRNPs  (Westman and Lamond, 2011; Westman et al., 2010). In all
these cases, the SUMOylation machinery seems to target several proteins of the
respective complexes synchronously and often at multiple sites. Therefore, protein
group modification appears to be a typical feature of the SUMO pathway. Importantly,
protein group modification in the SUMO pathway differs significantly from other PTM
waves like phosphorylation reactions, as most of the SUMO modifications do not
proceed via reaction cascade and are functionally additive or redundant.
In addition to sites of DNA damage, several other SUMOylation hotspots appear
to exist in the nucleus. Particular hubs for SUMOylation are telomeres, where the
SUMOylation machinery targets multiple proteins involved in telomere length
homeostasis and genomic stability. In S. pombe and S. cerevisiae, SUMOylation
appears to limit telomere length, and multiple telomere-binding proteins (Cdc13,
Yku70/80, Pif1, Rap1) have been identified as SUMO substrates. The SUMOylation
of S. cerevisiae Cdc13 promotes its association with the Stn1-Ten1 telomerase
inhibitory complex (likely through binding to multiple SIMs of Stn1) and thus restrains
telomerase-mediated lengthening of telomeres directly (Hang et al., 2011). Telomere
elongation is further inhibited by reversible telomere anchoring to the nuclear
periphery, a process that is mediated by Siz2-catalyzed SUMOylation of Yku70/80
and Sir4 proteins (Ferreira et al., 2011). Conversely, telomere elongation in yeast
requires the release of telomeres from the nuclear periphery, most likely by Ulp1-
mediated deSUMOylation of several SUMOylated telomere-anchoring proteins
(Nagai et al., 2011). Interestingly, in human ALT (alternative lengthening of
telomeres) cancer cells, telomeres re-localize to specialized so-called ALT-
associated PML bodies (APBs), where telomeres become elongated by an HR-
dependent mechanism. This telomere movement is mediated by a re-localization of
the SUMO ligase NSE2 to APBs and concomitant SUMOylation of four subunits of
the hexameric telomere-protecting shelterin complex (TRF1, TRF2, TIN2, RAP1).
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Indeed, SUMOylation-defective mutants of TRF1 and TRF2 fail to localize to PML
bodies, suggesting that SUMOylation of multiple subunits of the shelterin complex is
required for APB formation (Potts and Yu, 2007). Similarly, siRNA-mediated depletion
of NSE2 in ALT cells inhibits APB formation and HR at telomeres, resulting in
telomere shortening and cell senescence. Thus, both in yeast and human (ALT) cells,
collective protein group SUMOylation of telomere-associated proteins leads to a re-
localization of telomeres, yet to different nuclear compartments (periphery versus
APBs), and with different outcomes for telomere length and stability.
PML nuclear bodies generally emerge as strong hubs for SUMOylation in
mammalian cells. These dot-like nuclear territories are functionally associated with a
variety of functions including DNA repair, transcriptional control and tumorigenesis,
and are thought to function as a dynamic repository for nuclear factors (Bernardi and
Pandolfi, 2007). The tumor suppressor protein PML, initially identified as an
oncogenic protein fusion in promyelocytic leukemia patients, localizes to PML bodies
and is also crucial for their formation. Because PML proteins are SUMOylated and
possess multiple SIMs, it has been suggested that PML proteins trigger the formation
of protein networks with themselves and other proteins through multiple SUMO-SIM
interactions (Shen et al., 2006). Indeed, other proteins of PML bodies like SP100 and
the transcriptional repressor Daxx are SUMO modified or contain SIMs, and may thus
be incorporated into the PML network (Lin et al., 2006).
A particularly active SUMOylation hub is the nucleolus, largely because
SUMOylation controls pre-ribosome assembly, as indicated by phenotypes of SUMO
pathway mutants. Indeed, in S. cerevisiae, pre-ribosomal particles along the 60S and
the 40S synthesis pathways are decorated with SUMO, and several proteins of these
pathways are known SUMO substrates (Panse et al., 2006). Similarly, in human cells
deSUMOylation of several substrates implicated in ribosome biogenesis mediated by
the nucleolar deSUMOylation enzyme SENP3 is important for the maturation of the
28S rRNA and subsequent export of the 60S pre-ribosomal particle (Finkbeiner et al.,
2011a; Haindl et al., 2008). Notably, a proteomic approach identified among potential
nucleolar SUMO targets specifically snoRNP-related proteins (Nop58, Nhp2, Dkc1
and Nolc1). Indeed, the functional characterization of Nop58 SUMOylation revealed
its importance for snoRNP biogenesis (Westman et al., 2010), once again
strengthening the extensive role of SUMO system for ribosome biogenesis.
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IV.2 Specificity of SUMO Modification
Protein group SUMO modification is based on different principles of substrate
specificity. Whereas selective modification of an individual substrate involves a highly
specific interaction between a modifying enzyme and its target, protein group
modification may only require close proximity of a promiscuous E2 enzyme to its
multiple substrates, plus accessible modification sites within flexible protein domains
(scenario observed for SUMOylation of substrates in vitro by Ubc9 alone without the
need for ligases). In other words, a simple organization and the promiscuous
character of the SUMO conjugation machinery are key features of the SUMO system
that underlie protein group modification. Specificity toward an entire protein group is
in turn provided by two principles: a highly specific trigger and topological specificity.
In case of HR-mediated DSB repair pathway, the crucial trigger for damage-induced
SUMOylation is the resection of the DSB ends and exposure of ssDNA, which serves
as a platform for the loading of repair factors in the vicinity of the responsible
chromatin-bound SUMO ligase Siz2 (Fig. 33). Interestingly, the requirement for
resection as the trigger for Siz2-mediated SUMOylation in HR can be bypassed by
artificially targeting repair proteins to DNA (e.g., by fusing them to the DBD of the
Gal4 transcription factor). These experiments support the conclusion that the SUMO
ligase is not being specifically recruited to resected ssDNA at damage sites, but is
pre-bound to chromatin in a sequence nonspecific manner and collides with the
substrates that become loaded onto DNA in its proximity. Therefore, the topological
specificity for protein group modification is provided by the precise localization of the
SUMO ligases, which play the role of adaptors for recruiting SUMO-conjugating
enzyme Ubc9 in the vicinity of its substrates.
While protein group modification of septin network involves Siz1 localized to the
yeast bud neck via its C-terminal tail (Takahashi et al., 2008), the HR protein group
SUMOylation requires chromatin localization of related canonical Siz/PIAS ligase
Siz2 via its sequence nonspecific SAP domain. Even though both Siz1 and Siz2
harbor SAP domains and have similar DNA-binding properties, they differ in other
aspects (e.g., protein abundance, C-terminal tails) and in particularly in Siz2’s ability
(mediated in part by its C-terminal SIM) to bind selectively the Mre11 subunit of the
DSB-sensing MRX complex, potentially restricting the localization of the ligase and
concentrating SUMOylation activity at the sites of ongoing DNA repair. Moreover, the
SIMs of the E3 ligases might in general facilitate their binding to the SUMOylated
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substrates further promoting concentration of ligase activity and accelerating
SUMOylation, perhaps with characteristics of a chain reaction. This could explain the
rapid accumulation of mammalian SUMO ligases PIAS1 and PIAS4 in repair foci at
sites of DNA damage (Galanty et al., 2009).
Taken together, these features of the SUMO system reveal, how upon certain
stimuli rather simply organized promiscuous SUMOylation machinery mediates
specific simultaneous modification of multiple substrates within dedicated pathways
and collectively provides its targets with new properties. Moreover, protein group
SUMOylation specifically marks functionally-engaged protein pools for the action by
downstream factors, e.g., SUMO-targeted ubiquitin ligases, which in turn use their
own SIMs in order to distinguish the right targets to bind and to act upon.
Figure 33. Events Leading to Collective Protein Group SUMOylation of Factors
Involved in Homologous Recombination (HR)
The SUMOylation machinery (SUMO-charged Ubc9, Siz2) is pre-bound to chromatin via
SAP domain of Siz2 that binds DNA in a sequence nonspecific manner. Upon DNA damage
(DSB induction), HR factors assemble on resected DNA (ssDNA). Collision with Siz2 initiates
protein group SUMOylation of HR proteins. Stable binding of Siz2 to the HR complex is
fostered by a SUMO-interacting motif (SIM) in Siz2’s C-terminal tail. Because the HR
proteins are decorated with multiple SIMs (indicated by wedges), collective SUMOylation
stabilizes the complex through multiple SUMO-SIM interactions and fosters DNA repair.
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IV.3 Synergy in the SUMO Pathway
In contrast to typical substrate-selective posttranslational modifications that
specifically endow individual targets with new properties, protein group SUMOylation
affects collectively an entire set of physically and functionally engaged factors
simultaneously providing all of them with new characteristics. In fact, systematic
mutation analysis of SUMOylation sites in HR protein group revealed that individual
SUMO modifications act in concert, explaining why single acceptor-site mutants often
exhibit barely any deleterious phenotypes (Sacher et al., 2006; Silver et al., 2011).
Because SUMOylation of HR proteins fosters protein-protein interactions, the most
reasonable explanation for the observed functional synergy is that individual SUMO-
SIM interactions add up affinities for complex formation. Several important features
appear to be relevant for this activity. First, factors within functionally engaged protein
group already possess low affinities towards each other on their own, even in the
absence of SUMOylation, which allows them to interact. Second, upon the formation
of protein assemblies interacting factors become collectively modified at numerous
accessible SUMO-acceptor sites by a highly localized SUMOylation machinery.
Finally, because recognition of SUMO modifications is mediated by simple
hydrophobic linear SIMs, individual components of the modified group harbor these
motifs, often in multiple copies. Indeed, we could show that basically all HR proteins
possess in vitro functional SIMs (Fig. 27), providing many binding surfaces for
potential SUMO interactions. Thus, SUMO functions comparable to a glue in order to
foster physical interactions and stabilize protein assemblies.
In case of HR protein group SUMOylation, upon DNA damage and DSB
resection, a chromatin-bound, concentrated SUMO ligase Siz2 mediates local
modification of HR proteins loaded onto exposed ssDNA in its vicinity, thereby
facilitating formation of functional repair protein complexes and in that way
accelerating overall DSB repair (Fig. 33). However, because the SUMO conjugation
machinery is highly promiscuous, it readily modifies all accessible acceptor sites in its
proximity, even additional lysines introduced by epitope tagging of SUMO-targeted
proteins (e.g., Myc-tag). Therefore, although SUMO modifications in the HR pathway
act synergistically and add up for efficient repair, not all of them are expected to be
equally important for complex formation. Nevertheless, because similar to DNA repair
many biological pathways take place within so-called nuclear bodies or foci, it seems
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plausible that the protein group SUMOylation stabilizes several of these large protein
assemblies.
IV.4 Dynamics of SUMO-SIM-assisted Assemblies
If SUMOylation drives the stabilization or formation of protein complexes, networks or
nuclear bodies, then the question arises: how do such interactions become
eventually disentangled? The SUMO pathway seems to offer three possibilities
(Fig. 34). The first option is disassembly catalyzed by recruited deSUMOylation
enzymes ULPs/SENPs, which typically possess multiple SIMs (Hickey et al., 2012).
In humans, this mechanism is employed at sites of DSB repair and pre-ribosome
assembly (Dou et al., 2010; Finkbeiner et al., 2011a; Haindl et al., 2008). In S.
cerevisiae, the deSUMOylation enzyme Ulp1 localizes primarily to the inner face of
the nuclear pore, but redistributes to the nucleolus under stress conditions
(Sydorskyy et al., 2010), and a fraction also to the septin ring during final stages of
cell division (Li and Hochstrasser, 2003; Makhnevych et al., 2007). The second
deSUMOylation enzyme of yeast, Ulp2, appears to be more specific for chromatin-
related functions like DNA repair and SUMO-regulated sister-chromatid cohesion at
centromeres (Felberbaum and Hochstrasser, 2008; Kroetz et al., 2009; Lee et al.,
2011).
A second way to disrupt SUMO-SIM-stabilized interactions is selective
proteasomal degradation promoted by SUMO-targeted ubiquitin ligases. These
enzymes are RING-type ubiquitin ligases, which, due to the presence of SIMs,
possess affinities for SUMO conjugates (Geoffroy and Hay, 2009; Perry et al., 2008;
Praefcke et al., 2012). One of the known S. cerevisiae STUbLs, Slx5/Slx8, is a
heterodimer formed by two RING-finger proteins, of which Slx5 harbors two strong
SIMs. Slx5/Slx8 is genetically linked to DNA repair and localizes to nuclear DNA
repair foci (Cook et al., 2009; Prudden et al., 2007), but also at nuclear pores (Nagai
et al., 2008). Monomeric RNF4, a vertebrate homolog of Slx5/Slx8, possesses four
putative SIMs through which the RING-finger ligase is potentially targeted to multiple
SUMOylated proteins including DDR factors (Galanty et al., 2012; Yin et al., 2012).
Intriguingly, RNF4 localizes also to PML bodies, where it attaches a polyubiquitin
chain specifically on PML proteins that are modified by poly-SUMO chains.
Polyubiquitylation of PML causes its proteasomal degradation, which in turn leads to
the destabilization of PML bodies (Lallemand-Breitenbach et al., 2008; Tatham et al.,
2008). However, the finding that Slx5/Slx8 mediates ubiquitylation and degradation of
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the yeast MAT 2 transcription factor independent of SUMOylation (Xie et al., 2010)
brings to attention that targeting to SUMO conjugates is just one option for substrate
selection of enzymes originally classified as STUbLs. Moreover, STUbLs may play
non-proteolytic roles as well. For example, S. cerevisiae Rad18 binds via its SIM to
SUMO-modified PCNA, thereby stimulating non-proteolytic mono- or K63-linked
polyubiquitylation of a different subunit of PCNA (Parker and Ulrich, 2012). Likewise,
in human cells upon DNA damage, RNF4 is recruited to SUMOylated DNA-damage
response factors where it promotes formation of non-proteolytic K63-linked
polyubiquitin chains (Yin et al., 2012).
Figure 34. Pathways Used for Disentangling SUMO-SIM Stabilized Protein Assemblies
First, deSUMOylation (left) weakens physical interactions. Second, recruitment of STUbLs
(middle) mediates polyubiquitylation (K48-linked) of SUMOylated factors, typically leading to
proteasomal degradation of the conjugate. Third, the chaperone-like enzyme Cdc48 (p97), in
conjunction with its heterodimeric co-factor Ufd1-Npl4, recognizes SUMO conjugates and
mediates their disassembly by an ATP-driven mechanism (right). Because the Cdc48
complex also associates with ubiquitin conjugates and ubiquitin ligases (not shown), it may
integrate ubiquitin and SUMO signaling and may function as a STUbL as well. Notably, all
three pathways employ SIM-harboring factors for SUMO conjugate recognition.
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The third mechanism used to disrupt SUMO-SIM-mediated interactions involves
Cdc48 (p97 in mammals), a conserved chaperone-like AAA-type ATPase. This
homohexameric segregase was previously known to bind and dislodge specifically
ubiquitylated proteins from their protein environment (Dantuma and Hoppe, 2012;
Jentsch and Rumpf, 2007; Rape et al., 2001). For example, in endoplasmic
reticulum-associated degradation (ERAD), Cdc48, assisted by substrate-recruiting
ubiquitin-binding cofactors (Ufd1-Npl4), is thought to mobilize ubiquitylated ERAD
substrates from the ER for cytosolic proteasomal degradation. However, it is now
known that Cdc48 acts on SUMOylated substrates as well. Interestingly, both Cdc48
and Ufd1 not only bind ubiquitin via special domains, but also SUMO via SIMs
(Bergink et al., 2013; Nie et al., 2012). In yeast, Cdc48 associates with SUMOylated
Rad52 in complex with Rad51, which possesses a SIM but is not SUMO modified
itself. By acting on this SUMO-SIM-stabilized complex, Cdc48 displaces the two
proteins from chromatin. Notably, inactivation of Cdc48 leads to increased
spontaneous recombination and causes aberrant Rad51 foci formation in yeast and
mammalian cells (Bergink et al., 2013). Inferring from this finding, Cdc48 might be
generally competent to break up SUMO-SIM-assisted protein complexes or networks.
Moreover, because Cdc48 also associates with a number of ubiquitin ligases (Bohm
et al., 2011; Koegl et al., 1999; Verma et al., 2011), the Cdc48 complex may not only
function as a segregase but also as a multisubunit STUbL. Additionally, the presence
of both ubiquitin- and SUMO-binding motifs suggests that the segregase complex
may also integrate SUMO- and ubiquitin-dependent signals similar to human RAP80.
This protein, via tandem SIM/UIM motifs, preferentially binds RNF4-synthesized
hybrid SUMO-ubiquitin chains, thereby promoting BRCA1 recruitment to DNA
damage sites (Guzzo et al., 2012).
Taken together, protein group SUMOylation not only targets protein pools already
engaged in their respective functions, possibly explaining why the SUMOylated
fraction of a given substrate is typically very small, but it also simultaneously marks
these pools for subsequent action by other SIM-containing factors that ensure the
dynamic nature of SUMO modification and offer extensive possibilities for the
regulation of the SUMO-SIM-assisted protein assemblies. It is attractive to speculate,
that similar to ULPs or STUbLs, other enzymatic activities (e.g., phoshphorylation,
methylation, acetylation) could be recruited by SIM-harboring proteins to the
SUMOylated substrates, further expanding the versatility of the SUMO pathway.
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V. MATERIALS AND METHODS
Unless otherwise mentioned, chemicals and reagents were purchased from
Amersham-Pharmacia, Applied Biosystems, Biomol, Biorad, Difco, Fluka, Invitrogen,
Merck, New England Biolabs, Promega, Roth, Roche, Riedel de Haen, Serva,
Sigma, and Thermo Scientific. The following microbiological, molecular biological and
biochemical methods are based on standard techniques (Ausubel, 2001; Sambrook
and Russell, 2001) or on the instructions of the manufacturer. For all methods
described, de-ionized sterile water, sterile solutions and sterile flasks were used.
V.1 Computational Analyses
For database searches (sequence search and comparison, physical and genetic
interactions, phenotypes, literature search) electronic services were used provided by
the Saccharomyces Genome Database (http://www.yeastgenome.org/), the National
Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/) and the Universal
Protein Resource (http://www.uniprot.org/). Most of the protein sequence analyses
were performed using software programs from ExPASy Proteomics Server
(http://www.expasy.org/). For the prediction of SUMOylation consensus sites and
SUMO-binding motifs the software packages SUMOsp 2.0 and GPS-SBM 1.0 from
the CUCKOO Workgroup (http://www.biocuckoo.org/) were used. DNA sequence
analyses (DNA restriction enzyme maps, DNA sequencing analyses, DNA primer
design) were done with DNA Star software (DNA Star Inc.). For assessment of
protein domain composition the program SMART (http://smart.embl-heidelberg.de/)
was used. Protein 3D-structure coordinates obtained by X-ray crystallography and
NMR analysis were downloaded from the protein databank (http://www.rcsb.org/pdb/)
and structures were visualized using the PyMOL Molecular Graphics System
(http://www.pymol.org/).
Chemiluminescence signals of immunoblots were detected by a CCD camera (LAS
3000, Fujifilm), quantified using ImageJ software (http://rsb.info.nih.gov/ij/) and
processed with Adobe Photoshop (Adobe Systems Inc.). For the presentation of text,
tables, graphs and figures, software programs of the Microsoft Office package 2008
(Microsoft Corp.) were used, as well as GraphPad Prism version 5.0 for Mac OS X
(http://www.graphpad.com/).
V.2 Microbiological and Genetic Techniques
V.2.1 E. coli techniques
E. coli strains Genotype Source
XL1-Blue hsd R17 rec A1 end A1 gyrA46 thi-1 sup E44relA1 lac [F’ pro AB lacIqZ M15 Tn10 (Tetr)] Stratagene
BL21(DE3)/RIL B F
- ompT hsdS (rB- mB-) dcm+ Tetr gal (DE3)
EndA Hte [argU ileY leuW Camr] Stratagene
Rosetta 2(DE3)
pLysS
F- ompT hsdSB (rB mB ) gal dcm (DE3)
pLysSRARE2 (Camr ) Novagen
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E. coli plasmids
pQE30- and pET28a(+)-versions of Siz2 (Nfi1) (full-length) were created by cloning
the PCR-amplified open reading frame (ORF) from DF5 yeast genomic DNA
extracts. pET28a(+)-siz2- SAP and pET28a(+)-siz2-SAP variants were generated
by site-directed mutagenesis of pET28a(+)-Siz2.
E. coli media:
LB-medium/[plates]: 1% Tryptone (Difco)
0.5% yeast extract (Difco)
1% NaCl
[1.5% agar]
sterilized by autoclaving
Cultivation and storage of bacteria cells
Liquid cultures were grown in LB media at 37°C (or 18°C and 30°C for expression
experiments) with constant shaking. Cultures on agar plates were incubated at 37°C.
For the selection of transformed bacteria, ampicillin (50 g/ml) and kanamycin (50-
100 g/ml) were added to the media. The culture density was determined by
measuring the absorbance at a wavelength of 600nm (OD600). Cultures on solid
media were stored at 4°C for up to 5 days. For long-term storages, stationary
cultures were frozen in 15% (v/v) glycerol solutions at –80°C.
Preparation of competent bacteria cells
DNA plasmids were transformed into E. coli competent cells either by electroporation
or by calcium chloride transformation. For the preparation of competent cells, 1l liquid
LB medium was inoculated with 10ml of an overnight (ON) culture derived from a
single colony and grown to an OD600 of 0.8 at 37°C. After cooling the culture flask on
ice for 30-60min, cells were harvested by centrifugation (10min, 4000g, 4°C). All
following steps were performed with pre-cooled sterile materials and solutions at 4°C.
For the preparation of electro-competent E. coli, the pellets were washed once with
1l ice-cold water, centrifuged and washed once again with 0.5l ice-cold water
containing 10% (v/v) glycerol. After another sedimentation, the cells were finally
resuspended in 3ml 10% (v/v) glycerol and stored in 100 l aliquots at –80°C. For the
preparation of chemically competent bacteria, sedimented cells were first carefully
resuspended in 200ml MgCl2 solution (100mM), then pelleted again by
centrifugation, resuspended second time in 400ml CaCl2 solution (100mM) and
incubated on ice for 30 min. Finally, the competent cells were re-pelleted by
centrifugation, suspended in 15 ml 100mM CaCl2 solution containing 10% (v/v)
glycerol and stored at –80°C in 150 l aliquots after freezing the cells in liquid
nitrogen.
E. coli vectors Purpose Source
pQE30 Expression with N-terminal 6xHis-tag Qiagen
pET28a(+) Expression with N-terminal 6xHis-tag Novagen
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Transformation of plasmid DNA into competent E. coli cells
Shortly prior to transformation, electro-competent cells were thawed on ice. For the
electroporation, 20-40 l electro-competent cells were mixed with 2 l of ligation
sample dialyzed against water or 10ng plasmid DNA. The suspension was
electroporated in a pre-chilled 0.1cm electrode gap Gene Pulser cuvette (Biorad)
with a pulse of 1.8kV and 25 F at a resistance of 200 . After addition of 1ml pre-
warmed LB medium (without antibiotics), the suspension was incubated for 1h on a
shaker at 37°C to recover the cells. Selection of transformants was subsequently
carried out on antibiotic-containing LB agar plates ON at 37°C. For chemical
transformation, 50 l competent cells were mixed with 10ng of E. coli vector DNA and
incubated on ice for 15 min. Then, a 42°C heat-shock was performed for 45s,
followed by a 2 min incubation on ice. For recovery, the cells were resuspended in
1ml pre-warmed LB medium lacking antibiotics and incubated at 37°C on a shaker
for 1h prior to ON selection on LB agar plates containing proper antibiotics.
Expression of recombinant proteins in E. coli cells
For the overexpression of recombinant proteins, the E. coli strains BL21(DE3)/RIL
and Rosetta 2(DE3)pLysS were used. Liquid LB medium containing proper
antibiotics was inoculated at an OD600 of 0.2 with an ON culture of a freshly
transformed colony grown at 37°C. Cultures were incubated at 30°C until they reach
an OD600 of 0.4. Then cells were grown at room temperature for 1h and protein
expression was induced by addition of IPTG to a 1mM final concentration. Cells were
subsequently grown at room temperature (or 18°C) with constant shaking and
harvested 3-12h after IPTG addition by centrifugation (15min, 4000g, 4°C), washed
in ice-cold PBS and stored at –80°C after freezing in liquid nitrogen. Expression of
the protein of interest was confirmed by analyzing samples taken before and after
IPTG-induction using SDS-PAGE and Coomassie blue staining (Thermo Scientific
PageBlue protein staining solution).
V.2.2 S. cerevisiae techniques
S. cerevisiae vectors Purpose Reference
pYCplac33, pYCplac22, pYCplac111 CEN plasmids (Gietz and Sugino, 1988)
pYEplac195, pYEplac112, pYEplac181 m plasmids (Gietz and Sugino, 1988)
pYIplac211, pYIplac204, pYIplac128 INT plasmids (Gietz and Sugino, 1988)
pGAD-C1-3, pGBD-C1-3 Two-hybrid (James et al., 1996)
S. cerevisiae plasmids
All yeast two-hybrid constructs generated in this study were based on pGAD-C1-3
vectors for the AD N-terminal fusions and pGBD-C1-3 vectors for the BD N-terminal
fusions. The respective ORFs (full-length or fragments) were amplified by PCR from
genomic DNA of DF5 yeast extracts using specific primers and compatible restriction
enzyme sites. Truncations and mutations were introduced by site-directed
mutagenesis using specific primer pairs. Phusion and PFU Turbo high-fidelity
polymerases were used for all PCR reactions and restriction enzymes were
purchased from NEB.
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Integrative plasmids were based on the YIplac vector series. For the expression of
studied proteins at their endogenous levels, the full-length ORFs plus sequences of
the upstream promoter and downstream terminator were cloned into integrative
plasmids. All rfa1, rfa2, rfa3, rad52, rad59, siz2 mutant plasmids were constructed by
site-directed mutagenesis using specific primer pairs.
Yeast pYCplac111 centromeric plasmids expressing EXO1 and exo1-ND (D173A)
were designed by Grzegorz Sienski, while exo1-SA (S372A,S567A,S586A,S692A)
was generated by mutagenesis of YCplac111-Exo1 in this study. Centromeric
plasmid expressing HO under the control of a GAL10 promoter (pGAL-HO) was
obtained from the Jackson laboratory (Downs et al., 2000).
HisSUMO constructs under the control of its endogenous and ADH1 promoters were
used in previous studies in the Jentsch laboratory. A HisSUMO-KRall construct with
all lysine residues of Smt3 (SUMO) replaced by arginine residues was generated by
Oliver Gassner. All HisSUMO constructs were integrated either into the URA3/LEU2
loci by cutting the plasmid with EcoRV or into SMT3 locus by cutting with BglII and
expression levels were tested by Western blot analysis.
S. cerevisiae strains
Chromosomally tagged yeast strains and mutants used in this study were
constructed by a PCR-based strategy, by genetic crosses and standard techniques
(Janke et al., 2004; Knop et al., 1999). Strains expressing mutant proteins with
SUMO-acceptor lysine residues replaced by arginine residues were constructed by a
pop-in/pop-out allele replacement method (Scherer and Davis, 1979).
Strain Relevant Genotype Reference
DF5 trp1-1 ura3-52 his3 200 leu2-3,11 lys2-801 CAN1 BAR1  (Ulrich and Jentsch, 2000)
IP503 lys1::natNT2 arg4::hphNT1 pADH-HisSMT3::URA3 This study
IP698 pADH-HisSMT3::LEU2 This study
Y1094 pADH-HisSMT3::SMT3 SJ strain collection library
Y2203 RFA16HA::klTRP1 SJ strain collection library
Y2204 RFA26HA::klTRP1 SJ strain collection library
Y2205 RFA36HA::klTRP1 SJ strain collection library
IP046 RFA16HA::klTRP1 pADH-HisSMT3::URA3 This study
IP047 RFA26HA::klTRP1 pADH-HisSMT3::URA3 This study
IP048 RFA36HA::klTRP1 pADH-HisSMT3::URA3 This study
IP423 RAD596HA::hphNT1 lys1::natNT2 This study
IP349 RAD596HA::hphNT1 pADH-HisSMT3::URA3 This study
IP164 Mre113HA::klTRP1 RFA29MYC::klTRP This study
IP166 Mre113HA::klTRP1 RFA29MYC::klTRP1 pADH-HisSMT3::SMT3 This study
IP760 RAD506HA::HIS3MX6 This study
IP762 RAD506HA::HIS3MX6 pADH-HisSMT3::LEU2 This study
IP778 SAE26HA::HIS3MX6 This study
IP780 SAE26HA::HIS3MX6 pADH-HisSMT3::LEU2 This study
IP809 RAD96HA::HIS3MX6 This study
IP811 RAD96HA::HIS3MX6 pADH-HisSMT3::LEU2 This study
IP904 MRC19MYC::HIS3MX6 This study
IP905 MRC19MYC::HIS3MX6 pADH-HisSMT3::LEU2 This study
IP782 MEC16HA::HIS3MX6 This study
IP783 MEC16HA::HIS3MX6 pADH-HisSMT3::LEU2 This study
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Strain Relevant Genotype Reference
IP784 TEL16HA::HIS3MX6 This study
IP785 TEL16HA::HIS3MX6 pADH-HisSMT3::LEU2 This study
Y2200 RFA19MYC::klTRP1 pADH-HisSMT3::SMT3 SJ strain collection library
Y2201 RFA29MYC::klTRP1 pADH-HisSMT3:: SMT3 SJ strain collection library
Y2202 RFA39MYC::klTRP1 pADH-HisSMT3:: SMT3 SJ strain collection library
IP231 RAD599MYC::kanMX4 pADH-HisSMT3::SMT3 This study
IP775 bar1::HIS3MX6 pADH-HisSMT3::URA3 This study
IP773 bar1::HIS3MX6 exo1::natNT2 pADH-HisSMT3::URA3 This study
IP787 bar1::HIS3MX6 exo1::natNT2 pADH-HisSMT3::URA3
YCplac111 (empty)
This study
IP788 bar1::HIS3MX6 exo1::natNT2 pADH-HisSMT3::URA3
YCplac111-Exo1
This study
IP789 bar1::HIS3MX6 exo1::natNT2 pADH-HisSMT3::URA3
YCplac111-exo1-D173A
This study
IP790 bar1::HIS3MX6 exo1::natNT2 pADH-HisSMT3::URA3
YCplac111-exo1-S372A, S567A, S586A, S692A
This study
IP902 pol32::klTRP1 pADH-HisSMT3::LEU2 This study
IP733 sml1::HIS3MX6 pADH-HisSMT3::LEU2 This study
IP734 mec1::hphNT1 sml1::HIS3MX6 pADH-HisSMT3::LEU2 This study
IP099 ddc2::natNT2 sml1::HIS3MX6 pADH-HisSMT3::SMT3 This study
IP754 rad9::URA3 pADH-HisSMT3::LEU2 This study
Y2325 pSMT3-HisSMT3::SMT3 SJ strain collection library
Y2333 rad17::kanMX4 pSMT3-HisSMT3::SMT3 SJ strain collection library
Y2334 mec3::kanMX4 pSMT3-HisSMT3::SMT3 SJ strain collection library
Y2340 rad24::natNT2 pSMT3-HisSMT3::SMT3 SJ strain collection library
IP735 mec1::hphNT1 sml1::HIS3MX6 pADH-HisSMT3::LEU2
exo1::natNT2
This study
IP746 mec1::hphNT1 sml1::HIS3MX6 pADH-HisSMT3::LEU2
sgs1::kanMX4
This study
IP736 mec1::hphNT1 sml1::HIS3MX6 pADH-HisSMT3::LEU2
exo1::natNT2 sgs1::kanMX4
This study
IP681 mec1::hphNT1 sml1::HIS3MX6 pADH-HisSMT3::LEU2
rad50::kanMX4
This study
IP253 siz2::HIS3MX6 RAD599MYC::kanMX4 pADH-HisSMT3::SMT3 This study
IP871 ura3-52::natNT2::pCUP1-siz2-SAP*9MYC::hphNT1::URA3
siz2::HIS3MX6 pADH-HisSMT3::LEU2
This study
IP057 rad51::HIS3MX6 RFA19MYC::klTRP1 pADH-HisSMT3::SMT3 This study
IP042 rad51::HIS3MX6 RFA29MYC::klTRP1 pADH-HisSMT3::SMT3 This study
IP044 rad52:: natNT2 RFA29MYC::klTRP1 pADH-HisSMT3::SMT3 This study
IP064 RFA29MYC::klTRP1 mec1::hphNT1 sml1::HIS3MX6 This study
IP088 siz2::HIS3MX4 RFA29MYC::klTRP1 pADH-HisSMT3::SMT3 This study
IP658 hml::ADE1 MAT hmr::ADE1 ade1-100 leu2-3,112 lys5
trp1::hisG' ura3-52 ade3::GAL::HO pADH-HisSMT3::LEU2
This study
IP659 HML  MATa hmr::ADE1 ade1-100 leu2-3,112 lys5 trp1::hisG'
ura3-52 ade3::GAL::HO pADH-HisSMT3::LEU2
This study
IP717 mre11::hphNT1 pADH-HisSMT3::LEU2 This study
IP719 rad50::natNT2 pADH-HisSMT3::LEU2 This study
IP701 xrs2::kanMX4 pADH-HisSMT3::LEU2 This study
IP849 sae2::kanMX4 pADH-HisSMT3::LEU2 This study
IP670 exo1::natNT2 sgs1::kanMX4 pADH-HisSMT3::LEU2 This study
IP671 exo1::natNT2 pADH-HisSMT3::LEU2 This study
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Strain Relevant Genotype Reference
IP672 sgs1::kanMX4 pADH-HisSMT3::LEU2 This study
IP845 mre11::hphNT1 sae2::kanMX4 pADH-HisSMT3::LEU2 This study
IP865 mre11::hphNT1 sae2::kanMX4 pADH-HisSMT3::LEU2
YIplac211-Mre11::URA3
This study
IP866 mre11::hphNT1 sae2::kanMX4 pADH-HisSMT3::LEU2
YIplac211-mre11-H125N::URA3
This study
IP828 yku70::hphNT1 bar1::HIS3MX6 pADH-HisSMT3::URA3 This study
IP829 yku70::hphNT1 bar1::HIS3MX6 pADH-HisSMT3::URA3
exo1::natNT2
This study
IP870 cdc13ts pADH-HisSMT3::LEU2 This study
IP496 lys1::natNT2 arg4::hphNT1 pADH-HisSMT3::URA3
siz1::HIS3MX6
This study
IP497 lys1::natNT2 arg4::hphNT1 pADH-HisSMT3::URA3
siz2::HIS3MX4
This study
IP525 lys1::natNT2 arg4::hphNT1 pADH-HisSMT3::URA3
mms21-11::natNT2
This study
IP676 siz2::HIS3MX4 pADH-HisSMT3::URA3 This study
IP1009 siz2::HIS3MX4 pADH-HisSMT3::LEU2 This study
IP850 siz2::HIS3MX4 pADH-HisSMT3::LEU2
YIplac211-Siz29MYC::hphNT1::URA3
This study
IP852 siz2::HIS3MX4 pADH-HisSMT3::LEU2
YIplac211-siz2-SAP*9MYC::hphNT1::URA3
This study
IP885 siz2::HIS3MX4 pADH-HisSMT3::LEU2
YIplac211-siz2-Siz1SAP9MYC::hphNT1::URA3
This study
IP235 rad59::hphNT1 pADH-HisSMT3::LEU2 This study
IP299 rfa2-K199R This study
IP314 rfa3-K46R This study
IP324 rfa2-K199R rfa3-K46R This study
IP364 rfa2-K199R pADH-HisSMT3::URA3 This study
IP365 rfa2-K199R rfa3-K46R pADH-HisSMT3::URA3 This study
IP269 smt3::HIS3MX6 YIplac211-smt3-KRall::URA3 This study
IP372 smt3::HIS3MX6 YIplac211-smt3-KRall::URA3
RFA36HA::klTRP1
This study
IP374 rfa2-K199R rfa3-K46R6HA::klTRP1 pADH-HisSMT3::URA3 This study
IP376 rfa1-K170R,K427R rfa2-K199R rfa3-K46R This study
IP385 rfa1-K170R,K427R rfa2-K199R rfa3-K46R
pADH-HisSMT3::URA3
This study
IP391 rfa1-K133R,K170R,K427R rfa2-K199R rfa3-K46R This study
IP396 rfa1-K133R,K170R,K427R rfa2-K199R rfa3-K46R
pADH-HisSMT3::URA3
This study
IP350 rad59-K228R6HA::hphNT1 pADH-HisSMT3::URA3 This study
IP383 rad59-K228R,K238R6HA::klTRP1 pADH-HisSMT3::URA3 This study
IP387 rad59-K207R,K228R,K238R6HA::klTRP1
pADH-HisSMT3::URA3
This study
IP434 rad59-K207R,K228R,K238R This study
IP422 rfa1-K133R,K170R,K427R rfa2-K199R rfa3-K46R
rad59-K207R,K228R,K238R
This study
IP444 rfa1-K133R,K170R,K427R rfa2-K199R rfa3-K46R
rad52-K10R,K11R,K220R rad59-K207R,K228R,K238R
This study
IP445 rad52-K10R,K11R,K220R This study
IP461 rad52-K10R,K11R,K220R rad59-K207R,K228R,K238R This study
YMS258/Y2011 rad52::kanMX6 (Sacher et al., 2006)
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Strain Relevant Genotype Reference
YMS417/Y2012 rad50:: HIS3MX6 (Sacher et al., 2006)
Y1136 siz2::HIS3MX4 SJ strain collection library
IP895 rfa1-K133R,K170R,K427R rfa2-K199R rfa3-K46R
rad52-K10R,K11R,K220R rad59-K207R,K228R,K238R
siz2::HIS3MX6
This study
Y0710 his1-1/his1-7 (Pfander et al., 2005)
IP639 his1-1/his1-7 rad52::natNT2/rad52::natNT2 This study
IP643 rfa1-K133R,K170R,K427R/rfa1-K133R,K170R,K427R
rfa2-K199R/rfa2-K199R rfa3-K46R/rfa3-K46R
rad52-K10R,K11R,K220R/rad52-K10R,K11R,K220R
rad59-K207R,K228R,K238R/rad59-K207R,K228R,K238R
his1-1/his1-7
This study
IP678 his1-1/his1-7 siz2::kanMX6/siz2::hphNT1 This study
IP224 hml::ADE1 MAT hmr::ADE1 ade1-100 leu2-3,112 lys5
trp1::hisG' ura3-52 ade3::GAL::HO RFA19MYC::natNT2
This study
IP283 hml::ADE1 MAT hmr::ADE1 ade1-100 leu2-3,112 lys5
trp1::hisG' ura3-52 ade3::GAL::HO RFA19MYC::natNT2
siz2::hphNT1
This study
IP1015 siz2 Cterm9MYC::hphNT1 pADH-HisSMT3::LEU2 This study
IP1023 siz2::HIS3MX4 pADH-HisSMT3::LEU2
YIplac211-siz2-Gal4DBD9MYC::hphNT1::URA3
This study
IP1024 siz2::HIS3MX4 pADH-HisSMT3::LEU2
siz1-siz2Cterm9MYC::hphNT1::URA3
This study
IP1025 siz2-VV720,721AA9MYC::hphNT1 pADH-HisSMT3::LEU2 This study
IP1031 siz2::HIS3MX4 pADH-HisSMT3::LEU2
YIplac211-siz2-II472,473AA9MYC::hphNT1::URA3
This study
IP1067 siz2::HIS3MX4 pADH-HisSMT3::LEU2
YIplac211-siz2-Siz1PINIT9MYC::hphNT1::URA3
This study
IP1072 Siz29MYC::kanMX4 pADH-HisSMT3::LEU2 This study
All strains are isogenic to DF5, except for IP224, IP283, IP658, which are derived
from JKM179 (Lee et al., 1998), and IP659, which is a derivative of JKM161
(Sugawara et al., 2003).
S. cerevisiae media and solutions
YPD/YPGal [plates]: 1% yeast extract (Difco)
2% bacto-peptone (Difco)
2% D-(+)-glucose or galactose
[2% agar]
sterilized by autoclaving
YP-Lactate: 1% yeast extract (Difco)
2% bacto-peptone (Difco)
3% lactic acid
(adjust pH to 5.5 with NaOH)
sterilized by autoclaving
YPD G418/NAT/Hph plates: YPD medium containing 2% agar was autoclaved and
cooled to 50°C prior to addition of G418 (geneticine
disulfate; Sigma), NAT (noursethricin, HKI Jena) or Hph
(hygromycin B, PAA Laboratories) to 200mg/l, 100mg/l
or 500mg/l, respectively.
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SC-media [plates]: 0.67% yeast nitrogen base (Difco)
0.2% drop out amino acid mix
(according to the requirements)
2% carbon source (glucose, galactose or raffinose)
[2% agar]
sterilized by autoclaving
SC-Lactate: 0.67% yeast nitrogen base (Difco)
0.2% amino acid drop out mix
(according to the requirements)
3% lactic acid
(adjust pH to 5.5 with NaOH)
sterilized by autoclaving
SC-5'FOA plates: 0.67% yeast nitrogen base (Difco)
0.2% amino acid drop out mix
(according to the requirements)
3% adenine
3% uracil
2% glucose
2% agar
After autoclaving, the mixture is cooled to 50°C prior to
5'FOA addition to the final concentration of 0,1%.
Drop out amino acid mix: 30 mg Arg, Tyr, Leu, Lys
50 mg Phe
100 mg Glu, Asp
150 mg Val
200 mg Thr
400 mg Ser
Sporulation medium: 2% (w/v) potassium acetate (in sterile water)
Zymolase 100T solution: 0.9 M sorbitol
0.1 M Tris-HCl, pH 8.0
0.2 M EDTA, pH 8.0
50 mM DTT
0.5 mg/ml Zymolase 100T (Seikagaku Corp., Japan)
SORB: 100 mM LiOAc
10 mM Tris-HCl, pH 8.0
1 mM EDTA, pH 8.0
1 M sorbitol
sterilized by filtration
PEG: 100 mM LiOAc
10 mM Tris-HCl, pH 8.0
1 mM EDTA, pH 8.0
40 % (w/v) PEG-3350
sterilized by filtration, stored at 4°C
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Cultivation and storage of S. cerevisiae
Liquid cultures were inoculated with a single yeast colony from freshly streaked
plates and grown ON at 30ºC with constant shaking. In general, from this preculture
the main culture was inoculated to an OD600 of 0.1-0.2 and incubated in baffled-flasks
(size  5x liquid culture volume) on a shaking platform (150-220 rpm) at 30ºC until
mid-log phase growth had been reached (equals to OD600 of 0.6-0.9). The culture
density was determined photometrically (OD600 of 1 is equal to 1.5x107 cells/ml).
Cultures on agar plates were stored at 4°C up to 1-2 months. For long-term storage,
stationary cultures were frozen in 15% (v/v) glycerol solutions at –80°C.
Preparation of competent yeast cells
Yeast cells from a mid-log phase growing culture (generally, 50 ml at OD600 of  0.5-
0.7) were harvested by centrifugation (500g, 3 min, room temperature), washed first
with 1/2 volume sterile water, then with 1/10 volume SORB solution, pelleted and
suspended again in 360 l SORB solution. After addition of 40 l carrier DNA (heat
denatured salmon sperm DNA, 10mg/ml, Invitrogen) and further resuspension,
competent cells were stored in 50 l aliquots at –80°C.
Transformation of yeast cells
For transformation, 200ng of circular or 2 g of linearized plasmid DNA/PCR product
were mixed with 10 l or 50 l competent yeast cells, respectively. Six volumes of
PEG solution were added and the cell suspension was incubated at 30°C for 30min.
Subsequently, DMSO (final concentration 10%) was added and a heat-shock
performed at 42°C for 15 min. Cells were sedimented by centrifugation (500g for
3min at room temperature), resuspended in 100 l sterile water and plated on the
respective SC medium plates. If antibiotics were used for selection, the transformed
cells were first incubated for 3h in 1 ml liquid YPD medium prior to plating. Selection
of transformants was carried out for 2-3 days at 30°C (or 23°C for temperature
sensitive strains). If necessary, the transformants were replica-plated on selection
plates to remove the background of false-positive colonies.
Genomic integration by homologous recombination
The YIplac vector series was used for stable integration of DNA into the yeast
genome. Because these plasmids do not contain autonomous replication elements,
only stably integrated vectors are propagated in yeast. The ORFs of the respective
genes were cloned into YIplac vectors including the endogenous, constitutive (e.g.,
the ADH1 promoter for overexpression) or inducible promoter (e.g., CUP1 or GAL10
promoter) and terminator elements. Before transformation, vectors were linearized by
a restriction enzyme that specifically cuts within the auxotrophy marker gene. These
linearized plasmids are then integrated into the genome by homologous
recombination with the endogenous locus of the marker gene. Alternatively, the
constructs can be targeted to the endogenous loci of studied genes, if the plasmids
are specifically cut within the cloned gene sequence.
A similar approach was used in order to delete, truncate, C-/N-terminally tag
endogenous genes with epitopes (Janke et al., 2004; Knop et al., 1999; Longtine et
al., 1998) or generate point mutants/fusions. For this method, PCR products were
used to transform competent yeast cells. To allow homologous recombination with
the endogenous locus of a gene, PCR products were generated using primers that
contain sequences for amplification of special cassettes or regions of interest in the
genome (including the marker gene for selection) as well as sequences
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complementary to the gene of interest required for proper integration. For gene
deletions, the forward primer contains 55bp of the promoter sequence 5' of the start
codon of the respective gene, while the reverse primer includes 55bp of the
terminator sequence 3' of the stop codon. For C-terminal epitope tagging of a gene, a
forward primer containing 55bp 5' of the stop codon were used instead. In a similar
fashion, gene truncations, fusions, point mutations were introduced through
homologous recombination. Generally, PCR products were purified and concentrated
after amplification using ethanol precipitation, and competent yeast cells transformed
and plated on selection plates. The correct recombination was confirmed by yeast
colony PCR, Western blot analysis (if applicable) and sequencing of the modified
genomic loci.
Strains expressing mutant proteins with SUMO-acceptor lysine residues replaced by
arginine residues (KR) were constructed by a pop-in/pop-out allele replacement
method (Scherer and Davis, 1979). Briefly, pYIplac211 URA3-based integrative
plasmid containing mutagenized gene of interest was linearized by cutting within the
cloned gene and targeted to its endogenous chromosomal locus. This creates a
gene duplication containing the wild-type copy and the mutant copy separated by the
URA3 marker and plasmid sequences. Finally, the integrated cassette is excised
through pop-out recombination by selecting on 5'FOA plates and the 5'FOA-resistant
colonies are sequenced. Crossovers that take place on the appropriate side of the
mutated site replace the WT chromosomal site with mutant sequences specifically
introducing chromosomal point mutations.
PCR screening of genomic recombination events (“yeast colony-PCR”)
For the verification of chromosomal gene disruptions, correct recombination events
were identified by “yeast colony-PCR”. The screening strategy is based on
oligonucleotide probes, which anneal upstream/downstream of altered chromosomal
locus (primer 1) and within the introduced selection marker gene (primer 2). Prior to
the PCR, a single yeast colony from a selection plate was resuspended in 50 l of
0.02M NaOH and incubated at 95°C for 5min with rigorous shaking (1400rpm). Next,
the solution was briefly centrifuged (13000rpm at room temperature) and 4.0 l of the
supernatant was directly used as a template for PCR. DNA oligonucleotides for PCR
were custom-made by Eurofins MWG Operon.
PCR reaction mix: 4.0 l template DNA
5.0 l 10x Thermopol buffer (NEB)
2.0 l dNTP-Mix (10 mM each; New England Biolabs)
0.5 l primer 1 (100 M)
0.5 l primer 2 (100 M)
0.5 l Taq DNA polymerase
37.5 l dH2O
Cycling parameters (30 amplification cycles):
PCR step T (°C) Time
Initial denaturation 94 5 min
Denaturation 94 30 s
Annealing 50 30 s
Elongation 72 1 min/kb
Final elongation 72 10 min
Cooling 4
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Mating type analysis of haploid yeast strains
The tester strains RC634a and RC75-7  were used for the identification of yeast
mating types. These strains are hypersensitive to the pheromone secreted by yeast
strains of the opposite mating type. 500 l of a dense suspension of a tester strain in
sterile water was mixed with 50ml of molten agar (1% w/v water, pre-cooled to 40°C)
and 5ml were poured over each YPD plate. Plates containing cultures to be analyzed
were either replica-plated on the a- and -tester plates, or single colonies of
unknown mating type were streaked on each tester plate. The tester strains cannot
grow in proximity of colonies of different mating type, thereby generating a so-called
“halo” of clear agar. Therefore, after 1-2 days of incubation at 30°C, a halo appears
around a haploid colony, if the mating type of the strain is different. The diploid cells
do not secrete any mating type pheromones and therefore do not give halos on both
mating type tester plates.
Mating of haploid yeast strains
Freshly streaked haploid strains of opposite mating types (MATa, MAT ) were mixed
and spotted together on YPD plates ON at 30°C to allow mating. Cells were then
either streaked on respective selection plates to identify diploids or mating type
analysis was performed for individual colonies.
Sporulation and tetrad analysis of diploid yeast strains
500 l of diploid stationary phase yeast cells were harvested by centrifugation (500g,
3min, room temperature), washed 2 times with sterile water and resuspended in 4ml
sporulation medium (2% potassium acetate). After incubation on a shaker at room
temperature for 3-7 days, 10 l of the culture was mixed with 10 l Zymolase 100T
solution and incubated at room temperature for 10min. The spores were dissected in
tetrads with a micromanipulator (Singer MSM Systems) and grown on YPD plates at
30°C for 2-3 days. Subsequently, tetrads were analyzed genotypically by replica
plating on selection plates or by their phenotypes, where applicable.
Analysis of protein-protein interactions using the two-hybrid system
The full-length ORFs, fragments and mutant variants of proteins used for yeast two-
hybrid assays in this study were fused to the C-terminus of the DNA-binding domain
(BD) or activation domain (AD) of the Gal4 transcription factor by cloning them into
pGBD-C1 or pGAD-C1 vectors, respectively. The expression constructs were used to
transform PJ69-7A cells (James et al., 1996). Physical interaction between BD- and
AD-fusion proteins leads to reconstitution of the Gal4 transcription factor, which
induces expression of HIS3 and ADE2 reporter genes and allows cell growth on the
respective selection plates. White colony color is indicative of better growth. Images
were usually taken after growth for 3 days at 30°C.
Synchronization by a-factor (G1 arrest)
Treatment of MATa cells with the -factor pheromone results in cell cycle arrest at
the G1 phase. For such cell cycle synchronization, mid-log phase MATa BAR1 cell
cultures were supplemented with 10 M -factor (stock solution in DMSO) and
incubated at 30°C with constant shaking. After 2-3h, the arrest efficiency was
determined microscopically (typically >90%) or by FACS analysis. Cells were
released into the cell cycle by washing one time in sterile water and one time in fresh
YPD at room temperature to remove -factor. For MATa bar1 cells, -factor was
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used at 200nM and release was achieved by addition of pronase (25 g/ml;
Calbiochem).
Phenotypic analysis of yeast mutants, growth and cell survival assays
Nonessential gene knockout strains and mutants were tested for growth impairments
and DNA-damage sensitivity by spotting equal amounts of cells in serial dilutions
onto solid YPD media containing DNA-damage inducing agents such as MMS,
Zeocin, HU or 4NQO. For all growth and cell survival analyses, overnight cultures
were harvested and resuspended in sterile water. After dilution to OD600=0.5-1, ten-
fold serial dilutions were prepared and spotted onto the respective plates. Plates
were incubated for 2-3 days at 30°C and images were obtained.
When not indicated otherwise, growing cell cultures were incubated for 90 min at
30°C in the presence of MMS (0.2%), Zeocin (0.2 mg/ml), HU (100 mM) or 4NQO
(1 g/ml). Cells irradiated with UV-light (80 J/m2) in the irradiation chamber BS-03
(Dr. Gröbel UV-Elektronik GmbH) were harvested 30 min after irradiation and
incubation in the dark. cdc13ts cells were grown at permissive conditions (24°C) and
were subsequently shifted to 37°C for 3 hrs before harvesting. pol32 cells were
grown at 30°C and subsequently shifted to 14°C for overnight incubation before
harvesting. To induce the CUP1 promoter, CuSO4 (100  M)  was  added  to  YPD-
medium.
For qualitative analysis of MMS sensitivity, cells from overnight cultures were
inoculated into 200 l fresh YPD liquid medium containing MMS (0.02%) at a final
OD600=0.2. A Type FP-1100-C Bioscreen C machine (Thermo Labsystems) was
used to measure growth every 15 min at 30°C for 48 hours with constant shaking. All
physiological studies were done in triplicates.
Measuring the interchromosomal recombination rates
Spontaneous interchromosomal recombination rates between the heteroalleles his1-
1 and his1-7 in diploid cells were determined by fluctuation analysis as previously
described (Pfander et al., 2005). Briefly, individual colonies were used to inoculate
twelve parallel cultures in non-selective YPD medium for each studied yeast strain.
The cultures were then grown to saturation at 30°C overnight with constant shaking
to obtain equal cell densities. After making appropriate dilutions in sterile water with
extensive vortexing steps in between, the cells were then plated (2 plates per
independent parallel culture) onto SC-His plates to obtain the number of
recombinants, and dilutions were also plated onto YPD plates to calculate the total
number of viable cells. The number of recombination events was determined by the
MSS-maximum likelihood estimator method. The program FALCOR was used to
assist the analysis. Averages were obtained from at least three independent
experiments. MMS-induced interchromosomal recombination rates were assayed by
inoculating appropriate dilutions of cells onto SC-His plates and YPD plates
containing given concentrations of MMS. Colonies were counted after 3 days
incubation at 30°C.
FACS / Flow cytometry analysis
For flow cytometry analysis, approximately 7x106 cells for each time-point were
collected, washed in sterile water, and permeabilized in 70% ethanol. Cells were
suspended in 10 mM Tris pH 7.5 buffer, and RNA together with proteins were
removed by RNaseA (0.4 mg/ml final concentration) and proteinase K (1 mg/ml)
treatment. Subsequently, cells were stained with PI (propidium iodide 50 g/ml). Cell
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cycle profiles were obtained at the FL1 channel (voltage 520) using a FACSCalibur
system operated via the CELLQuest software (Becton Dickinson). Data was
analyzed quantitatively with FlowJo (Tree Star).
V.3 Molecular Biology Techniques
General molecular biology and cloning techniques such as DNA amplification/site-
directed mutagenesis by PCR, restriction digest, ligation or analysis of DNA by
agarose gel electrophoresis were performed according to standard (Sambrook and
Russell, 2001) or manufacturer’s protocols.
General buffers and solutions
TE buffer: 10 mM Tris-HCl, pH 8.0
1 mM EDTA
sterilized by autoclaving
TBE buffer 5x: 90 mM Tris
90 mM boric acid
2.5 mM EDTA, pH 8.0
sterilized by autoclaving
DNA loading buffer 6x: 0.5% SDS
0.25% (w/v) bromophenol blue
0.25% glycerol
25 mM EDTA, pH 8.0
V.3.1 Isolation of DNA
Isolation of plasmid DNA from E. coli
LB medium (5 ml) containing appropriate antibiotic was inoculated with a single E.
coli colony carrying the DNA plasmid of interest and incubated overnight at 37°C.
Plasmids were isolated using the AccuPrep plasmid extraction kit (Bioneer Corp.)
according to the manufacturer’s instructions. The yield of isolated DNA was
determined photometrically.
Isolation of 2 m plasmid DNA from S. cerevisiae
For isolation of 2 m plasmid DNA from the transformed yeast strains the yeast
plasmid isolation kit (GE Healthcare) was used according to the manufacturer’s
instructions.
Isolation of chromosomal DNA from S. cerevisiae
Breaking buffer: 2% Triton X-100
1% SDS
100 mM NaCl
10 mM Tris-HCl, pH 8.0
1 mM EDTA, pH 8.0
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Yeast genomic DNA was isolated for further use as a template for amplification of
genes via PCR. Cells from a stationary culture (10ml) were pelleted by centrifugation
(1500g, 5 min), washed once in 0.5ml water and resuspended in 200 l breaking
buffer. Subsequently, 200 l phenol/chloroform/isoamyl alcohol (24:24:1 v/v/v) and
300mg acid-washed glass beads (425-600 m; Sigma) were added, and the mixture
was vortexed for 5 min. The lysate was mixed with 200 l TE buffer, centrifuged for
5 min at 14000rpm at 23°C and the supernatant transferred to a microcentrifuge
tube. DNA was precipitated by addition of 1ml ethanol (absolute) followed by
centrifugation at 14000rpm for 3 min at room temperature. The pellet was
resuspended in 0.4ml TE buffer and RNA contaminants were destroyed by treatment
with 30 l of DNase-free RNase A (1 mg/ml) for 5 min at 37°C. Afterwards, DNA was
reprecipitated by mixing with 10 l ammonium acetate (3M) and 1ml ethanol
(absolute). After a brief centrifugation at 14000rpm, the pellet was resuspended in
100 l TE buffer.
Alternatively, yeast genomic DNA was isolated using the MasterPure yeast DNA
purification kit (Epicentre) according to the manufacturer’s instructions.
Precipitation of DNA
For ethanol precipitation, 1/10 volume sodium acetate (3M, pH 4.8) and 2.5 volumes
ethanol (absolute) were added to the DNA solution and incubated at –20 °C for
30min. The mixture was centrifuged (13000rpm, 15min) and the pellet was washed
once with 0.5ml of 70% ethanol. Finally, the DNA pellet was air-dried and
resuspended in TE buffer or sterile water.
Determination of DNA concentration
The DNA concentration was photometrically determined by measuring the
absorbance at a wavelength of 260nm (OD260) using the NanoDrop ND-1000
spectrophotometer (PeqLab). An OD260 of 1 equals to a concentration of 50 g/ml
double-stranded DNA.
V.3.2 Molecular cloning
Digestion of DNA with restriction enzymes
The sequence-specific cleavage of DNA with restriction enzymes was performed
according to standard protocols (Sambrook and Russell, 2001) and the instructions
of the manufacturer (NEB). In general, 5 to 10 units of the respective restriction
enzyme were used for digesting 1 g DNA. Typically, the reaction samples were
incubated for 2 hours in the appropriate buffers (NEB) at the recommended
temperature. To avoid re-circulation of linearized vectors, the 5’ end of the vector
DNA was dephosphorylated by incubation at 37°C for 1h with 1 l of the Calf
Intestinal Phosphatase (CIP; NEB).
Separation of DNA by agarose gel electrophoresis
To isolate DNA fragments, DNA samples were mixed with 6x DNA loading buffer and
subjected to electrophoresis using 1.5% agarose gels containing 0.5 g/ml ethidium
bromide at 120V in TBE buffer. Separated DNA fragments were visualized using an
UV transilluminator (324 nm), due to intercalation of ethidium bromide into DNA. The
size of the fragments was estimated using standard size markers (1kb DNA ladder,
Invitrogen).
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Isolation of DNA fragments from agarose gels
After separation by gel electrophoresis, DNA fragments were excised from the
agarose gel using a sterile razor blade. DNA was then extracted from the agarose
block using kits from Qiagen (QIAquick Gel Extraction Kit) or Bioneer (AccuPrep Gel
Purification Kit) according to manufacturer’s instructions and eluted with an
appropriate volume of sterile water.
Ligation of DNA fragments
The amounts of the linearized vector and insert required for the ligation reaction were
estimated by gel electrophoresis of the purified fragments. A ratio of 1:3–1:10 of
vector to insert was used. The 10 l ligation reaction sample contained 100ng of
vector DNA and 10 units of T4 DNA ligase (NEB). The ligation was performed at
16°C for 4-12h. Prior to electroporation of the ligation products into electro-competent
E. coli, the sample was dialyzed against deionized water for 15 min using a
nitrocellulose filter (pore size 0,05 m, Millipore).
DNA sequencing
The DNA sequencing reactions were carried out by the Core Facility of the Max
Planck Institute of Biochemistry using the ABI-Prism 3730 DNA sequencer (Applied
Biosystems Inc.). The 10 l samples contained 1 g DNA and 5pmol primer. The
sequencing reactions and the subsequent sample preparation steps were done with
the DYEnamic ET terminator cycle sequencing kit (GE Healthcare), according to the
instructions of the manufacturer.
V.3.3 Polymerase chain reaction
To specifically amplify DNA fragments from small amounts of DNA templates the
polymerase chain reaction (PCR) techniques were used. PCR was applied for
amplification of DNA fragments for subsequent cloning, amplification of yeast
targeting cassettes (e.g., for chromosomal gene disruptions), screening/sequencing
of genomic recombination events, site-directed mutagenesis and quantitative real-
time PCR.
Amplification of genomic DNA fragments
For the generation of genomic DNA fragments for subsequent cloning/direct yeast
transformation/sequencing, full-length ORFs or selected sequences were amplified
from genomic DNA using the Phusion High-Fidelity DNA polymerase (NEB). PCR
reactions were prepared in 0.2 ml tubes (Biozym) on ice, in a volume of 50-100 l for
preparative PCR. A PCR Mastercycler (Eppendorf) was used for the reaction.
PCR reaction mix: 200 ng genomic DNA
10 l 5x HF/GC buffer
2.0 l dNTP-Mix (10 mM each; NEB)
0.5 l forward primer (100 M)
0.5 l reverse primer (100 M)
0.5 l Phusion DNA polymerase
adjust to 50 l with dH2O
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Cycling parameters (30 amplification cycles):
PCR step T (°C) Time
Initial denaturation 98 30 s
Denaturation 98 30 s
Annealing 55-58 30 s
Elongation 72 30 s/kb
Final elongation 72 10 min
Cooling 4
Amplification of chromosomal targeting cassettes
Chromosomal gene deletions/epitope tagging and other alterations of the yeast
genome were performed by a PCR strategy based on the targeted introduction of
heterologous DNA sequences into genomic locations via homologous recombination
(Janke et al., 2004; Knop et al., 1999). Targeting cassettes were amplified by PCR
using primers containing homology to the genomic target locus. The 100 l PCR
reactions were prepared as indicated below, whereas cycling conditions were
described previously (Janke et al., 2004). After amplification, PCR products were
concentrated by ethanol precipitation, dissolved in 25 l of sterile water and 5 l were
directly used for the transformation of competent yeast cells, while the remaining
DNA was stored at –20°C.
PCR reaction mix: 400 ng genomic DNA/ 100 ng plasmid DNA
10 l 10x Thermopol buffer (NEB)
4.0 l dNTP-Mix (10 mM each; NEB)
1 l forward primer (100 M)
1 l reverse primer (100 M)
3.2 l Taq DNA polymerase
1.6 l Vent DNA polymerase (NEB)
adjust to 100 l with dH2O
Site-directed mutagenesis
To introduce specific point mutations, insertions or deletions in plasmid DNA
sequences, a PCR-based strategy was developed based on the Quick-change
protocol (Stratagene). This method uses two complementary oligonucleotide primers
with the codon/region to be mutated in the middle of the sequence flanked by at least
15-20 additional nucleotides, each corresponding to the target sequence. For this
technique the Pfu Turbo DNA polymerase (Stratagene) has proven to be the enzyme
of choice. Alternatively, the Phusion High-Fidelity DNA polymerase (NEB) was used
according to the manufacturer’s instructions. DNA oligonucleotides for PCR (up to
120 nucleotides-long) were custom-made by Eurofins MWG Operon.
PCR reaction mix: 50-100 ng plasmid DNA
5 l 10x Pfu buffer (Stratagene)
2.0 l dNTP-Mix (10 mM each; NEB)
0.5 l forward mutagenesis primer (100 M)
0.5 l reverse mutagenesis primer (100 M)
1 l Pfu Turbo DNA polymerase
adjust to 50 l with dH2O
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Cycling parameters (25 amplification cycles):
PCR step T (°C) Time
Initial denaturation 95 5 min
Denaturation 95 30 s
Annealing 45-55 45 s
Elongation 72 1 min/kb
Final elongation 72 20 min
Cooling 4
To eliminate template plasmid DNA that does not harbor the mutation, 45 l of the
PCR reaction were treated with 2 l of DpnI endonuclease (and 5 l of the respective
buffer) for 1-2 hours at 37°C. DpnI endonuclease is specific for methylated and
hemimethylated DNA and as most plasmid DNA from E. coli is methylated, DpnI
treatment of the PCR product leads to the selective digestion of the parental DNA
template. After digestion, the PCR product carrying the mutation was purified using
the QIAquick PCR purification kit (Qiagen), eluted with water and directly used for E.
coli transformation. Mutated plasmids were identified by DNA sequencing.
V.4 Biochemistry Techniques
General buffers and solutions
HU sample buffer: 8 M Urea
5% SDS
1 mM EDTA
1.5% DTT
1% bromphenol blue
Laemmli sample buffer: 2% SDS
20% glycerol
100 mM Tris base
60 mM EDTA
1% bromophenol blue
MOPS running buffer: 50 mM MOPS
50 mM Tris base
3.5 mM SDS
1 mM EDTA
Transfer buffer: 250 mM Tris base
1.92 M glycine
0.1% SDS
20% methanol
TBST: 25 mM Tris-HCl, pH 7,5
137 mM NaCl
2.6 mM KCl
0.1% Tween 20
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V.4.1 Preparation of yeast protein extracts
Preparation of denatured protein extracts (TCA-precipitation)
To preserve post-translational modifications, yeast cells were in most cases lysed
under denaturing conditions. For preparation of denatured protein extracts, yeast
cultures grown to an OD600=0.7-1 were pelleted by centrifugation (4000rpm, 4min,
4°C) and immediately frozen in liquid nitrogen. After thawing on ice, the pellets were
lysed by addition of denaturing lysis buffer (1.85M NaOH, 7.5% -mercaptoethanol)
for 15min on ice. For the cell pellet of an OD600=1 typically 150 l of lysis buffer was
used. To precipitate the proteins, the lysate was subsequently mixed with an equal
volume (150 l in case of OD600=1) of 55% (w/v) trichloroacetic acid (TCA) and further
incubated on ice for 15min. The precipitated material was recovered by two
sequential centrifugation steps (13000rpm, 4°C, 15min). Pelleted denatured proteins
were then either directly resuspended in sample buffer (50 l per OD600=1) and stored
at -20°C, or used for downstream processing, e.g., Ni-NTA pull-downs of His-tagged
SUMO conjugates.
Preparation of native protein extracts
Native protein extracts were used for co-immunoprecipitation (co-IP) studies. To
avoid protein degradation and loss of PTMs, the samples were handled as close to
4ºC as possible and protease inhibitors were used. The logarithmically growing yeast
cells (typically 100-200 OD) were harvested by centrifugation (4000rpm, 4min, 4°C),
washed once with pre-cooled PBS and resuspended either in an equal volume of
lysis buffer (Tris-HCl, pH 7.5, 150mM NaCl), or alternatively, in PBS supplemented
with 10% glycerol, containing protease inhibitors: EDTA-complete inhibitor cocktail
(Roche), Pefabloc SC (Roche), and 20mM NEM. After adding 0.5mm zirconia/silica
beads (BioSpec Products, Inc.) the cells were lysed at 4°C using a multitube bead-
beater (MM301 from Retsch GmbH) 6x 1min (frequency 30/s), with 5min cooling
intervals on ice in between. To remove glass beads, lysates were transferred to new
tubes by piggyback method (1000rpm, 2min, 4°C). Collected extracts were then
incubated with 0.5% NP40 for 30min at 4°C and cleared by centrifugation (5000rpm,
5min, 4°C). Next, the protein concentration of the extracts was determined by the
colorimetric analysis following the Bradford method (Bio-Rad Laboratories GmbH),
appropriate aliquots for input control were taken, and the remaining extracts were
directly used for co-IPs.
As an alternative to cell disruption by bead-beating, the grinding of centrifuged cells
in liquid nitrogen was used. To this end, a cell pellet obtained from 100-200 OD of
log-phase yeast culture was broken under liquid nitrogen with a ceramic mortar and
pestle. 800 l of lysis buffer (PBS, 10% glycerol, 0.5% NP40, protease inhibitors) was
added to the frozen powder of broken cells, thawed and suspension was then
transferred to fresh 2ml tube. After incubation of protein extracts for 30min at 4°C
and clearing by centrifugation (5000rpm, 5min, 4°C), the obtained supernatants
further served as inputs for co-IPs.
V.4.2 Gel electrophoresis and immunoblot techniques
SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
For separation of proteins, SDS-PAGE was performed using self-poured (see recipe
below) or pre-cast 4-12% gradient NuPAGE Bis-Tris polyacrylamide gels
(Invitrogen). These gels allow resolution of proteins over a large range of different
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molecular weights (10-200kDa) and do not require stacking gels (gradient mixer
chamber is used instead). Generally, samples were prepared in Laemmli or HU
sample buffer and denatured by heating for 5min at 95°C or 10min at 65 °C,
respectively. Next, electrophoresis was carried out at a constant voltage of 140V
using MOPS running buffer. The All Blue Precision Plus protein pre-stained standard
(Bio-Rad) was used as a molecular weight marker. The gels were subsequently
subjected to Coomassie blue staining (Thermo Scientific PageBlue protein staining
solution applied for 1h to overnight at 4°C with subsequent background destaining in
dH2O) or immunoblotting.
Solutions for pouring 4-12% Bis-Tris SDS-PAGE gradient gels using gradient mixer:
4% solution 12% solution
30% acrylamide / 0.8% bis-acrylamide
(ProtoGel; National diagnostics)
2.2 ml 6.6 ml
2.5 M Bis-Tris-HCl, pH 7.5 2.4 ml 2.4 ml
65% sucrose — 1.2 ml
10% SDS 82.5 l 82.5 l
10% ammonium persulfate 82.5 l 82.5 l
TEMED (Sigma) 16.5 l 16.5 l
dH2O 11.85 ml 6.2 ml
Western blot analysis
For western blot analysis, proteins separated by PAGE were transferred to
polyvinylidene fluoride (PVDF) membranes (Immobilon-P, 0.45 m pore size;
Millipore) using a wet tank blot system (Hoefer). The blotting was performed in fresh
transfer buffer at a constant voltage of 70V for 90min at 4ºC. Subsequently,
membranes were blocked for 30min using 5% skim milk powder (Fluka) dissolved in
TBST and further incubated ON with primary antibody at 4ºC with constant shaking.
After two washes with TBST (5min each), blots were incubated with the respective
horseradish peroxidase (HRP)-coupled secondary antibody (Dianova; 1:5000
dilution) for 2h in TBST at room temperature. After four further washes with TBST
(5min each), the signals were obtained by chemiluminescence using ECL, ECL-Plus
or ECL advanced kits (Amersham/GE Healthcare) according to the manufacturer’s
instructions. Signal detection was performed using a luminescent image analyzer
LAS-3000 (Fujifilm) equipped with a high-sensitivity CCD camera.
Peptide array immunoblotting
Peptide arrays were synthesized automatically using SPOT technology with the
MultiPep instrument from INTAVIS Bioanalytical Instruments AG as previously
described (Brandt et al., 2003). 12-mer peptides harboring predicted SUMO-
interacting motif (SIM) with endogenous flanking sequences or mutated SIM version
with two hydrophobic residues replaced by alanines were produced in
quadruplicates. The peptide array membrane was blocked with 5% skim milk in
TBST for 1h at room temperature, then poly-SUMO-3 chains (ULC-310) from
BostonBiochem were added to a final concentration of 1 g/ml and incubated ON at
4°C. The membrane was then washed extensively with TBST before the monoclonal
SUMO-2/3 antibody (1E7; MBL) was added. The membrane was incubated with the
antibody at room temperature for another 2h prior to standard chemiluminescent
detection.
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Primary antibodies
Polyclonal antibodies against Rad52 are described (Sacher et al., 2006), polyclonal
antibodies against S. cerevisiae RFA (AS07 214) were obtained from Agrisera,
polyclonal antibodies against Rad51 (y-180), Rad53 (yC-19) and Exo1 (yD-17), and
the monoclonal antibody against the HA-epitope (F-7) were purchased from Santa
Cruz Biotechnology, monoclonal antibody against the MYC-epitope (9E10) was from
SIGMA, and monoclonal Pgk1 antibody (22C5) was from Invitrogen. Polyclonal
antibodies directed against Histone H3 trimethylated at lysine 4 (H3K4me3) were
from Diagenode (pAb-003-050), monoclonal Dpm1 antibody (5C5A7) was from
Molecular Probes, and monoclonal SUMO-2/3 antibody (1E7) was from MBL.
V.4.3 Protein purification and binding experiments
Purification of recombinant proteins from E. coli
His-tagged recombinant proteins were overexpressed in BL21(DE3)/RIL or
Rosetta 2(DE3)pLysS E. coli strains and purified by Ni-NTA affinity chromatography
either under native, or denaturing conditions (with subsequent protein refolding
during dialysis steps). For purification under native conditions, cell pellets collected
from 1l bacterial culture were resuspended in Ni-NTA lysis buffer (100mM NaCl,
5mM MgCl2, 40mM Tris-HCl, pH 7.5, 20mM imidazole), lysed using the Emulsiflex
C5 cell disruptor (Avestin) and sonicated for 2min using a Sonopuls HD2200
sonicator (Bandelin). After centrifugation (23000g, 30min, 4°C) the supernatant was
incubated for 2h with 600 l of a Ni-NTA Agarose (Qiagen) 50% slurry at 4°C with
constant rotation. The agarose was subsequently packed into 5ml polypropylene
column, washed several times with the Ni-NTA washing buffer (100mM NaCl, 5mM
MgCl2, 40mM Tris-HCl, pH 7.5, 50mM imidazole) and bound proteins were eluted by
repeated incubations with the Ni-NTA elution buffer (100mM NaCl, 5mM MgCl2,
40mM Tris-HCl, pH 7.5, 250mM imidazole). The eluted protein fractions were
analyzed by PAGE and Coomassie blue staining for purity, pooled together and
dialyzed ON against PBS at 4°C. For purification under denaturing conditions, the
protein pellet after cell lysis and centrifugation steps was further resuspended in
urea-containing buffer (8M urea, 100mM NaH2PO4, 10mM Tris-HCl, pH 6.3, 20mM
imidazole). Following purification and elution from Ni-NTA agarose, the dialysis of
denatured recombinant protein was performed against buffers with reducing urea
concentrations (6M, 4M, 2M urea) and finally against PBS in a sequential manner in
order to promote protein refolding. Because purified Siz2 (Nfi1) contains an SP-RING
zinc-finger domain, 100mM ZnCl2 was added to the buffers during refolding. After
dialysis the protein concentration was quantified by measuring the absorption at
280nm in an ND1000 spectrophotometer (Nanodrop Technologies), the protein
aliquots were frozen in liquid nitrogen and stored at –80°C for downstream
applications, e.g., EMSA.
Ni-NTA chromatography of HisSUMO conjugates from denatured yeast extracts
For isolation of in vivo SUMOylated substrates from yeast cells expressing N-
terminally His-tagged Smt3, denatured protein extracts were prepared and Ni-NTA
chromatography was carried out as described previously (Hoege et al., 2002; Sacher
et al., 2005). In general, 200 OD of logarithmically growing cells were harvested by
centrifugation (4000rpm, 4min, 4°C), washed with pre-chilled water, transferred to
50ml falcon tube and lysed with 6ml of 1.85M NaOH / 7.5% -mercaptoethanol for
15min on ice. The proteins were precipitated by adding 6ml of 55% TCA and another
15min incubation on ice (TCA-precipitation, described above). Next, the precipitate
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was pelleted by centrifugation (3500rpm, 15min, 4°C), washed twice with water and
finally resuspended in buffer A (6M guanidine hydrochloride, 100mM NaH2PO4,
10mM Tris-HCl, pH 8.0, 20mM imidazole) containing 0.05% Tween-20. After
incubation for 1h on a roller at room temperature with subsequent removal of
insoluble aggregates by centrifugation (23000g, 20min, 4°C), the protein solution was
incubated ON at 4°C with 50 l of Ni-NTA magnetic agarose beads (Qiagen) in the
presence of 20mM imidazole. After ON incubation, the beads were washed three
times with buffer A containing 0.05% Tween-20 and five times with buffer C (8M
urea, 100mM NaH2PO4, 10mM Tris-HCl, pH 6.3) with 0.05% Tween-20. HisSUMO
conjugates bound to the beads were finally eluted by incubation with 30 l of 1% SDS
at 65°C for 10min, dried in a SpeedVac (Eppendorf) for 30min and heated at 65°C
for 10min in 25 l of HU sample buffer for subsequent analysis by SDS-PAGE and
immunoblotting. To control for pull-down efficiency, SUMOylated Pgk1 species were
detected by Western blot analysis using an anti-Pgk1 antibody.
Co-immunoprecipitation (co-IP) of proteins from native yeast extracts
Protein-protein interactions from native yeast protein extracts were analyzed by co-
IPs. In general, native extracts of yeast strains expressing C-terminally HA-/Myc-
epitope-tagged proteins of interest under the control of their endogenous promoters
(or an untagged version as a control) were incubated with 25 l of the respective anti-
HA affinity matrix (Roche Diagnostics GmbH) or anti-MYC agarose conjugate
(SIGMA-ALDRICH) for 2 hours at 4°C with head-over-tail rotation. Background
binding to the beads was removed by stringent washing: 5 times with 1ml lysis buffer
(PBS, 10% glycerol, 0.5% NP40, protease inhibitors) and 3 times with lysis buffer
lacking detergent. After extensive washing, the beads were dried by aspiration
(0.4mm needle) and bound precipitated protein complexes were eluted from the
beads by incubation for 10min at 65°C in 30 l of HU sample buffer. Proteins were
then resolved on NuPAGE 4%-12% gradient gels (Invitrogen), and analyzed by
standard immunoblotting techniques. Western blots were quantified with ImageJ
software.
Detecting protein-DNA interactions by electrophoretic mobility shift assays
N-terminally His-tagged wild-type Siz2 protein and its SAP domain mutant variants
were cloned into pET28a(+) (Novagen), overexpressed in E. coli and affinity purified
using Ni-NTA Agarose (Qiagen). Protein-DNA binding interactions were
characterized by electrophoretic mobility shift assays (EMSA) using the Thermo
Scientific LightShift Chemiluminescent EMSA Kit according to the manufacturer’s
instructions. Biotin-TEG 5’-end-labeled oligos were synthesized by Eurofins MWG
Operon and 20 fmol were used for each binding reaction. DNA structures,
representing replication forks or 3’-end ssDNA overhangs, were pre-assembled in
vitro by first heating appropriate complementary oligos to 95°C and then slowly
cooling the mix to 22°C allowing the annealing to take place.
V.4.4 Chromatin immunoprecipitation, binding and related assays
HO-endonuclease-mediated DSB induction
Strains containing the HO gene under the control of a GAL promoter (either
chromosomally integrated or expressed from a centromeric pGAL-HO plasmid) were
grown in YP-lactate, and HO expression was induced by the addition of 2%
galactose. DSB formation at MAT locus could be monitored by real time quantitative
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PCR with primers flanking the HO-induced cut site. Time-course experiments were
essentially done as described (Lee et al., 1998; Sugawara et al., 2003). Samples for
ChIP and DSB repair efficiency measurements were taken at indicated time points
and processed as described below.
Chromatin immunoprecipitation (ChIP)
ChIP was performed as described (Aparicio et al., 2005; Kalocsay et al., 2009).
Chromatin was sheared to an average length of 300-500 bp by water bath sonication
(Bioruptor UCD-200, Diagenode). Polyclonal antibodies against Rad51 (y-180) from
Santa Cruz Biotechnology and the monoclonal antibody against the MYC-epitope
(9E10) from SIGMA were used. Quantitative PCR was performed on a Light Cycler
LC480 System (Roche) using the following primer pairs: 0.2 kb and 5.7 kb distal to
the DSB P+0.2 and P+5.7 as described (Sugawara et al., 2003), PMAT spanning the DSB
(5’-gagcatattactcacagtttggctc-3’, 5’-ggatagctatactgacaacattcag-3’), and control locus
primers PMDV1 (5’-gcgtgcctggtcacaggttcatacgac-3’, 5’-tcatacggcccaaatatttacgtccc-3’).
Signals distal to the DSB were normalized to an unaffected control locus (MDV1)
using the formula: Fold enrichment = (IP[test]/input[test])/(IP[control]/input[control]).
All signals were finally normalized to 1 for the signal before HO induction to visualize
protein factor recruitment after the DSB induction. The efficiency of DSB induction
was measured by quantitative PCR with primers PMAT spanning the break.
Real-time (RT)-PCR quantification
Quantitative real-time (RT)-PCR was performed on a Light Cycler LC480 System
using the Light Cycler 480 SYBR Green I Master hot-start reaction mix (Roche
Diagnostics GmbH). 18 l master-mix containing primers, SYBR Green I Master and
H2O was pipetted into 384-well Light Cycler plates and either 2 l ChIP sample
(undiluted) or 2 l input sample (diluted 1:10) was added. Reactions were done in
triplicates, and pipetting was carried out using a CAS-1200 automated PCR setup
robot (Corbett Lifescience). DNA concentrations were quantified from the second
derivative maximum of the Light Cycler PCR amplification curves using the input
sample dilution series as a standard for each primer pair. Amplification was followed
by a melting curve analysis, which served as quality control to ensure that primers
were specific and only single PCR product was amplified per reaction.
Light Cycler parameters for ChIP RT-PCR (45 amplification cycles):
PCR step T (°C) Time
Initial denaturation 95 10 min
Denaturation 95 10 s
Annealing 55 10 s
Elongation 72 16 s
Melting curve analysis
Cooling 4
Monitoring of DSB repair kinetics by RT-PCR
The speed of HO-induced DSB repair by homologous recombination (yeast mating
type switching) was monitored by quantitative real-time (RT)-PCR using the primer
pair: PA (5’-gcagcacggaatatgggact-3’) and PB (5’-atgtgaaccgcatgggcagt-3’), which
prime distal to MAT and within HML-Y  (Holmes and Haber, 1999; White and Haber,
1990). RT-PCR was performed on genomic DNA samples isolated using MasterPure
Yeast DNA Purification Kit from Epicentre Biotechnologies. The only difference to the
ChIP RT-PCR protocol described above was that the annealing temperature for the
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PA/PB primer pair was 57°C. The signals were normalized to an unaffected control
locus (MDV1) on chromosome X and the WT 3h time-point was set to 100%.
Chromatin fractionation
The chromatin binding assay was adapted from previously published protocols with
some modifications (Liang and Stillman, 1997; Wang et al., 2009). Briefly, for large
scale chromatin fractionation, native yeast protein extract was prepared from 200 OD
of logarithmically growing culture by grinding the cells under liquid nitrogen in
chromatin isolation buffer and subsequently cleared from cell debris by mild
centrifugation (1800g, 10min, 4°C) without pelleting the chromatin fraction (verified
by isolation of DNA and agarose gel electrophoresis). The resulting whole cell extract
(WCE) was carefully applied on top of the 30% sucrose cushion of equal volume and
centrifuged for 30min at 20000g at 4°C. The supernatant containing soluble protein
fraction (SOL) was carefully collected from the top of the cushion, sucrose aspirated
and the pellet containing the chromatin fraction (CHR) was either directly
resuspended in HU sample buffer for subsequent SDS-PAGE and Western blot
analysis, or collected for downstream assays, e.g., denaturing Ni-NTA pull-downs of
chromatin enriched HisSUMO conjugates. To control for chromatin fractionation
efficiency, the levels of histone H3 lysine-4 tri-methylation and the ER-membrane
protein Dpm1 were detected in collected fractions.
V.5 Mass Spectrometry Analyses
SILAC-based mass spectrometry
For the detection of SUMO-conjugates enriched upon MMS- and UV-light treatment
stable isotope labeling with amino acids in cell culture (SILAC) was used. Yeast cells
deficient in biosynthesis of lysine and arginine ( lys1 arg4) expressing His-tagged
Smt3  (HisSUMO) were grown for at least 10 divisions in SC media supplemented
either with unlabeled (Lys0, Arg0; Light) or heavy isotope labeled amino acids (Lys8,
Arg10; Heavy) from Cambridge Isotope Laboratories. Exponentially dividing cells
grown in heavy media were treated with 0.2% MMS for 90 minutes, harvested and
combined with equal amount of untreated cells grown in light media. Alternatively,
cells grown in heavy media were UV-irradiated (80 J/m2) instead of MMS-treatment.
Then, HisSUMO conjugates were isolated using denaturing Ni-NTA pull-down,
separated on 4-12% Bis-Tris gel, the whole lane was excised in 10 slices, proteins
were digested with trypsin and analyzed by LC-MS/MS at the Core Facility of the
Max Planck Institute of Biochemistry using LTQ-Orbitrap mass spectrometer. SILAC
ratios for quantified proteins were plotted against the sum of the relevant peptide
intensities using the GraphPad Prism version 5.0 for Mac OS X, and the proteins
were colored according to values of MaxQuant Significance(B).
Detection of SUMOylation sites
For the detection of SUMOylation sites, proteins were digested with trypsin
(Shevchenko et al., 1996) or thermolysin. Extracted peptides were analyzed by
Orbitrap mass spectrometry (Olsen et al., 2005) and identified using MaxQuant
software (Cox and Mann, 2008). The dataset was searched for peptides harboring
extra masses on lysines (branched peptides) corresponding to proteolytic remnants
of the C-terminal tail of SUMO. In case of trypsin digestion, extra masses
corresponding to a SUMO remnant with the sequence EQIGG were expected; in
case of thermolysin, with the sequence IGG.
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